tag:blogger.com,1999:blog-58806774664983544622024-03-14T14:23:00.235+05:30Truth about FitnessFITNESS for allKoushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.comBlogger85125tag:blogger.com,1999:blog-5880677466498354462.post-28272541588567158652014-09-16T16:28:00.002+05:302014-09-16T16:28:58.613+05:30Spinal Exercises + Right Moves = English & Tamil <div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjvmXTovwf7f2fAdFnIZwmxZuzooydcT1_YblUQUiaWUJJtFY1jj0QgK0TlTzwAHMpPl_ylA_fOqSVF7etsMQoAt8ojWLysde42f-IvuVLDF_pLdKIItdoQB74vdyzy6raGFi4hx4AV4aw/s1600/Spinal+exercises+English.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjvmXTovwf7f2fAdFnIZwmxZuzooydcT1_YblUQUiaWUJJtFY1jj0QgK0TlTzwAHMpPl_ylA_fOqSVF7etsMQoAt8ojWLysde42f-IvuVLDF_pLdKIItdoQB74vdyzy6raGFi4hx4AV4aw/s1600/Spinal+exercises+English.JPG" height="320" width="225" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhw_Ueq5SjdhUBWzTmhtJDCqC56_biiSdqiihRBIqShjeagTRVf0H8I_9fy9vzR4S3__ko20whCtI_S2WDMrhKpug99S12NlB8HWUhJEKOWE9zcU-l3gkphYc2tMprkATL0h8zvXpBGfp4/s1600/Spinal+exercises+Tamil.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhw_Ueq5SjdhUBWzTmhtJDCqC56_biiSdqiihRBIqShjeagTRVf0H8I_9fy9vzR4S3__ko20whCtI_S2WDMrhKpug99S12NlB8HWUhJEKOWE9zcU-l3gkphYc2tMprkATL0h8zvXpBGfp4/s1600/Spinal+exercises+Tamil.JPG" height="320" width="237" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBpsJANip8rYFg9XDNq54dF-UxpTt_rBuSHZyX0GSpSq9LbWxsXqo-f2XgKaDv0rDKu1q1DNxIhgv-DmvsyPwP7FLsokGFMbQ7pobUYeFix97jR-3gr5k2ePOFcXlHjZ-D8HbiA_Gw_K0/s1600/Right+moves++English.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBpsJANip8rYFg9XDNq54dF-UxpTt_rBuSHZyX0GSpSq9LbWxsXqo-f2XgKaDv0rDKu1q1DNxIhgv-DmvsyPwP7FLsokGFMbQ7pobUYeFix97jR-3gr5k2ePOFcXlHjZ-D8HbiA_Gw_K0/s1600/Right+moves++English.JPG" height="320" width="259" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjJemJsjYaN8lnrpix_Msp9b88zM0_vV0fmchKe3UKmmyfy8fndl10EXwCsUG0tLtnBl5g5Ym7BfuFWQdNSLzVZNE0MDO2q-ylfkd1_OpiuD0yekn7OtbZ8VXKvFA81EmL-h2V8X__Y2XM/s1600/Right+moves+Tamil.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjJemJsjYaN8lnrpix_Msp9b88zM0_vV0fmchKe3UKmmyfy8fndl10EXwCsUG0tLtnBl5g5Ym7BfuFWQdNSLzVZNE0MDO2q-ylfkd1_OpiuD0yekn7OtbZ8VXKvFA81EmL-h2V8X__Y2XM/s1600/Right+moves+Tamil.JPG" height="320" width="258" /></a></div>
<br /></div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-16687201008458180672014-01-24T11:07:00.004+05:302014-04-28T13:14:33.807+05:30BMR calculator<div dir="ltr" style="text-align: left;" trbidi="on">
<h1 class="entry-title" style="color: #ff6600; font-family: Oswald, arial, serif; font-size: 30px; font-weight: normal; line-height: 1.25; margin: 0px 0px 10px; padding: 0px; text-align: center;">
BMR Calculator</h1>
<div class="entry-content" style="color: #333333; font-family: Arial, serif; line-height: 20px; overflow: hidden;">
<div style="font-size: 13px; line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
The <span style="color: #cc3300;"><strong>BMR calculator</strong></span> below will provide you with your own unique BMR based on your gender, height, weight, age and activity level.</div>
<div style="font-size: 13px; line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
To understand the power of this simple calculator, you first need to understand that the number of calories that your body burns each day <em><strong>to remain at your current weight</strong></em> is referred to as your basal metabolic rate – your BMR.</div>
<div style="font-size: 13px; line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
<img align="left" alt="Losing Weight With The BMR Calculator" src="http://safedietplans.com/wp-content/uploads/scale-150x150.jpg" height="150" style="height: auto; margin-left: 0px; margin-right: 10px; max-width: 100%;" title="Losing Weight With The BMR Calculator" width="150" />The next important concept is that <strong>1 pound = 3500 calories</strong>. So if you are trying to lose weight, keep in mind that cutting 500 calories per day equals 3500 calories per week – which means you lose 1 pound per week.</div>
<div style="font-size: 13px; line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
When you use the bmr calculator below, obviously your gender, age, height and weight are known values. <em>The one thing that can vary is your activity level.</em></div>
<div style="font-size: 13px; line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
Please be sure to ‘play’ with the activity level button - it will open your eyes as to how movement, exercise and a generally higher activity level can dramatically help you lose weight.</div>
<div style="font-size: 13px; line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
<br /></div>
<div style="line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
<span style="font-size: large;">.......PLEASE CHECK THIS WEBSITE FOR FINEST INFO ON BMR online calculator & DIET that work advices .....</span></div>
<div style="line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
<span style="font-size: 13px;"> </span><span style="font-size: large;"> <a href="http://safedietplans.com/bmr-calculator">http://safedietplans.com/bmr-calculator</a></span></div>
<div style="font-size: 13px; line-height: 1.5625; margin-bottom: 15px; padding: 0px;">
<br /></div>
</div>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-29995208924930087472013-08-28T14:59:00.000+05:302013-08-28T15:00:41.045+05:30Top 12 Reasons to Use Carnitine<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Taking carnitine with omega-3 fish oil is one of the simplest things you can do to lose weight and raise your energy levels. The cool thing about carnitine is that by elevating the amount of carnitine stored in your muscles, you will see improvements in your quality of life. Fat loss and more energy are two of these benefits, but taking carnitine is known to improve all of the following:<br />
• <span class="Apple-converted-space"> </span><i style="border: 0px; margin: 0px; padding: 0px;"> High-intensity work capacity<br style="border: 0px; margin: 0px; padding: 0px;" />• Increase athletic performance<br style="border: 0px; margin: 0px; padding: 0px;" />• Speed your recovery from intense exercise<br style="border: 0px; margin: 0px; padding: 0px;" />• Make your brain work better<br style="border: 0px; margin: 0px; padding: 0px;" />• Prevent oxidative stress that leads to longer term health problems such as cardiovascular disease, diabetes, and chronic inflammation</i></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<br style="border: 0px; margin: 0px; padding: 0px;" />
A recent study in<span class="Apple-converted-space"> </span><i style="border: 0px; margin: 0px; padding: 0px;">The Journal of Physiology</i><span class="Apple-converted-space"> </span>provides groundbreaking evidence that carnitine supplementation can improve athletic performance, something that researchers have had trouble proving for years. Emerging research on the benefits of carnitine for health in conjunction with evidence that clarifies the best ways to take carnitine (insulin must be present in the body for carnitine to be delivered into the muscle), make it time to revisit this amino acid. Let’s look at the top ten health benefits of elevating your carnitine levels with a focus on achieving optimal body composition.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<br style="border: 0px; margin: 0px; padding: 0px;" />
<b style="border: 0px; margin: 0px; padding: 0px;">1) Take Carnitine to Burn Fat: The Basics</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Carnitine is an amino acid composite that is made from lysine and methionine. There are a couple of different forms of carnitine, such as acetyl-L-carnitine and L-carnitine tartrate, and we’ll look at which forms you should be taking and when. In this article, unless otherwise stated, “carnitine” will be used to refer to L-carnitine tartrate.<br />
<br />
Carnitine is a potent fat burner because it is responsible for the transport of fats into the cells to be used for energy in the body. By raising the level of muscle carnitine, you support the fat burning process, and because your body becomes more efficient at processing fuel, it will increase your energy levels. Elevating carnitine will also improve physical performance by burning more fat, sparing glycogen, clearing muscle lactate, and increasing anabolic hormone response.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">2) Pair Carnitine and Omega-3 Fish Oils For Fat Loss</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
For carnitine to be effective, you need to ensure you have adequate levels of omega-3 fish oils in the body. In order for your body to actually “load” carnitine that you take in supplement form into the muscles where you want it, it has to be accompanied by insulin.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Omega-3 fatty acids come into the equation because they will improve the health of every cell in your body if you get enough of them. The cells are made up of two layers of lipids or fats, which will be composed of good fats or bad fats depending on the type you eat. If the cell lipid layers are made up of omega-3s, the cell will be generally healthier, and it will also make them more sensitive to insulin. Having your cells be more sensitive to insulin allows your body to get the most energy production out of supplemental carnitine.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
I mention this relationship between omega-3s and carnitine because you won’t optimally benefit from taking carnitine unless you have already attended to your omega-3s. In working with obese clients, I’ve found that using high doses of fish oil with carnitine tartrate will allow the fat to start to come off.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Omega-3s increase metabolic rate by increasing cell activity and fat burning. Carnitine is the delivery system for long chain fatty acids such that the less carnitine you have in the body, the fewer fatty acids that get into the cell, meaning you don’t burn them for energy. Instead, the fatty acids go into a depository and are stored as fat. By elevating carnitine, fat burning increases and you give the cell the right genetic machinery to raise metabolism. You’ll have more energy, feel more motivated, and any excess fat begins to come off.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">3) No Need For Carbs: Carnitine with Omega-3s for Fat Loss</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
The new study in The Journal of Physiology, which I will highlight below starting with #5, showed that taking carnitine with carbs is effective for elevating muscle carnitine levels and improving athletic performance. But carbs aren’t necessary as long as you get adequate omega-3s. A study in the Annals of Nutrition and Metabolism showed that combining carnitine, omega-3s, and polyphenols resulted in lower blood lipid levels and better cellular energy production, which has the implication of fat loss if the study had been of longer duration—it was only 12 weeks.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Researchers found that triglycerides were lowered by 24 percent and free fatty acids decreased by 29 percent compared to a placebo group that had no changes. These changes indicate healthier markers of cholesterol, better energy use, and fat burning that will lead to fat loss. Additionally, genes that increase fat burning in the body were “activated” indicating a better metabolic profile. Take note that the polyphenols were included to raise antioxidant levels and fight oxidative stress that leads to chronic inflammation and poor cardiovascular health, among other things. They are not necessary for the carnitine to work its magic.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">4) Carnitine Fights Visceral Belly Fat</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Visceral belly fat is one of the toughest fats to lose once you’ve got it, and it causes numerous health problems. Once you begin to gain visceral fat around the belly, it will lead to fat gain within the organs such as the liver, the heart, or even in muscle. Fat gain in the liver leads to non-alcoholic fatty liver disease, while epicardial fat is a type of visceral fat that is deposited around the heart and is considered a metabolically active organ, altering heart function.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Raising your carnitine levels will fight this visceral fat gain because it increases fat burning, which has the effect of taking triglycerides and low-density lipoproteins out of the system so that they don’t build up causing high cholesterol and atherosclerosis. A new research study in the journal Food and Chemical Toxicology illustrates this. Researchers gave a carnitine supplement to mice who were fed a high-fat diet in order to make them gain weight. In comparison to a group of mice fed a placebo, the carnitine group gained substantially less visceral and subcutaneous fat (fat that is right below the surface of the skin that you can pinch with your fingers). The placebo group exhibited the beginning stages of non-alcoholic fatty liver disease and atherosclerosis, neither of which were evident in the carnitine group.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">5) Take Carnitine To Improve Performance</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
The study in The Journal of Physiology is the first to show that muscle carnitine content can be increased in humans through diet . Once carnitine is elevated, metabolism in the body is dependent on the intensity of exercise, allowing for better energy use and performance.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Researchers gave a placebo or a supplement of carnitine tartrate and carbs (2 g carnitine with 80 g of carbs twice a day) to experienced athletes who were training for a triathlon three to five times a week. At various points throughout the study subjects performed the following exercise tests: two thirty-minute repeated bouts of exercise (the first at 50 percent of maximal oxygen uptake and the second at 80 percent), followed by an all-out 30-minute performance trial.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
After 24 weeks of supplementation, the carnitine group increased performance from baseline by 11 percent in the exercise trials compared to no improvement in the placebo group. Participants who took carnitine also rated the trial and the exercise bout they performed at 80 percent of max to be easier than at baseline, while the placebo had no difference in rating of perceived exertion (RPE).</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Two key points from this study are essential for making carnitine supplementation effective at elevating performance. First, it takes a long supplementation period to raise muscle carnitine levels and reap the benefits of improved energy production. In this study after three months there were no changes in performance or RPE from baseline, but after 6 months those improvements were pronounced and statistically significant. Somewhere between 3 and 6 months is the magic number, meaning taking carnitine is a lifestyle supplement just like omega-3s are.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Second, carnitine doesn’t accumulate or “load” in muscle unless accompanied by high insulin concentrations. This explains why many previous studies have NOT shown increases in muscle carnitine after taking it in multi-gram doses. In this study the carnitine was taken with carbs because the carbs triggered insulin release, which allowed the carnitine to load into the muscle. Take note that there is a big focus in the health world on minimizing insulin secretion from carbs for optimal body composition. This is critical, but be aware that insulin is actually a potent anabolic hormone if the cells are sensitive to it and if appropriate levels are present.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Pairing carnitine with carbs is one option, but as shown in #3, carnitine can also be paired with omega-3s, which may be more appropriate for individuals whose primary goal is to lose fat. In my experience, best fat loss results come from a 5 to 1 ratio of omega-3s to carnitine. If you’re taking 20 grams of omega-3s, you’d pair it with 4 grams of carnitine. But, if you’re more conservative with your omega-3 supplementation, you can start with 1 to 2 grams of carnitine and work up to 4 grams, which was the dose used in this study.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">6) Increase Work Capacity With Carnitine</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Another benefit of raising carnitine levels is that you’ll have a greater work capacity, but it will not feel as physically difficult. You’ll be able to lift more weight, complete more reps, or run faster and longer, but with more ease. This is because higher muscle carnitine levels help decreases pain, muscle damage, and markers of metabolic stress from high-intensity exercise by decreasing lactic acid production.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
A higher level of carnitine increases energy production, but it also has the effect of accelerating muscle buffering by maintaining the pH of the muscle and minimizing the accumulation of hydrogen ions. Basically, carnitine helps eliminate the byproducts of intense exercise that cause pain and muscle damage (the burning you may feel when training hard), allowing you to work harder.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
In the<span class="Apple-converted-space"> </span><i style="border: 0px; margin: 0px; padding: 0px;">Journal of Physiology</i><span class="Apple-converted-space"> </span>study, results show how higher muscle carnitine levels increase work capacity by reducing lactate accumulation in the muscles. Following the exercise bout at 80 percent of maximal, muscle lactate buildup was 44 percent lower in participants that supplemented with carnitine compared to the control group. Following the exercise bout at 50 percent of maximal, the carnitine group used 55 percent less muscle glycogen than the control group indicating that they burned more fat for fuel and had improved energy production. ??</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
The combination of less lactate buildup and greater fat burning in the two exercise bouts allowed the carnitine group to increase work output by 35 percent, while having a lower RPE. In simple terms, taking carnitine is a no-brainer if you want to improve body composition by burning more fat and be able to train at a higher level!</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">7) Enhance Recovery with Carnitine</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Take carnitine to speed both short- and long-term recovery from intense training and you’ll have less pain, soreness, and feel more energized. Muscle lactate buildup is a limiting factor that inhibits performance and causes muscle pain, meaning that if you produce less of it and are able to clear it faster, you will have a faster recovery.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Taking carnitine will also support an anabolic response to exercise by up-regulating the androgen receptors, which will “help to mediate quicker recovery,” according to one research group. Two studies led by William J. Kraemer tested the hormonal response to taking carnitine tartrate. In one of these studies, supplementing with carnitine for 21 days produced an increase in the resting content of the androgen receptors that bind with testosterone, indicating a better anabolic environment. Following resistance exercise, participants also had increased androgen receptor content that indicated greater cellular uptake of testosterone and increased protein synthesis. Enhanced protein synthesis allows tissue that was damaged during training to regenerate faster and speed recovery.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
The second study also had participants take carnitine or a placebo for 21 days and found that after intense resistance training, the carnitine group had reduced muscle tissue damage (assessed by MRI) and increased IGFBP-3 levels (a binding protein that promotes tissue synthesis). Researchers suggest carnitine supplementation helps promote recovery by producing “more undamaged tissue, (and a) greater number of intact receptors that would be available for hormonal interactions.”</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">8) Improve Cognitive Performance with Acetyl-L-Carnitine and Increase Motivation</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
A form of carnitine called acetyl-l-carnitine will give you superior brain function and increase motivation, meaning it’s a great supplement for people who want to lose weight but feel unmotivated to exercise. Acetyl-l-carnitine helps DHA omega-3 fish oils work their magic on the brain—just like carnitine tartrate, this form needs to be taken with omega-3s in order to facilitate fat burning for energy in the brain.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<br style="border: 0px; margin: 0px; padding: 0px;" />
Acetyl-l-carnitine is a powerful antioxidant and can detoxify the brain of heavy metals. I suggest pairing it with Alpha Lipoic Acid along with DHA because all together they support dopamine levels, while increasing attention span and motivation. For depressed people or those who need to lose weight, it works wonders on motivation and self-initiative, both with training and work-related tasks. And by taking acetyl-l-carnitine, you’ll still benefit from improved energy, physical performance, work capacity, and a speedy recovery, all benefits to help you achieve a lean physique.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
A number of research studies support the use of acetyl-l-carnitine for a better brain. For example, a new study in the Scandinavian Journal of Gastroenterology found that giving patients with liver dysfunction acetyl-l-carnitine significantly improved their physical function, general health, overall mood, and well-being. They also reported less depression and anxiety.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">9) Prevent Diabetes and Improve Insulin Health With Carnitine</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Carnitine is emerging as a supplement that can prevent diabetes because of how it improves fat metabolism. It can counter the diseases of metabolic syndrome by preventing atherosclerosis, and supporting cardiovascular health, while inducing fat loss.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Plus, raising carnitine levels will fight related diabetes factors because it has antioxidant properties, meaning it abolishes free radicals and reduces oxidative stress. The key to improving your insulin health and losing fat with carnitine is to understand that the following interrelated factors must be present for this method to be effective:<br />
<i style="border: 0px; margin: 0px; padding: 0px;">A) </i> Take carnitine with omega-3 fish oils. Remember, a 1 to 5 ratio is suggested.<br />
<i style="border: 0px; margin: 0px; padding: 0px;">B) </i> Adopt this supplementation protocol as a lifestyle habit, not a one time thing. Research shows androgen receptors are up-regulated after three weeks, triglycerides are improved after three months, but muscle carnitine level isn’t elevated for close to six months.<br />
<i style="border: 0px; margin: 0px; padding: 0px;">C) </i> A high-protein diet and exercise will make it much more effective</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<b style="border: 0px; margin: 0px; padding: 0px;">10) Carnitine Supplementation Counters Cachexia or Wasting Disease</b></div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Raising carnitine levels can counter cachexia or wasting syndrome that is associated with diseases including cancer, AIDS, heart disease, and lung disease. Although this is not a common problem among the Poliquin readership, it should be mentioned here because carnitine supplementation is able to restore metabolic parameters in individuals with cachexia and thereby help fight the progression of life-threatening diseases.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Cachexia is characterized by progressive weight loss, muscle loss, cognitive decline, poor insulin health, inflammation, and poor organ function, among other things. Emerging evidence shows that in patients with cancer cachexia, carnitine is depleted and metabolism is impaired. A new study in Nutrition Journal found that giving carnitine to men with pancreatic cancer who were suffering from cachexia improved their lean mass, increased energy metabolism, and improved their quality of life. Using carnitine produced a trend to increased survival over the course of the study and towards reduced hospital stays.<br />
<br style="border: 0px; margin: 0px; padding: 0px;" />
<b style="border: 0px; margin: 0px; padding: 0px;">11) Take Carnitine to Improve Male Fertility</b><br />
Having adequate carnitine levels has been shown to be necessary for male fertility. One study found that fertile males had higher levels of carnitine and this was associated with healthier sperm. The men who were classified as infertile had lower carnitine and compromised sperm health. This study suggests that ensuring you have get adequate carnitine in conjunction with healthy lifestyle practices can support fertility.<br />
<br style="border: 0px; margin: 0px; padding: 0px;" />
<b style="border: 0px; margin: 0px; padding: 0px;">12) Use Carnitine for Better Skin</b><br />
A topical carnitine cream can improve the health of your skin by decreasing the amount of oil released by the pores. A new study in the Journal of Cosmetic Dermatology found that a carnitine cream increased the amount of fat that entered the cell, which decreased the oil secreted by the skin. This led to less oily skin and a smoother overall appearance. It also indicates the value of using carnitine to improve the transport of carnitine across the cellular wall to be burned for fat because Beta fat oxidation, or burning, was enhanced.</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<span style="-webkit-text-stroke-width: 0px; background-color: #efe7d0; color: #604d2c; display: inline !important; float: none; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: bold; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: uppercase; white-space: normal; widows: auto; word-spacing: 0px;">ACETYL-L-CARNITINE OVERVIEW INFORMATION</span> </div>
<div style="-webkit-text-stroke-width: 0px; background-color: white; border: 0px; color: #2e2e2e; font-family: arial; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; margin: 0px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<div style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; margin: 0px; orphans: auto; padding: 0px 0px 10px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Acetyl-L-carnitine is an amino acid (a building block for proteins) that is naturally produced in the body. It helps the body produce energy.<br />
<br />
Acetyl-L-carnitine is used for a variety of mental disorders including<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/alzheimers/default.htm" style="color: #006699; outline: none; text-decoration: none;">Alzheimer's</a>disease, age-related<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/brain/memory-loss" style="color: #006699; outline: none; text-decoration: none;">memory loss</a>, late-life<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/depression/default.htm" style="color: #006699; outline: none; text-decoration: none;">depression</a>, thinking problems related to<a href="http://www.webmd.com/mental-health/tc/Alcohol-Abuse-and-Dependence-Topic-Overview" style="color: #006699; outline: none; text-decoration: none;">alcoholism</a>, and thinking problems related to<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/rheumatoid-arthritis/arthritis-lyme-disease" style="color: #006699; outline: none; text-decoration: none;">Lyme disease</a>. It is also used for<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/parenting/baby/understanding-down-syndrome-basics" style="color: #006699; outline: none; text-decoration: none;">Down syndrome</a>, poor circulation in the<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/brain/picture-of-the-brain" style="color: #006699; outline: none; text-decoration: none;">brain</a>,<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/eye-health/cataracts/" style="color: #006699; outline: none; text-decoration: none;">cataracts</a>,<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/brain/nerve-pain-and-nerve-damage-symptoms-and-causes" style="color: #006699; outline: none; text-decoration: none;">nerve pain</a><span class="Apple-converted-space"> </span>due to<span class="Apple-converted-space"> </span><a href="http://diabetes.webmd.com/default.htm" style="color: #006699; outline: none; text-decoration: none;">diabetes</a>, nerve pain due to<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/drugs/index-drugs.aspx" style="color: #006699; outline: none; text-decoration: none;">drugs</a><span class="Apple-converted-space"> </span>used in the treatment of<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/hiv-aids/default.htm" style="color: #006699; outline: none; text-decoration: none;">AIDS</a>, and facial paralysis.<br />
<br />
Some men use acetyl-L-carnitine for<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/infertility-and-reproduction/default.htm" style="color: #006699; outline: none; text-decoration: none;">infertility</a>, symptoms of “<a href="http://men.webmd.com/guide/male-menopause" style="color: #006699; outline: none; text-decoration: none;">male menopause</a>” (low<a href="http://men.webmd.com/Men-Medical-Reference/Testosterone-15738" style="color: #006699; outline: none; text-decoration: none;">testosterone</a><span class="Apple-converted-space"> </span>levels due to aging), and a disease of the<span class="Apple-converted-space"> </span><a href="http://men.webmd.com/picture-of-the-penis" style="color: #006699; outline: none; text-decoration: none;">penis</a><span class="Apple-converted-space"> </span>called Peyronie’s disease.<br />
<br />
The body can convert L-carnitine to acetyl-L-carnitine and vice versa. But, no one knows whether the effects of acetyl-L-carnitine are from the chemical itself, from the L-carnitine it can make, or from some other chemical made along the way. For now, don’t substitute one form of carnitine for another.</div>
<h4 style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: bold; letter-spacing: normal; line-height: normal; margin: 0px; orphans: auto; padding: 0px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
How does it work?</h4>
<div style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; margin: 0px; orphans: auto; padding: 0px 0px 10px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Acetyl-L-carnitine helps the body produce energy. It is important for<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/heart/picture-of-the-heart" style="color: #006699; outline: none; text-decoration: none;">heart</a><span class="Apple-converted-space"> </span>and brain function, muscle movement, and many other body processes.</div>
<h3 class="arrow_on" id="uses3" style="-webkit-text-stroke-width: 0px; background-color: #f2f2f2; background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/arrowdrop_on.gif); background-position: 0px 0px; background-repeat: no-repeat no-repeat; border: 1px solid rgb(223, 223, 223); color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 9pt; font-style: normal; font-variant: normal; height: 17px; letter-spacing: normal; line-height: normal; margin: 4px 0px; orphans: auto; padding: 2px 0px 1px 25px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<a href="http://www.webmd.com/vitamins-supplements/ingredientmono-834-ACETYL-L-CARNITINE.aspx?activeIngredientId=834&activeIngredientName=ACETYL-L-CARNITINE" style="color: #006699; outline: none; text-decoration: none;"><br class="Apple-interchange-newline" />Possibly Effective</a><span class="Apple-converted-space"> </span>for:</h3>
<div class="dropbox" id="usebox3" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<ul style="font-size: 10pt; list-style: none; margin: 10px; padding: 0px;">
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Improving memory problems in elderly people.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Improving memory in people who use alcohol excessively. Taking acetyl-L-carnitine seems to improve memory in 30-60 year-old people whose use of alcohol has produced long-term thinking problems.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Reducing nerve pain (<a href="http://www.webmd.com/brain/understanding-peripheral-neuropathy-basics" style="color: #006699; outline: none; text-decoration: none;">neuropathy</a>) caused by diabetes. Acetyl-L-carnitine reduces pain best in people who have not had diabetes for a long time or who have poorly controlled<span class="Apple-converted-space"> </span><a href="http://diabetes.webmd.com/guide/type-2-diabetes" style="color: #006699; outline: none; text-decoration: none;">type 2 diabetes</a>.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Treating Peyronie’s disease, a connective tissue disease in men. Acetyl-L-carnitine seems to be more effective than a drug called<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/drugs/drug-4497-tamoxifen+oral.aspx" style="color: #006699; outline: none; text-decoration: none;">tamoxifen</a><span class="Apple-converted-space"> </span>for reducing pain and slowing worsening of the condition.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Treating male infertility caused by inflammation of some reproductive organs and tissues (<a href="http://men.webmd.com/picture-of-the-prostate" style="color: #006699; outline: none; text-decoration: none;">prostate</a>, seminal vesicles, and epididymis). Taking acetyl-L-carnitine by mouth, along with L-carnitine for 6 months, seems to increase<a href="http://www.webmd.com/infertility-and-reproduction/guide/semen-analysis" style="color: #006699; outline: none; text-decoration: none;">sperm count</a><span class="Apple-converted-space"> </span>and sperm movement. The carnitines are used following 2 months of treatment with non-steroidal anti-inflammatory drugs (NSAIDs), such as<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/drugs/mono-3-ASPIRIN+-+ORAL.aspx?drugid=1082&drugname=Aspirin+Oral" style="color: #006699; outline: none; text-decoration: none;">aspirin</a>.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Treating symptoms of age-related testosterone deficiency (“male menopause”). Taking acetyl-L-carnitine by mouth along with propionyl-L-carnitine seems to help symptoms related to declining male hormone levels. This combination taken for 6 months seems to improve sexual dysfunction, depression, and<a href="http://www.webmd.com/a-to-z-guides/weakness-and-fatigue-topic-overview" style="color: #006699; outline: none; text-decoration: none;"> fatigue</a><span class="Apple-converted-space"> </span>in much the same way the male hormone testosterone does.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Improving<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/heart/anatomy-picture-of-blood" style="color: #006699; outline: none; text-decoration: none;">blood</a><span class="Apple-converted-space"> </span>flow to the brain. Administering a single dose of acetyl-L-carnitine intravenously (by IV) seems to produce short-term improvements in blood flow in the brains of people who have poor blood circulation in the brain.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Treating Alzheimer’s disease. Acetyl-L-carnitine is more likely to help those with early-onset Alzheimer’s disease who are less than 66 years of age and have a faster rate of disease progression and mental decline.</li>
</ul>
</div>
<br style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;" />
<h3 class="arrow_on" id="uses7" style="-webkit-text-stroke-width: 0px; background-color: #f2f2f2; background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/arrowdrop_on.gif); background-position: 0px 0px; background-repeat: no-repeat no-repeat; border: 1px solid rgb(223, 223, 223); color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 9pt; font-style: normal; font-variant: normal; height: 17px; letter-spacing: normal; line-height: normal; margin: 4px 0px; orphans: auto; padding: 2px 0px 1px 25px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<a href="http://www.webmd.com/vitamins-supplements/ingredientmono-834-ACETYL-L-CARNITINE.aspx?activeIngredientId=834&activeIngredientName=ACETYL-L-CARNITINE" style="color: #006699; outline: none; text-decoration: none;">Insufficient Evidence</a><span class="Apple-converted-space"> </span>for:</h3>
<div class="dropbox" id="usebox7" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<ul style="font-size: 10pt; list-style: none; margin: 10px; padding: 0px;">
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Depression. Some research suggests acetyl-L-carnitine might improve mood and decrease depression in elderly people.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Muscle weakness caused by medications taken for<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/hiv-aids/default.htm" style="color: #006699; outline: none; text-decoration: none;">HIV</a><span class="Apple-converted-space"> </span>disease. Some research suggests acetyl-L-carnitine might help relieve muscle weakness caused by some<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/hiv-aids/guide/hiv-treatment-care" style="color: #006699; outline: none; text-decoration: none;">HIV treatments</a>.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Down syndrome.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Thinking problems related to Lyme disease.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Cataracts.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Other conditions.</li>
</ul>
More evidence is needed to rate the effectiveness of acetyl-L-carnitine for these uses.</div>
<div class="dropbox" id="usebox7" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<div style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; margin: 0px; orphans: auto; padding: 0px 0px 10px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Acetyl-L-carnitine is<span class="Apple-converted-space"> </span><b>LIKELY SAFE</b><span class="Apple-converted-space"> </span>for most adults. It can cause some side effects including<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/digestive-disorders/picture-of-the-stomach" style="color: #006699; outline: none; text-decoration: none;">stomach</a><span class="Apple-converted-space"> </span>upset,<span class="Apple-converted-space"> </span><a href="http://www.webmd.com/digestive-disorders/digestive-diseases-nausea-vomiting" style="color: #006699; outline: none; text-decoration: none;">nausea</a>, vomiting, and restlessness. It can cause a "fishy" odor of the urine, breath, and sweat.</div>
<h4 style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: bold; letter-spacing: normal; line-height: normal; margin: 0px; orphans: auto; padding: 0px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
Special Precautions & Warnings:</h4>
<b style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><a href="http://www.webmd.com/baby/default.htm" style="color: #006699; outline: none; text-decoration: none;">Pregnancy</a><span class="Apple-converted-space"> </span>and breast-feeding</b><span style="-webkit-text-stroke-width: 0px; background-color: white; color: black; display: inline !important; float: none; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">: Not enough is known about the use of acetyl-L-carnitine during pregnancy and breast-feeding. Stay on the safe side and avoid use.</span><br />
<br style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;" />
<b style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">Under-active<span class="Apple-converted-space"> </span><a href="http://women.webmd.com/picture-of-the-thyroid" style="color: #006699; outline: none; text-decoration: none;">thyroid</a><span class="Apple-converted-space"> </span>(<a href="http://www.webmd.com/a-to-z-guides/hypothyroidism-topic-overview" style="color: #006699; outline: none; text-decoration: none;">hypothyroidism</a>)</b><span style="-webkit-text-stroke-width: 0px; background-color: white; color: black; display: inline !important; float: none; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">: There is some concern that acetyl-L-carnitine might interfere with thyroid hormone. Don’t use acetyl-L-carnitine if you have an under-active thyroid.</span><br />
<br style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;" />
<b style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">Seizures</b><span style="-webkit-text-stroke-width: 0px; background-color: white; color: black; display: inline !important; float: none; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">: An increase in the number or seriousness of seizures has been reported in people with a history of seizures who have used L-carnitine by mouth or by IV (intravenously). Since L-carnitine is related to acetyl-L-carnitine, there is a concern that this might also occur with acetyl-L-carnitine. If you have ever had a seizure, don’t take acetyl-L-carnitine.</span></div>
<div class="dropbox" id="usebox7" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
</div>
<div class="dropbox" id="usebox7" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<h3 class="arrow_on" id="inter1" style="-webkit-text-stroke-width: 0px; background-color: #f2f2f2; background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/arrowdrop_on.gif); background-position: 0px 0px; background-repeat: no-repeat no-repeat; border: 1px solid rgb(223, 223, 223); color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 9pt; font-style: normal; font-variant: normal; height: 17px; letter-spacing: normal; line-height: normal; margin: 4px 0px; orphans: auto; padding: 2px 0px 1px 25px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<br class="Apple-interchange-newline" /><img alt="" border="0" class="interact_icons" height="16" src="http://img.webmd.com/drugs/PortalLiteResources/images/interact_major.gif" style="float: left; margin: 0px 5px 5px 0px;" width="16" /><a href="http://www.webmd.com/vitamins-supplements/ingredientmono-834-ACETYL-L-CARNITINE.aspx?activeIngredientId=834&activeIngredientName=ACETYL-L-CARNITINE" style="color: #006699; outline: none; text-decoration: none;">Major Interaction</a><span class="Apple-converted-space"> </span>Do not take this combination</h3>
<div class="dropbox" id="interbox1" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<ul style="font-size: 10pt; list-style: none; margin: 10px; padding: 0px;">
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Acenocoumarol (Sintrom) interacts with ACETYL-L-CARNITINE<br /><div style="color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; margin: 10px 0px 0px 10px; padding: 0px;">
Acenocoumarol (Sintrom) is used to slow blood clotting. Acetyl-L-carnitine might increase the effectiveness of acenocoumarol (Sintrom). Increasing the effectiveness of acenocoumarol (Sintrom) might slow blood clotting too much. The dose of your acenocoumarol (Sintrom) might need to be changed.</div>
</li>
</ul>
</div>
<br style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;" />
<h3 class="arrow_on" id="inter2" style="-webkit-text-stroke-width: 0px; background-color: #f2f2f2; background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/arrowdrop_on.gif); background-position: 0px 0px; background-repeat: no-repeat no-repeat; border: 1px solid rgb(223, 223, 223); color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 9pt; font-style: normal; font-variant: normal; height: 17px; letter-spacing: normal; line-height: normal; margin: 4px 0px; orphans: auto; padding: 2px 0px 1px 25px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<img alt="" border="0" class="interact_icons" height="16" src="http://img.webmd.com/drugs/PortalLiteResources/images/interact_warning.gif" style="float: left; margin: 0px 5px 5px 0px;" width="18" /><a href="http://www.webmd.com/vitamins-supplements/ingredientmono-834-ACETYL-L-CARNITINE.aspx?activeIngredientId=834&activeIngredientName=ACETYL-L-CARNITINE" style="color: #006699; outline: none; text-decoration: none;">Moderate Interaction</a><span class="Apple-converted-space"> </span>Be cautious with this combination</h3>
<div class="dropbox" id="interbox2" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<ul style="font-size: 10pt; list-style: none; margin: 10px; padding: 0px;">
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">Warfarin (Coumadin) interacts with ACETYL-L-CARNITINE<br /><div style="color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; margin: 10px 0px 0px 10px; padding: 0px;">
Warfarin (Coumadin) is used to slow blood clotting. Acetyl-L-carnitine might increase the effects of warfarin (Coumadin) and increase the chances of bruising and bleeding. Be sure to have your blood checked regularly. The dose of your warfarin (Coumadin) might need to be changed.</div>
</li>
</ul>
</div>
<br style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;" />
<div style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; margin: 0px; orphans: auto; padding: 0px 0px 10px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
The following doses have been studied in scientific research:<br />
<br />
<b>BY MOUTH:</b></div>
<ul style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; list-style: none; margin: 10px; orphans: auto; padding: 0px; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">For Alzheimer’s disease: 1500-4000 mg daily, usually divided into two or three doses during the day.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">In age-related memory loss: 1500-2000 mg daily.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">For depression in the elderly: 1500-3000 mg daily in divided doses.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">For male infertility:</li>
<ul style="font-size: 10pt; list-style: none; margin: 10px; padding: 0px;">
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">1 gram of acetyl-L-carnitine plus 2 grams of L-carnitine daily.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">4000 mg daily has been used to improve sperm function.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">For male infertility secondary to abacterial prostatovesiculoepididymitis: acetyl-L-carnitine 500 mg plus carnitine 1 gram every 12 hours has been used following 2 months of treatment with nonsteroidal anti-inflammatory drugs.</li>
</ul>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">For Peyronie’s disease: 1 gram twice daily for 3 months.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">For symptoms of age-related testosterone deficiency: 2 grams of acetyl-L-carnitine plus 2 grams of propionyl-L-carnitine daily.</li>
<li style="background-image: url(http://img.webmd.com/drugs/PortalLiteResources/images/bullet.gif); background-position: 0px 5px; background-repeat: no-repeat no-repeat; font-size: 9pt; margin: 0px 0px 5px; padding: 0px 0px 0px 10px;">For<span class="Apple-converted-space"> </span><a href="http://diabetes.webmd.com/diabetes-neuropathy" style="color: #006699; outline: none; text-decoration: none;">diabetic neuropathy</a>: 1500 to 3000 mg per day in divided doses.</li>
</ul>
<br class="Apple-interchange-newline" />
<br class="Apple-interchange-newline" />
</div>
</div>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-46407648108251574642013-05-22T15:18:00.000+05:302013-05-22T15:18:42.075+05:30Benefits of Whole eggs : Eating whole eggs can improve lipoprotein profiles for patients with metabolic syndrome<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjLE5EvC5B8jBgQoc8X2Jq9WzHKZ5pyu6N7pdzngFTPZ9U0I-c98A_qH9FPdVu3B0U1UVFVmXxdu5CUAlBF8ZAH7hecUuZ_K5oCeltpAX99rMxaGjvVppSlfG6C-eZ3ckRuLaKNdXQpdh4/s1600/egg.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjLE5EvC5B8jBgQoc8X2Jq9WzHKZ5pyu6N7pdzngFTPZ9U0I-c98A_qH9FPdVu3B0U1UVFVmXxdu5CUAlBF8ZAH7hecUuZ_K5oCeltpAX99rMxaGjvVppSlfG6C-eZ3ckRuLaKNdXQpdh4/s320/egg.jpg" width="320" /></a></div>
<br />
<div>
<br /></div>
<div>
<b style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Eating whole eggs can improve lipoprotein profiles for patients with metabolic syndrome and also help them with weight management.</b><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">The finding came from new research that was conducted by a team led by Dr. Maria Luz Fernandez, Professor at the University of Connecticut, and was published in the journal </span><i style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Metabolism</i><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Approximately 34% of people in the United States have metabolic syndrome, a condition becoming increasingly common. According to prior research, </span><a href="http://www.medicalnewstoday.com/articles/243972.php" style="background-color: white; color: #990099; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px; text-decoration: none;">women have a higher chance of developing metabolic syndrome than men</a><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;"> because they are less likely to work out for at least a half of an hour each day.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">A person develops metabolic syndrome when he/she has 3 or more of the following risk factors:</span><ul style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px; margin-bottom: 20px; margin-left: 15px; margin-top: 20px; padding-left: 15px;">
<li style="padding-bottom: 10px;">high triglycerides</li>
<li style="padding-bottom: 10px;">low HDL <a href="http://www.medicalnewstoday.com/articles/9152.php" style="color: #990099; text-decoration: none;" title="What is Cholesterol? What Causes High Cholesterol?">cholesterol</a></li>
<li style="padding-bottom: 10px;">large waistline</li>
<li style="padding-bottom: 10px;">increased blood sugar</li>
<li style="padding-bottom: 10px;"><a href="http://www.medicalnewstoday.com/articles/159283.php" style="color: #990099; text-decoration: none;" title="What Is High Blood Pressure? What Causes High Blood Pressure?">high blood pressure</a></li>
</ul>
<span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Patients with this condition have an increased probability of developing cardiovascular disease and </span><a href="http://www.medicalnewstoday.com/info/diabetes/" style="background-color: white; color: #990099; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px; text-decoration: none;" title="What is Diabetes?">diabetes</a><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">, due to a diversity of risk factors.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Since there has been varied information on dietary cholesterol, many people try to stay away from particular foods, including eggs, especially those who struggle with health problems.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">For the purpose of the research, middle-aged males and females with metabolic syndrome were split into 2 groups: one group ate 3 whole eggs each day and the other ate the same amount of egg substitute each day as part of a carbohydrate-restricted diet to lose weight.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><b style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">After the subjects in the whole eggs group spent 3 months on the diet, the researchers found that it had no impact on their LDL cholesterol or total blood cholesterol</b><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">, even though they were eating two times the amount of cholesterol than they were before the experiment began.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><b style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Both the whole eggs group and the egg substitute group had increases in HDL cholesterol, decreases in plasma triglycerides, and improved lipid profiles</b><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Dr. Luz Fernandez explained:</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><blockquote style="background-color: white; border-left-color: rgb(0, 102, 204); border-left-style: solid; border-left-width: 10px; color: #555555; font-family: Arial, Helvetica; font-size: 14px; font-style: italic; line-height: 20px; margin-bottom: 10px; margin-left: 0px; margin-top: 5px; padding-bottom: 0px; padding-left: 20px;">
"Eating egg yolks was actually associated with enhanced health benefits in these high-risk individuals. Subjects consuming whole eggs had greater increases in HDL cholesterol and more significant reductions in the LDL/HDL cholesterol ratio than those who ate the cholesterol-free egg substitute."</blockquote>
<h2 class="blue_sea_paddingtop" style="background-color: white; color: #0f3f9f; font-family: Arial, Helvetica; font-size: 17px; margin-top: 25px;">
One Large Egg Provides 13 Critical Nutrients</h2>
<span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Eggs actually have 64% more </span><a href="http://www.medicalnewstoday.com/articles/161618.php" style="background-color: white; color: #990099; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px; text-decoration: none;" title="What Is Vitamin D? What Are The Benefits Of Vitamin D?">vitamin D</a><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;"> than scientists believed in the past and currently have 14% less cholesterol (reduced from 215 mg to 185 mg), according to the U.S. Department of Agriculture's Agricultural Research service.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Thirteen critical </span><a href="http://www.medicalnewstoday.com/articles/195878.php" style="background-color: white; color: #990099; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px; text-decoration: none;" title="What Are Vitamins? What Vitamins Do I Need?">vitamins</a><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;"> and minerals, such as vitamin D and choline, can be found in one large egg. This is important because vitamin D and choline are not found plentifully in other foods.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">The yolk provides most of these nutrients, including lutein and zeaxanthin, which help protect against </span><a href="http://www.medicalnewstoday.com/articles/152105.php" style="background-color: white; color: #990099; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px; text-decoration: none;" title="What Is AMD? What Is Macular Degeneration?">macular degeneration</a><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;"> and its resulting age-related blindness. Studies have demonstrated that although eggs provide just small amounts of these nutrients, receiving them from eggs may be more beneficial, or bioavailable, than receiving them from supplements.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">A different report published in </span><i style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Food and Function</i><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;"> discovered that eating egg yolks each day was linked with increases in plasma lutein, β-carotene, and zeaxanthin in patients with metabolic syndrome, a condition that is normally linked to reduced levels of the same nutrients.</span><h2 class="blue_sea_paddingtop" style="background-color: white; color: #0f3f9f; font-family: Arial, Helvetica; font-size: 17px; margin-top: 25px;">
High-Quality Egg Protein Helps Manage Weight</h2>
<span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">A critical way to halt the development of chronic disease, such as metabolic syndrome, is to control weight.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">People can control their weight by keeping track of what they eat. For example, consuming all-natural, high-quality protein can help people feel satisfied for a longer period, give them energy, and helps create muscle.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Research has shown that </span><b style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">consuming eggs for breakfast, as opposed to eating a bagel of comparable calories, keeps people feeling fuller longer and decreases the amount of food consumed throughout the day, therefore, causing a notable reduction in BMI and waist circumference.</b><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">An effective way to prevent chronic disease and manage weight, according to Dr. Dixie Harms, a nurse practitioner who specializes in diabetes care, is to begin each morning with a protein-rich breakfast.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">In fact, previous research indicated that </span><a href="http://www.medicalnewstoday.com/articles/243972.php" style="background-color: white; color: #990099; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px; text-decoration: none;">obese and overweight patients with metabolic syndrome and Type 2 diabetes experienced significant improvements in their health after just 3 weeks of diet and moderate exercise</a><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">.</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Harms said:</span><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><blockquote style="background-color: white; border-left-color: rgb(0, 102, 204); border-left-style: solid; border-left-width: 10px; color: #555555; font-family: Arial, Helvetica; font-size: 14px; font-style: italic; line-height: 20px; margin-bottom: 10px; margin-left: 0px; margin-top: 5px; padding-bottom: 0px; padding-left: 20px;">
"Management of chronic disease takes a coordinated effort with diet and lifestyle. A balanced breakfast including high-quality protein plus regular physical activity can help put individuals on a path to a healthier lifestyle."</blockquote>
<br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><br style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;" /><span style="background-color: white; color: #333333; font-family: Arial, Helvetica; font-size: 14px; line-height: 20px;">Fortunately, making a healthy breakfast is rather simple. Include foods such as fruits, veggies, eggs, whole grains, and low-fat dairy foods</span></div>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-8687205065224877062013-05-17T14:10:00.002+05:302013-05-22T15:19:25.689+05:30Herbal Products<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjvUmk9vg3hJ2q7UIwmBrGxb4H_RpsflBE1S2N2dOw0NBZ8Z-Gsq45E0XLv2ApGTKc-I0nD3RrEbSs0m6w3HkxQRaKip1LnWwzWQRkpIyWMNzgixc5OwuRWLAIv9ompyuKItrOoxdM1wk8/s1600/Herbal+productsjpg_Page1.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjvUmk9vg3hJ2q7UIwmBrGxb4H_RpsflBE1S2N2dOw0NBZ8Z-Gsq45E0XLv2ApGTKc-I0nD3RrEbSs0m6w3HkxQRaKip1LnWwzWQRkpIyWMNzgixc5OwuRWLAIv9ompyuKItrOoxdM1wk8/s640/Herbal+productsjpg_Page1.jpg" width="503" /></a></div>
<br /></div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-58253360108341230982013-05-17T14:09:00.003+05:302013-05-22T15:19:54.078+05:30A Food PHarmacy that May fight Diseases<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjkwcWOiiEjh8Ft7v7NFwCZCkcU-9jr2tYZoIAL3CgI46dcfayx792aW6qhsNecRFeVg7K1ZhpdHwA7k2BylfikMD22ichneoM58k-QJgZ9Ou3KzrHh1nAzArwFNlFeUwho7zHaOdPzTIg/s1600/A+food+pharmacy+that+may+fight+diseasesjpg_Page1.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjkwcWOiiEjh8Ft7v7NFwCZCkcU-9jr2tYZoIAL3CgI46dcfayx792aW6qhsNecRFeVg7K1ZhpdHwA7k2BylfikMD22ichneoM58k-QJgZ9Ou3KzrHh1nAzArwFNlFeUwho7zHaOdPzTIg/s640/A+food+pharmacy+that+may+fight+diseasesjpg_Page1.jpg" width="503" /></a></div>
<br /></div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-5302225575598093252013-05-17T13:43:00.000+05:302013-05-22T15:20:26.837+05:30Vitamins and Minerals as Antioxidants<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div class="MsoNormal">
<div style="text-align: justify;">
<b>Several vitamins and minerals are considered antioxidants</b>.
These include vitamins E and C, beta-carotene (which can be converted to
vitamin A), other carotenoids (some may be converted to vitamin A and also play
a role in cell development), and the minerals selenium, copper, zinc, and
manganese. What are antioxidants? What do they do? Every cell in our body needs
oxygen to use the nutrients that food provides.
However, when oxygen is used by cells, by-products called free radicals
are formed. If allowed to accumulate,
these free radicals can damage tissues, cells, and deoxyribonucleic acid (DNA,
the genetic material of cells). The
process of oxidative damage can be observed as the browning that occurs when
sliced apples or potatoes are exposed to the air or the rancid flavor that
butter and cooking oils develop when stored for long periods. Environmental
pollutants such as cigarette smoke and ultraviolet light from the sun also
contribute to the formation of free radicals in our bodies. Although not proved, studies suggest that
excess free-radical production can increase the risk of cancer, heart disease,
cataracts, and the other types of cell deterioration that are associated with
aging. Just as the vitamin C in lemon juice can prevent sliced apples from
browning, antioxidants scavenge and neutralize the effects of free radicals in
our bodies. Each antioxidant has its own
unique effect. Vitamin C, which is water
soluble, removes free radicals from body fluids and cell structures composed
mainly of water. Beta-carotene and
vitamin E are fat-soluble. They seem to
be active primarily in fat tissues and cell membranes throughout the body. The mineral selenium is an antioxidant that
assists vitamin E. What is the best
source of antioxidants? With the
possible exception of vitamin E, the best source of antioxidants is food. Fruits, vegetables, and grains provide a wide
variety of both known and yet to be discovered antioxidants that appear to
protect your body’s vital functions.</div>
</div>
<div class="MsoNormal">
<div style="text-align: justify;">
<br /></div>
</div>
<div class="MsoNormal">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjk9Z7ApHEjI6MXTaOtMixeHF9e6c7OCR6-XZwqxW64xV-XQ-TvjIpRfXvSEG1u6RFQ4aZDmQCnuU5MYsUBM_GFbqJBD9KUMEL0j53AeQ0V_CNOvlkDiUqctw60wB-nqVHH811AUn4ZqsI/s1600/Antioxidanrs.JPG" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="345" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjk9Z7ApHEjI6MXTaOtMixeHF9e6c7OCR6-XZwqxW64xV-XQ-TvjIpRfXvSEG1u6RFQ4aZDmQCnuU5MYsUBM_GFbqJBD9KUMEL0j53AeQ0V_CNOvlkDiUqctw60wB-nqVHH811AUn4ZqsI/s640/Antioxidanrs.JPG" width="640" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_cXtybRgL-FDe1iQWXaXyMznjdxfE5EgPTD9UBzIGYzvcYMFpDfWMlzAP8a87rxDJXLdU9jkCT9kcRBloAdvldwQjewgrOjV87Qvj-wRQKJujxmirMjo0KUw3vNLBIRiYspOSgMRb52Q/s1600/food+sources+of+Antioxidants.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_cXtybRgL-FDe1iQWXaXyMznjdxfE5EgPTD9UBzIGYzvcYMFpDfWMlzAP8a87rxDJXLdU9jkCT9kcRBloAdvldwQjewgrOjV87Qvj-wRQKJujxmirMjo0KUw3vNLBIRiYspOSgMRb52Q/s640/food+sources+of+Antioxidants.JPG" width="500" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-16128148335683500892013-05-17T13:28:00.003+05:302013-05-22T15:20:51.131+05:30Antioxidants and Free radicals<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgEukNTS37hWWxyqzxCZ9grZqk1yRUp2GxBfY8Gn13-aa-TDoeLdNQlLU-JcDAXVtX-He2Fa0UeIfeYcEQXPrfZPZxcQeDrc6W1U44qWzOBCvjDa1MGvj6uPoveK_AKoOlCvnyXDPdPTdo/s1600/Antioxidanrs+&+Free+radicals.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="230" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgEukNTS37hWWxyqzxCZ9grZqk1yRUp2GxBfY8Gn13-aa-TDoeLdNQlLU-JcDAXVtX-He2Fa0UeIfeYcEQXPrfZPZxcQeDrc6W1U44qWzOBCvjDa1MGvj6uPoveK_AKoOlCvnyXDPdPTdo/s320/Antioxidanrs+&+Free+radicals.JPG" width="320" /></a></div>
<br />
<br />
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
When oxygen is used by cells, by-products called free
radicals are naturally formed. Free
radicals are molecules with a missing electron.
Simply put, free radicals “want” their full share of electrons. They
will take electrons from vital cell structures, causing damage and leading to
disease. Antioxidants are able to donate electrons. Nutrients such as vitamin C, vitamin E, or
beta-carotene are antioxidants that block some of this damage by donating electrons
to stabilize and neutralize the harmful
effects of free radicals.</div>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-47580043593166552782012-11-20T11:03:00.001+05:302013-05-22T15:21:04.821+05:30<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<h1 style="border-bottom-color: rgb(125, 18, 55); border-bottom-style: solid; border-width: 0px 0px 2px; color: #7d1237; font-family: Georgia, 'Times New Roman', Times, serif; font-size: 25px; font-weight: normal; margin: 0px 0px 5px; outline: rgb(0, 0, 0); padding: 0px; text-align: -webkit-auto; vertical-align: baseline;">
</h1>
<div>
<br /></div>
<div>
<br /></div>
<div>
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.eugenegoesthailand.com/wp-content/uploads/2008/12/dsc_1229.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="265" src="http://www.eugenegoesthailand.com/wp-content/uploads/2008/12/dsc_1229.jpg" style="-webkit-user-select: none;" width="400" /></a></div>
<div>
<br /></div>
<div>
</div>
<div>
<br /></div>
<div>
<br /></div>
<div>
<br /></div>
<h1 style="border-bottom-color: rgb(125, 18, 55); border-bottom-style: solid; border-width: 0px 0px 2px; color: #7d1237; font-family: Georgia, 'Times New Roman', Times, serif; font-size: 25px; font-weight: normal; margin: 0px 0px 5px; outline: rgb(0, 0, 0); padding: 0px; text-align: -webkit-auto; vertical-align: baseline;">
Benefits of Custard Apple</h1>
<div class="date" style="border: 0px; color: #444444; font-family: tahoma; font-size: 12px; margin: 0px; outline: rgb(0, 0, 0); padding: 0px; text-align: -webkit-auto; vertical-align: baseline;">
</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Custard Apple or Seethaphal is a tropical fruit tree that grows easily. The flesh is white and creamy with a sugary taste. The seeds are black in colour with a shine. The seeds are not consumed for they are slightly poisonous.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Custard apple promotes digestion and is used as a cure for vomiting, diarrhea, dysentery and vertigo. The unripe fruit is dried and powdered and is used as a cure for treating lice. The fruit is high in calorie content but contains minerals like iron, phosphorous, calcium and riboflavin.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
<span style="border: 0px; margin: 0px; outline: rgb(0, 0, 0); padding: 0px; text-decoration: underline; vertical-align: baseline;"><strong style="border: 0px; margin: 0px; outline: rgb(0, 0, 0); padding: 0px; vertical-align: baseline;">Custard apple Nutrition</strong></span><br />
Custard apples are packed with vitamin C, an antioxidant that can combat the free radicals in the body. The fruit also has vitamin A, which is good for healthy skin, better vision and for healthy hair.<br />
The magnesium in custard apples can protect the heart from cardiac diseases and can relax the muscles.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Custard apples are an excellent source of copper. Copper is a trace mineral that helps are body form hemoglobin. When a woman doesn’t have enough copper in her system, there is an increased risk that her child will be born early.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Other side effects of a copper deficiency include brittle bones and a low white blood cell count. The average person needs about nine hundred micrograms of copper each day. Pregnant women need one thousand micrograms of copper each day, and if she decides to breastfeed she will need approximately thirteen hundred micrograms of copper.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Custard apples are also rich in vitamin B6 and potassium. Custard apples are also rich in copper and have plenty of dietary fiber, which is good for keeping the digestive tract healthy and aids digestion as well prevents constipation. Custard apples have low levels of fat, which is good for health.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
It is believed that a paste made with the creamy flesh of the fruit can be used as a balm to treat boils, abscesses and ulcers.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Custard apples can be sun-dried and then ground into a powder, which can treat dysentery and diarrhea. Custard apples also act as coolants, stimulants and expectorants. These fruits are good for treating anemia.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Some people make the fruit into a beverage that can act as a substitute to milk.<br />
Even the bark of the custard apple tree, which contains astringents and tannins, is used in making herbal medicines. The leaves of the tree are supposed to be god for treating cancer and tumors; while the bark can relieve toothaches and gum pain.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Custard apples are a rich source of the Vitamin B6. It is important that you eat a diet that is rich in Vitamin B6 because a deficiency can cause skin problems, an extremely sore tongue, convulsions, depressions, and depression. The older a person gets the greater the chances of a Vitamin B6 deficiency.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
<strong style="border: 0px; margin: 0px; outline: rgb(0, 0, 0); padding: 0px; vertical-align: baseline;">Custard apple calories</strong><br />
100 gm of custard apple contains:<br />
Calories: 100<br />
Water: 75.0 g<br />
Fat: 0.6 g<br />
Sugar: 15 gm<br />
Dietary fiber: 3.5 g<br />
Carbohydrate: 23.71 gm<br />
Protein: 1 to 4.3 gm<br />
Iron: 0.7 mg<br />
Calcium: 20 mg</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Custard apples are a well-balanced food having protein, fibre, minerals, vitamins, energy and little fat. They are an excellent source of Vitamin C, a good source of dietary fibre, a useful source of Vitamin B6, magnesium and potassium, and with some B2 and complex carbohydrate.</div>
<div style="border: 0px; color: #444444; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 18px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">
Health tips for Custard apple<br />
There are lots of custard apple benefits and custard apple is consumed in row form. Custard milk shake also tasted good. Custard Apple Benefits are immense. Custard apples do taste well, but they are also good for health. Custard apples are good to have them as part of one’s diet.</div>
<span style="border: 0px; color: #444444; float: left; font-family: Arial; font-size: 12px; line-height: 20px; margin: 0px; outline: rgb(0, 0, 0); padding: 0px 0px 10px; text-align: -webkit-auto; vertical-align: baseline;">Benefits of Custard Apple can be healthy for you and may help you lose weight when included in your diet & exercise plan.</span></div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com2tag:blogger.com,1999:blog-5880677466498354462.post-46562113554674371772012-10-18T12:02:00.002+05:302013-05-22T15:21:32.629+05:30The Blind Man Who Taught Himself To See<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div style="text-align: -webkit-auto;">
</div>
<div id="BlogContent" style="font-family: Arial; font-size: 12px; margin-top: 10px; text-align: -webkit-auto;">
<h2 style="font-weight: normal;">
<a href="http://www.mensjournal.com/wp-content/uploads/m203bata.jpg" style="color: #d71a11; text-decoration: none;"><img alt="" class="alignleft size-medium wp-image-20456" height="300" src="http://www.mensjournal.com/wp-content/uploads/m203bata-300x300.jpg" style="border-color: black; float: left; margin: 0px 10px 10px 0px;" title="m203bata" width="300" /></a>Daniel Kish has been sightless since he was a year old. Yet he can mountain bike. And navigate the wilderness alone. And recognize a building as far away as 1,000 feet. How? The same way bats can see in the dark.</h2>
<h5>
by Michael Finkel</h5>
<h5>
photograph by Steve Pyke</h5>
<div style="line-height: 1.3em;">
The first thing Daniel Kish does, when I pull up to his tidy gray bungalow in Long Beach, California, is make fun of my driving. “You’re going to leave it that far from the curb?” he asks. He’s standing on his stoop, a good 10 paces from my car. I glance behind me as I walk up to him. I am, indeed, parked about a foot and a half from the curb.</div>
<div style="line-height: 1.3em;">
The second thing Kish does, in his living room a few minutes later, is remove his prosthetic eyeballs. He does this casually, like a person taking off a smudged pair of glasses. The prosthetics are thin convex shells, made of acrylic plastic, with light brown irises. A couple of times a day they need to be cleaned. “They get gummy,” he explains. Behind them is mostly scar tissue. He wipes them gently with a white cloth and places them back in.</div>
<div style="line-height: 1.3em;">
Kish was born with an aggressive form of cancer called retinoblastoma, which attacks the retinas. To save his life, both of his eyes were removed by the time he was 13 months old. Since his infancy — Kish is now 44 — he has been adapting to his blindness in such remarkable ways that some people have wondered if he’s playing a grand practical joke. But Kish, I can confirm, is completely blind.</div>
<div style="line-height: 1.3em;">
He knew my car was poorly parked because he produced a brief, sharp click with his tongue. The sound waves he created traveled at a speed of more than 1,000 feet per second, bounced off every object around him, and returned to his ears at the same rate, though vastly decreased in volume.</div>
<div style="line-height: 1.3em;">
But not silent. Kish has trained himself to hear these slight echoes and to interpret their meaning. Standing on his front stoop, he could visualize, with an extraordinary degree of precision, the two pine trees on his front lawn, the curb at the edge of his street, and finally, a bit too far from that curb, my rental car. Kish has given a name to what he does — he calls it “FlashSonar” — but it’s more commonly known by its scientific term, echolocation.</div>
<div style="line-height: 1.3em;">
Bats, of course, use echolocation. Beluga whales too. Dolphins. And Daniel Kish. He is so accomplished at echolocation that he’s able to pedal his mountain bike through streets heavy with traffic and on precipitous dirt trails. He climbs trees. He camps out, by himself, deep in the wilderness. He’s lived for weeks at a time in a tiny cabin a two-mile hike from the nearest road. He travels around the globe. He’s a skilled cook, an avid swimmer, a fluid dance partner. Essentially, though in a way that is unfamiliar to nearly any other human being, Kish can see.</div>
<div style="line-height: 1.3em;">
This is not enough for him. Kish is seeking — despite a lack of support from every mainstream blind organization in America — nothing less than a profound reordering of the way the world views blind people, and the way blind people view the world. He’s tired of being told that the blind are best served by staying close to home, sticking only to memorized routes, and depending on the unreliable benevolence of the sighted to do anything beyond the most routine of tasks.</div>
<div style="line-height: 1.3em;">
Kish preaches complete and unfettered independence, even if the result produces the occasional bloody gash or broken bone. (He once fractured the heel of his left foot after leaping from a rock and has broken a couple of teeth.) He’s regarded by some in the blind community with deep veneration. Others, like a commenter on the <a href="http://www.nfb.org/nfb/default.asp" style="color: #d71a11; text-decoration: none;" target="_blank">National Federation of the Blind</a>’s listserv, consider him “disgraceful” for promoting behavior such as tongue clicking that could be seen as off-putting and abnormal.</div>
<div style="line-height: 1.3em;">
Kish and a handful of coworkers run a nonprofit organization called <a href="http://www.worldaccessfortheblind.org/" style="color: #d71a11; text-decoration: none;" target="_blank">World Access for the Blind</a>, headquartered in Kish’s home. World Access offers training on how to gracefully interact with one’s environment, using echolocation as a primary tool. So far, in the decade it has existed, the organization has introduced more than 500 students to echolocation. Kish is not the first blind person to use echolocation, but he’s the only one to meticulously document it, to break it down into its component parts, and to figure out how to teach it. His dream is to help all sight-impaired people see the world as clearly as he does.</div>
<div style="line-height: 1.3em; text-align: center;">
—-</div>
<div class="wp-caption alignright" id="attachment_20458" style="float: left; margin: 0px 10px 5px 0px; width: 310px;">
<a href="http://www.mensjournal.com/wp-content/uploads/m203batc.jpg" style="color: #d71a11; text-decoration: none;"><img alt="" class="size-medium wp-image-20458 " height="300" src="http://www.mensjournal.com/wp-content/uploads/m203batc-300x300.jpg" title="m203batc" width="300" /></a><br />
<div class="wp-caption-text" style="line-height: 1.3em;">
Kish, here biking in Long Beach, preaches total independence. Photo courtesy Daniel Kish</div>
</div>
<div style="line-height: 1.3em;">
It begins with the lid of a pot. “Stand up,” Kish instructs, then guides me to the center of his living room and ties a blindfold around my head, while mentioning, in a schoolteachery tone, that I should not for an instant think that wearing a blindfold represents the experience of being blind. A blindfold almost always causes someone who can see to feel frightened, confused, and disoriented. Kish is none of these things.</div>
<div style="line-height: 1.3em;">
“Now wait here,” he says. Though he was born and raised in Southern California, Kish has an odd, almost foreign-sounding accent — a bouillabaisse of Canadian, British, and relaxed Los Angeleno. He says it’s a result of his many travels. “I’m a natural mimic,” he explains. Kish is 5-foot-7, thin and fit, with an impressive mane of dark brown hair and a meandering winestain birthmark on his left cheek.</div>
<div style="line-height: 1.3em;">
I hear him walk into his kitchen, his bare feet padding faintly on the hardwood floor. “I’m very particular about feeling life and air around my feet,” he once wrote in the journal he braille-typed and shared with me. I’m barefoot as well. Kish asked me to remove my shoes, which is one of his many little rules you quickly learn to adopt. Like: He’s Daniel Kish, and anyone who calls him “Dan” more than once may be struck with withering disdain. And don’t disturb him during his sleep time — lately, he’s been sleeping just two hours twice a day, usually from 5 to 7 in the morning and again from 5 to 7 in the evening. He often stays up all night dealing with World Access logistics. He lives alone and does not have a significant other. He plays a lot of Celtic hymnal music.</div>
<div style="line-height: 1.3em;">
I listen as Kish opens a cabinet and rummages amid his pots. He returns and stands behind me. “Make a click,” he says.</div>
<div style="line-height: 1.3em;">
It’s a terrible click, a sloppy click; what Kish calls a “clucky click.” Kish’s click is a thing of beauty — he snaps the tip of his tongue briefly and firmly against the roof of his mouth, creating a momentary vacuum that pops upon release, a sound very much like pushing the igniter on a gas stove. A team of Spanish scientists recently studied Kish’s click and deemed it acoustically ideal for capturing echoes. A machine, they wrote, could do no better.</div>
<div style="line-height: 1.3em;">
My click will work for now. Kish tells me that he’s holding a large glass lid, the top to a Crock-Pot, a few inches in front of me. “Click again,” he says. There’s a distinct echo, a smearing of sound as if I’m standing in my shower. “Now click,” he says. The echo’s gone. “I’ve lifted it up. Can you tell?”</div>
<div style="line-height: 1.3em;">
I can, quite clearly. “Click again,” he instructs. “Where is it?” I click; there’s no echo.</div>
<div style="line-height: 1.3em;">
“It’s still lifted,” I say.</div>
<div style="line-height: 1.3em;">
“Try again,” says Kish. “But move your head, listen to your environment.”</div>
<div style="line-height: 1.3em;">
I turn my head to the right and click. Nothing. Then I click to the left. Bingo. “It’s over here,” I say, tilting my head in the direction of the lid.</div>
<div style="line-height: 1.3em;">
“Exactly,” says Kish. “Now let’s try it with a pillow.”</div>
<div style="line-height: 1.3em;">
There are two reasons echolocation works. The first is that our ears, conveniently, are located on both sides of our head. When there’s a noise off to one side, the sound reaches the closer ear about a millisecond — a thousandth of a second — before it reaches the farther ear. That’s enough of a gap for the auditory cortex of our brain to process the information. It’s rare that we turn the wrong way when someone calls our name. In fact, we’re able to process, with phenomenal accuracy, sounds just a few degrees off-center. Having two ears, like having two eyes, also gives us the auditory equivalent of depth perception. We hear in stereo 3-D. This allows us, using only our ears, to build a detailed map of our surroundings.</div>
<div style="line-height: 1.3em;">
The second reason echolocation works is that humans, on average, have excellent hearing. We hear better than we see. Much better. On the light spectrum, human eyes can perceive only a small sliver of all the varieties of light — no ultraviolet, no infrared. Converting this to sound terminology, we can see less than one octave of frequency. We hear a range of 10 octaves.</div>
<div style="line-height: 1.3em;">
We can also hear behind us; we can hear around corners. Sight can’t do this. Human hearing is so good that if you have decent hearing, you will never once in your life experience true silence. Even if you sit completely still in a soundproof room, you will detect the beating of your own heart.</div>
<div style="line-height: 1.3em; text-align: center;">
—-</div>
<div style="line-height: 1.3em;">
Kish does not go around clicking like a madman. He uses his click sparingly and, depending on his location, varies the volume. When he’s outside, he’ll throw a loud click. In good conditions, he can hear a building 1,000 feet away, a tree from 30 feet, a person from six feet. Up close, he can echolocate a one-inch diameter pole. He can tell the difference between a pickup truck, a passenger car, and an SUV. He can locate trail signs in the forest, then run his finger across the engraved letters and determine which path to take. Every house, he explains, has its own acoustic signature.</div>
<div style="line-height: 1.3em;">
He can hear the variation between a wall and a bush and a chain-link fence. Bounce a tennis ball off a wall, Kish says, then off a bush. Different response. So too with sound. Given a bit of time, he can echolocate something as small as a golf ball. Sometimes, in a parking garage, he can echolocate the exit faster than a sighted person can find it.</div>
<div style="line-height: 1.3em;">
I accompanied Kish on several occasions as he cruised the busy streets of Long Beach. The outside world is an absolute cacophony. Every car, person, dog, stroller, and bicycle makes a sound. So do gusts of wind, bits of blowing garbage, and rustling leaves. Doors open and close. Change jangles. People talk. Then there are the silent obstacles — what Kish calls urban furniture: benches, traffic signs, telephone poles, postal boxes, fire hydrants, light posts, parked vehicles. Kish hears the sonic reflections from his click even in a place teeming with ambient noise. “It’s like recognizing a familiar voice in a crowd,” he says. The load upon his mind is undoubtedly immense. Yet he casually processes everything, constructing and memorizing a mental map of his route, all while maintaining an intricate conversation with me. It’s so extraordinary that it seems to border on the magical.</div>
<div style="line-height: 1.3em;">
When we walk into a restaurant — never a simple choice with Kish, since he’s a strict vegan — he makes a much quieter click. Kish describes the images he receives as akin to a brief flick of the lights in a dark room; you get enough essential information — tables here, stairway there, support pillars here — to navigate your way through. “It becomes as ridiculous for blind people to run into a wall as it is for sighted people,” he once wrote in his FlashSonar manual. He strolls casually across the restaurant, making one or two more clicks as we approach our table, then sits down. It’s both smooth and subtle. Kish says that it is rare a sighted person even notices he’s making an unusual noise. Almost all blind people instantly do.</div>
<div style="line-height: 1.3em;">
What people do notice about Kish is his long white cane. His blind person’s cane. Using echolocation, Kish could get around without one. For most of his youth, in fact, he never carried a cane, seeking to avoid the stigma attached to it. Now, as he approaches middle age, he’s come to believe that whatever can conveniently provide him with more information about his environment he will use. Echolocation’s chief liability is that it is not good at detecting holes in the ground, or small dropoffs, which a cane can do. There are also some figure-ground issues with echolocation — a park bench can “disappear” when it’s directly in front of a stone wall — and a cane, in essence, increases the length of your arm by as much as five feet.</div>
<div style="line-height: 1.3em;">
Kish also keeps aware, during the day, of where the sun is striking him — a good way to determine direction — and how the cracks between sidewalk blocks line up; if you remain steadily perpendicular to them, you’re not veering.</div>
<div style="line-height: 1.3em;">
When it’s all put together, says Kish, he has very rich, very detailed pictures in his head.</div>
<div style="line-height: 1.3em;">
“In color?” I ask.</div>
<div style="line-height: 1.3em;">
“No,” he says. “I’ve never seen color, so there’s no color. It’s more like a sonar, like on the Titanic.”</div>
<div style="line-height: 1.3em; text-align: center;">
—-</div>
<div class="wp-caption alignleft" id="attachment_20459" style="float: left; margin: 0px 10px 5px 0px; width: 310px;">
<a href="http://www.mensjournal.com/wp-content/uploads/m203bate.jpg" style="color: #d71a11; text-decoration: none;"><img alt="" class="size-medium wp-image-20459 " height="300" src="http://www.mensjournal.com/wp-content/uploads/m203bate-300x300.jpg" title="m203bate" width="300" /></a><br />
<div class="wp-caption-text" style="line-height: 1.3em;">
At his high school graduation in 1984, Kish was voted "most likely to succeed." Photo courtesy Daniel Kish</div>
</div>
<div style="line-height: 1.3em;">
Kish can hardly remember a time when he didn’t click. He came to it on his own, intuitively, at age two, about a year after his second eye was removed. Many blind children make noises in order to get feedback — foot stomping, finger snapping, hand clapping, tongue clicking. These behaviors are the beginnings of echolocation, but they’re almost invariably deemed asocial by parents or caretakers and swiftly extinguished. Kish was fortunate that his mother never tried to dissuade him from clicking. “That tongue click was everything to me,” he says.</div>
<div style="line-height: 1.3em;">
He has a vivid recollection of sneaking out his bedroom window in the middle of the night, at age two and a half, and climbing over a fence into his neighbor’s yard. “I was in the habit of exploring whatever I sensed around me,” he writes in his journal. He soon wondered what was in the yard of the next house. And the one after that. “I was on the other side of the block before someone discovered me prowling around their backyard and had the police return me home to completely flummoxed parents.”</div>
<div style="line-height: 1.3em;">
Kish was born in Montebello, California, into a difficult family situation. His younger brother, Keith, was also born with retinoblastoma — it’s genetic, though neither of Kish’s parents had the disease. Doctors managed to save enough of Keith’s eyesight so that he doesn’t need echolocation. He’s now a middle school English teacher. Kish’s father, who worked as an automobile mechanic, was a physically abusive alcoholic, and his mother left him when Kish was six.</div>
<div style="line-height: 1.3em;">
“I was a violent kid,” says Kish. He frequently got into fistfights. “I rarely lost. My strategy consisted of immobilizing opponents before they could hit me too often.” He went to mainstream schools and relied almost exclusively on echolocation to orient himself, though at the time neither he nor his mom had any concept of what he was doing. “There was no one to explain it, there was no one to help me enhance it, and we all just kind of took it for granted,” he says. “My family and friends were like, ‘Yeah, he does this funny click thing and he gets around.’ ” They called it his radar. Navigating new places, he says, was like solving a puzzle.</div>
<div style="line-height: 1.3em;">
He rode his bike with wild abandon. “I used to go to the top of a hill and scream ‘Dive bomb!’ and ride down as fast as I could,” he says. This is when he was eight. The neighborhood kids would scatter. “One day I lost control of the bicycle, crashed through these trash cans, and smashed into a metal light pole. It was a violent collision. I had blood all over my face. I picked myself up and went home.”</div>
<div style="line-height: 1.3em;">
He was raised with almost no dispensation for his blindness. “My upbringing was all about total self-reliance,” he writes, “of being able to go after anything I desired.” His career interests, as a boy, included policeman, fireman, pilot, and doctor. He was a celebrated singer and voracious consumer of braille books. He could take anything apart and put it back together — a skill he retains. Once, when I was driving Kish to an appointment with a student, the GPS unit in my car stopped working. Kish examined the unit with his hands, instructed me from the passenger seat how to get to the nearest Radio Shack, and told me which part to buy (the jack on the power cord was faulty). He was named “best brain” in middle school and graduated high school with a GPA close to 4.0. He was voted “most likely to succeed.”</div>
<div style="line-height: 1.3em;">
He attended the University of California Riverside, then earned two master’s degrees — one in developmental psychology, one in special education. He wrote a thesis on the history and science of human echolocation, and as part of that devised one of the first echolocation training programs. The ability of some blind individuals to perceive objects well before they could touch them was noted as early as 1749 by French philosopher Denis Diderot. He theorized it had something to do with vibrations against the skin of the face. In the early 1800s, a blind man from England named James Holman journeyed around the world — he may have been the most prolific traveler in history up to that point, Magellan and Marco Polo included — relying on the echoes from the click of his cane. Not until the 1940s, in Karl Dallenbach’s lab at Cornell University, was it irrefutably proven that humans could echolocate.</div>
<div style="line-height: 1.3em;">
The thesis was the first time Kish really studied what he’d been doing all his life; it was the beginning, as he put it, of “unlocking my own brain.” He then became the first totally blind person in the United States (and likely the world) to be fully certified as an orientation and mobility specialist — that is, someone hired by the visually impaired to learn how to get around.</div>
<div style="line-height: 1.3em; text-align: center;">
—-</div>
<div class="wp-caption alignright" id="attachment_20460" style="float: left; margin: 0px 10px 5px 0px; width: 310px;">
<a href="http://www.mensjournal.com/wp-content/uploads/m203batf.jpg" style="color: #d71a11; text-decoration: none;"><img alt="" class="size-medium wp-image-20460 " height="300" src="http://www.mensjournal.com/wp-content/uploads/m203batf-300x300.jpg" title="m203batf" width="300" /></a><br />
<div class="wp-caption-text" style="line-height: 1.3em;">
Kish teaching echolocation. Photo courtesy Daniel Kish</div>
</div>
<div style="line-height: 1.3em;">
It was never Kish’s goal to run a foundation dedicated to the blind. He planned to be a psychologist. But he could not ignore the fact that few blind people enjoyed anything close to his freedom of movement, and he had grown weary of society’s attitude toward the blind. “I am belittled, patronized, disrespected, invaded, restricted, and presumed weak, vulnerable, or otherwise incapacitated,” he wrote in his journal. It still drives him crazy when he’s congratulated for simply crossing the street or preparing dinner.</div>
<div style="line-height: 1.3em;">
In a letter he posted on his website a few years ago, Kish responded to a public school program in New Jersey called Kindness Beats Blindness, in which hundreds of middle school students were blindfolded while others led them around, to develop sympathy for the blind. “I have felt beaten and pummeled by many things,” he wrote, “misplaced kindness foremost among them.” When I asked Kish about the letter he said, “I have a reputation for being a pain in the ass.” One of his closest friends sometimes refers to him as “the bridge burner.”</div>
<div style="line-height: 1.3em;">
Young people, says Kish, are especially hard-hit. “Most blind kids hear a lot of negative talk. ‘Don’t do this, don’t do that, don’t move. No, here, let me help you.’ The message you get, if you’re blind, is you’re intellectually deficient, you’re emotionally deficient, you’re in all ways deficient.” A few sighted people have commented to Kish that they’d rather be dead than blind.</div>
<div style="line-height: 1.3em;">
So in 2001 he started World Access for the Blind. One of its missions is to counter every no that blind people hear. Blindness, Kish says, should be understood — by both the blind and the sighted — as nothing more than an inconvenience. “Most of my life,” he writes, “I never even thought of myself as blind. In fact, I saw myself as smarter, more agile, stronger, and generally more capable than most other boys my age.”</div>
<div style="line-height: 1.3em;">
World Access operates on what Kish calls “an annual budget of silliness” — less than $200,000 a year. (Kish himself makes only “a survival wage.”) He depends on the “blind vine,” the chattery network of the visually impaired, to spread the word. When a potential student, or a parent of a student, agrees to hire World Access, either Kish or one of three other World Access teachers — all blind or visually impaired — will pay a visit, whether it’s on the other side of Los Angeles or the other side of the world.</div>
<div style="line-height: 1.3em;">
Lessons can consist of private meetings a few times a month, or an intensive week of training for students farther afield. He’s visited a group of blind students in northern Mexico three times and traveled to Scotland eight times. In all, Kish has taught in 14 countries, including Armenia, South Africa, Switzerland, and Ukraine. Blind students or organizations in more than a dozen other nations, from Afghanistan to Guatemala, are now on his waiting list. The chief focus of World Access classes is setting students on the path to complete autonomy. Echolocation is an essential element of what Kish terms “a holistic approach” that also includes lessons on comfortable social interactions, confident self-image, and nonvisual conversational cues (a head turn can be noted by the sound of hair swishing; arm gestures by the whisper of skin brushing against clothing; the shift of someone’s body by the creaking of furniture).</div>
<div style="line-height: 1.3em;">
World Access doesn’t turn anyone away for lack of resources. But there are a couple of reasons why the organization hasn’t trained more students. The first is Kish’s general ethos about how blind children should be raised. “Running into a pole is a drag, but never being allowed to run into a pole is a disaster,” he writes. “Pain is part of the price of freedom.” This attitude is not wildly popular, especially in a safety-first nation like the United States. Also, echolocation is not easy to master. Kish compares it with piano lessons — anyone can learn basics; very few will make it to Carnegie Hall. Only about 10 percent of the people who learn echolocation, he admits, find their abilities immediately enriched.</div>
<div style="line-height: 1.3em;">
And then there is resistance from mainstream organizations. The National Federation of the Blind, the largest blind organization in America, does not endorse Kish’s work. “Let’s just say he’s unique,” says John Paré, the federation’s executive director for strategic initiatives, clearly straining to be polite. Paré believes that for most people, echolocation is not worth the tremendous effort required to grasp it. “We urge people to learn how to use a long white cane,” he says. According to Kish, a colleague once overheard members of the federation refer to him as Clicker Boy. “The blindness field is firmly based in tradition and dogma and is very slow to evolve,” says Kish. “It’s been traditionally dominated by sighted people who feel the need to tell blind people what to do.”</div>
<div style="line-height: 1.3em;">
The same afternoon I first visit Kish, I also meet Brian Bushway and Juan Ruiz. Bushway became blind at age 14 due to a genetic condition known as optic nerve atrophy and was introduced to Kish soon after. Ruiz was born blind and was one of Kish’s first students; Kish began working with him while preparing his echolocation thesis. They both told me, individually, that Kish’s teaching transformed them, allowing them to feel at peace with their blindness and at one with the world.</div>
<div style="line-height: 1.3em;">
Bushway and Ruiz are now in their late 20s and have become instructors with World Access. They often hang out at Kish’s home, forming a foul-mouthed and funny little gang. (Bushway: “You know why echolocators get all the girls? ’Cause they’re skilled with their tongues and comfortable in the dark.”) They’ve become so adept at echolocation that, in many ways, they have surpassed their teacher — at least in terms of fearlessness, sociability, and willingness to run into poles. They’re the next generation of echolocators, ready to take Kish’s work and see how far they can push it.</div>
<div style="line-height: 1.3em;">
<span style="color: white;">————————————————————————-</span>—-</div>
<div style="line-height: 1.3em;">
If you happen to be blind and want to live a bold, stereotype-smashing life, there will be blood. I witness this firsthand when I spend a day mountain biking with Bushway and Ruiz. (Kish, acceding to the realities of near–middle age, stays home.) We ride on a roller-coastery ridgetop trail in the Santa Ana Mountains, above the town of Mission Viejo. Clipped to the rear fork of each of our bikes is a plastic zip tie, attached so that the end flicks through our spokes, creating a constant snapping sound that lets Bushway and Ruiz know where the other bikes are. But to determine where the trail is going, and where the bushes and rocks and fence posts and trees are, the boys rely on echolocation.</div>
<div style="line-height: 1.3em;">
Bushway is a fearless biker. He often flies down the dirt trail in aerodynamic form, hands off the brakes, clicking as fast and as loud as he can. “Your brain is on overload,” he says to me during a water break. “You feel like you can hear every bush, every tree. Your body is hyperaware.” I try and warn them when the trail presents a serious consequence, like a long drop-off on one side or a cactus jutting out. But mostly I’m just along for the ride. It’s difficult to believe, even though it’s happening right in front of me. It’s incredible.</div>
<div style="line-height: 1.3em;">
And then, suddenly, it’s not. When I look behind me and see that Ruiz has drifted back, I stop and wait for him. I’m just standing there, silently, and before I realize what’s happening, he is bearing down on me. I shout, and he pulls the brakes, but it’s too late. He smashes into me and crushes his left hand between his handlebar and the back of my seat post. He falls off his bike and rolls about in pain, clutching his hand. There’s a trickle of blood, though nothing seems broken. I feel terrible, but Ruiz says it’s his fault — he should have echolocated my bike, even if I wasn’t moving. We finish the ride, with Ruiz using only one hand.</div>
<div style="line-height: 1.3em;">
The next day I join Kish and Bushway as they teach Sebastian Mancipe, who is 15 and has been working with World Access for three years. When he started, he rarely came out of his bedroom. He had little interaction with the outside world. He developed infant glaucoma and was blind by age three months. His parents moved from Colombia to the United States to give him a chance at a better life. His mother, Viviana, saw a brief appearance by Kish on the Ripley’s Believe It or Not television show, and soon hired World Access to work with Sebastian.</div>
<div style="line-height: 1.3em;">
He now rides a skateboard. He ice-skates. He’s popular at school, stocked with friends and a busy social life. I follow as Kish and Bushway stroll around Sebastian’s neighborhood, in a busy section of Burbank. He’d obviously mastered the echolocation basics — the pot lid, the pillow, general shapes. Kish and Bushway encourage him to push his skills further. “A tree,” says Kish, clicking a couple of times, “is like a bush on a pole.” They walk on. “A tree without a bush on top is probably a telephone pole.” They pass a parking lot. “A large object that starts out low at one end, rises in the middle, and drops off again at the other end — that’s a parked car.”</div>
<div style="line-height: 1.3em;">
Back at home, I ask Sebastian’s mother about the impact World Access has had on her son. “It was an awakening,” she says. “He believes he can do anything. To see Sebastian as a normal child…” She can’t complete the sentence before the tears come.</div>
<div style="line-height: 1.3em; text-align: center;">
—-</div>
<div style="line-height: 1.3em;">
The longer the waiting list for his services grows, the more conflicted Kish feels. He knows what he’s doing is important. But what he really wants, as more people clamor for his time, as the frequent-flier miles add up, is to hand over the reins of World Access and run away from it all.</div>
<div style="line-height: 1.3em;">
He’s essentially a loner. “My constitution,” he says, “is that of Grizzly Adams.” In 2003 he purchased a 12-foot by 12-foot cabin deep in the Angeles National Forest. It was built in 1916; he paid $10,000 for it. To get there he’d take a taxi to the end of the road and hike in. “My only company,” he wrote in his journal at the time, “is a small family of mice.” He explored the wilderness. “I taught myself how to negotiate tricky, winding trails with sharp switchbacks, how to cross rushing streams on slippery stones. I’ve gone for miles and days without meeting another soul.”</div>
<div style="line-height: 1.3em;">
He was once asked by a colleague what he thought the biggest problem was with being blind. “My biggest barrier is people,” he answered. “Especially sighted people.” He has never once in his life had a girlfriend or, for that matter, a boyfriend. When I ask him, via e-mail, to explain why, his response is three words: “Lack of interest.”</div>
<div style="line-height: 1.3em;">
Two tragedies, nearly 20 years apart, have bookended his adult life. The first was the death of his dog, a black lab named Whiska. This was in 1990. She was run over by a car while Kish was walking with her. Kish has always blamed himself for the accident. “I loved Whiska with an intensity that completely distorted my better judgment,” he wrote. “I spoiled her rotten and took over her job. She forgot to watch for traffic, because I’d always done that for her.” He had nightmares for a year after the accident. “The chain’s just dangling and there’s no dog. I’ll never forget that moment.” Not long after, he got another dog, but soon started traveling and gave him away. That was his last pet.</div>
<div style="line-height: 1.3em;">
The second tragedy occurred in January 2007 when his cabin burned down. He’d had a wood-burning stove installed, and the wrong materials were used for the chimney. The fire was fast-moving and horrific — “my last memories of my cabin are the ominous crackle and rumble of advancing flames” — and Kish had no idea if it would engulf the entire canyon, incinerating him as well. The disaster haunts him; he keeps a chunk of melted glass from the cabin in his home in Long Beach. “A piece of my own heart has gone up in flames,” he wrote. He plans to one day return to the woods, perhaps permanently. “I find people,” he says, “to be incredibly draining.”</div>
<div style="line-height: 1.3em; text-align: center;">
—-</div>
<div style="line-height: 1.3em;">
Kish has an idea. Beyond the pot lid and the pillow, beyond the mission of World Access, there is something he has been quietly working on for more than a decade. If his wish is fulfilled — if someone else takes over World Access and he’s able to escape from life’s perpetual rush hour — it may prove to be his true legacy. What Kish envisions is the next leap in human echolocation. His idea is to become more like a bat.</div>
<div style="line-height: 1.3em;">
Bats are the best. Some can fly in complete darkness, navigating around thousands of other bats while nabbing insects one millimeter wide. Bats have evolved, over millions of years, to possess the ideal mouth shape and the perfect ear rotation for echolocation. They can perceive high-frequency sound waves, beyond the range of human hearing — waves that are densely packed together, whose echoes give precise detail.<br />
There is evidence that humans could be that good. Bats have tiny brains. Just the auditory cortex of a human brain is many times larger than the entire brain of a bat. This means that humans can likely process more complex auditory information than bats. What we’ll require, to make up for bats’ evolutionary head start, is a little artificial boost.</div>
<div style="line-height: 1.3em;">
Actually, two boosts. We need a way to create batlike sound waves, and we need to be able to hear those waves. In pursuit of these goals, Kish has spent time in New Zealand with Leslie Kay, who worked on underwater sonar for the British Navy during the Cold War. For nearly 50 years, Kay tinkered with ideas for helping the blind to see with sound. He eventually introduced, after many weeks of consultation with Kish, a product called the K-Sonar, a flashlight-size machine that attaches to a blind person’s cane and emits ultrasonic pulses. The pulses are then digitally translated into tones humans can hear, through earphones. “Flowers actually sound soft,” says Kish. “Stones sound hard and crisp. It pretty much represents the physical environment as music.” The problem is range: The K-Sonar can detect a postage stamp from 15 feet, but not the side of a barn from 30 feet.</div>
<div style="line-height: 1.3em;">
If money were no object, Kish believes that blind people could essentially mimic bats within five years. A next generation of K-Sonar, using the input from a global consortium of scientists that Kish has been corresponding with, should have a nearly limitless range. Our hearing, Kish says, can be increased tenfold through surgical augmentation — basically, inner-ear microphone implants. Combine the two and it’s possible that the blind will be able to take up tennis. Kish figures it would require $15 million to prove whether or not his idea is feasible. He fears he’ll never get the opportunity.</div>
<div style="line-height: 1.3em;">
“It’s virtually impossible to gather funding for experimental devices for the blind,” he says. “The blind population is seen as a lost cause.” Kish’s patience is running thin. He is still reaching out to scientists and studying scholarly journals and pondering ways to conjure the money. But more and more these days, he finds himself daydreaming about rebuilding his cabin and devoting himself to playing music, to writing. Let the new crop of echolocators take over the research and the networking and the panhandling. So for the foreseeable future, at least, Kish will continue to click in his usual way. And the sighted world will continue to not notice.</div>
<div style="line-height: 1.3em; text-align: center;">
—</div>
<div style="line-height: 1.3em; text-align: center;">
<em>This article originally appeared in the March 2011 issue of</em> Men’s Journal.</div>
</div>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com1tag:blogger.com,1999:blog-5880677466498354462.post-21063489146668409942012-10-09T14:16:00.003+05:302013-05-22T15:22:09.441+05:30A Brief Biography of Jean Piaget<div dir="ltr" style="text-align: left;" trbidi="on">
<h2 align="center">
A Brief Biography of Jean Piaget</h2>
<div align="center">
Text and images provided courtesy of the <a href="http://www.archivesjeanpiaget.ch/" target="_blank">Archives
Jean Piaget</a> </div>
<table align="center" border="0" cellpadding="2" cellspacing="0" style="width: 600px;"><tbody>
<tr align="center" valign="MIDDLE"><td valign="top"><img alt="Piaget" border="0" height="108" src="http://www.piaget.org/biography/bio1a.gif" width="175" /><br />
<br />
<img alt="Jean Piaget" border="0" height="126" src="http://www.piaget.org/biography/bio2a.gif" width="102" />
<br />
<br />
<img alt="Jean Piaget" border="0" height="166" src="http://www.piaget.org/biography/bio5a.gif" width="122" />
<br />
<br />
<img alt="Jean Piaget" border="0" height="120" src="http://www.piaget.org/biography/bio3a.gif" width="168" />
<br />
<br />
<img alt="Jean Piaget" border="0" height="123" src="http://www.piaget.org/biography/bio4a.gif" width="169" />
<br />
<br />
<img height="169" src="http://www.piaget.org/biography/bio6a.jpg" width="139" /></td>
<td align="left" valign="top"><h2 class="content">
Jean Piaget (1896-1980)</h2>
<span class="content"><img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />Jean
Piaget was born in Neuchâtel (Switzerland) on August 9, 1896.
He died in Geneva on September 16, 1980. He was the oldest child of
Arthur Piaget, professor of medieval literature at the University,
and of Rebecca Jackson. At age 11, while he was a pupil at Neuchâtel
Latin high school, he wrote a short notice on an albino sparrow. This
short paper is generally considered as the start of a brilliant scientific
career made of over sixty books and several hundred articles. </span>
<span class="content"><img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />His
interest for mollusks was developed during his late adolescence
to the point that he became a well-known malacologist by finishing
school. He published many papers in the field that remained of interest
for him all along his life. </span>
<br />
<span class="content"><img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />After
high school graduation, he studied natural sciences at the University
of Neuchâtel where he obtained a Ph.D. During this period,
he published two philosophical essays which he considered as "adolescence
work" but were important for the general orientation of his thinking.
</span>
<br />
<span class="content"><img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />After
a semester spent at the University of Zürich where he developed
an interest for psychoanalysis, he left Switzerland for France.
He spent one year working at the Ecole de la rue de la Grange-aux-Belles
a boys' institution created by Alfred Binet and then directed by
De Simon who had developed with Binet a test for the measurement
of intelligence. There, he standardized Burt's test of intelligence
and did his first experimental studies of the growing mind. </span>
<br />
<span class="content"><img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />In
1921, he became director of studies at the J.-J. Rousseau Institute
in Geneva at the request of Sir Ed. Claparède and P. Bovet.
</span>
<br />
<span class="content"><img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />In
1923, he and Valentine Châtenay were married. The couple had
three children, Jacqueline, Lucienne and Laurent whose intellectual
development from infancy to language was studied by Piaget. </span>
<br />
<span class="content"><img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />Successively
or simultaneously, Piaget occupied several chairs: psychology, sociology
and history of science at Neuchâtel from 1925 to 1929; history
of scientific thinking at Geneva from 1929 to 1939; the International
Bureau of Education from 1929 to 1967; psychology and sociology
at Lausanne from 1938 to 1951; sociology at Geneva from 1939 to
1952, then genetic and experimental psychology from 1940 to 1971.
He was, reportedly, the only Swiss to be invited at the Sorbonne
from 1952 to 1963. In 1955, he created and directed until his death
the International Center for Genetic Epistemology. </span>
<br />
<span class="content"><img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />His
researches in developmental psychology and genetic epistemology
had one unique goal: how does knowledge grow? His answer is that
the growth of knowledge is a progressive construction of logically
embedded structures superseding one another by a process of inclusion
of lower less powerful logical means into higher and more powerful
ones up to adulthood. Therefore, children's logic and modes of thinking
are initially entirely different from those of adults. </span>
<br />
<div class="content">
<img alt="[just a dot]" height="1" hspace="8" src="http://www.piaget.org/images/dot_clear.gif" width="1" />Piaget's
oeuvre is known all over the world and is still an inspiration in
fields like psychology, sociology, education, epistemology, economics
and law as witnessed in the annual catalogues of the Jean Piaget
Archives. He was awarded numerous prizes and honorary degrees all
over the world.</div>
<img height="95" src="http://www.piaget.org/biography/signature.gif" width="288" /></td></tr>
</tbody></table>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-77223816137371773352012-10-09T14:15:00.001+05:302013-05-22T15:22:49.654+05:30Abraham Harold Maslow<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="http://upload.wikimedia.org/wikipedia/commons/6/60/Maslow%27s_Hierarchy_of_Needs.svg"><img alt="http://upload.wikimedia.org/wikipedia/en/thumb/e/e0/Abraham_Maslow.jpg/220px-Abraham_Maslow.jpg" src="http://upload.wikimedia.org/wikipedia/en/thumb/e/e0/Abraham_Maslow.jpg/220px-Abraham_Maslow.jpg" /></a><br />
<b>Abraham Harold Maslow</b> (April 1, 1908 – June 8, 1970) was an <a href="http://en.wikipedia.org/wiki/United_States" title="United States">American</a> psychologist who was best known for creating <a href="http://en.wikipedia.org/wiki/Maslow%27s_hierarchy_of_needs" title="Maslow's hierarchy of needs">Maslow's hierarchy of needs</a>, a theory of self-actualization.<sup class="reference" id="cite_ref-obit_1-0"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-obit-1">[2]</a></sup> Maslow was a <a href="http://en.wikipedia.org/wiki/Psychology" title="Psychology">psychology</a> professor at <a href="http://en.wikipedia.org/wiki/Brandeis_University" title="Brandeis University">Brandeis University</a>, <a href="http://en.wikipedia.org/wiki/Brooklyn_College" title="Brooklyn College">Brooklyn College</a>, <a class="mw-redirect" href="http://en.wikipedia.org/wiki/New_School_for_Social_Research" title="New School for Social Research">New School for Social Research</a> and <a href="http://en.wikipedia.org/wiki/Columbia_University" title="Columbia University">Columbia University</a>.
He stressed the importance of focusing on the positive qualities in
people, as opposed to treating them as a "bag of symptoms."<sup class="reference" id="cite_ref-hoffman109_2-0"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-hoffman109-2">[3]</a></sup><br />
<h2>
<span class="mw-headline" id="Abraham_Maslow_Quotes">Abraham Maslow Quotes</span></h2>
"For any man of good will, there is work to be done here, effective,
virtuous, satisfying work which can give rich meaning to one's own life
and to others"<br />
<h3>
<span class="mw-headline" id="Metamotivation">Metamotivation</span></h3>
Maslow used the term <a href="http://en.wikipedia.org/wiki/Metamotivation" title="Metamotivation">metamotivation</a>
to describe self actualized people who are driven by innate forces
beyond their basic needs, so that they may explore and reach their full
human potential.<sup class="reference" id="cite_ref-36"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-36">[37]</a></sup><br />
<h3>
<span class="mw-headline" id="B-values">B-values</span></h3>
In studying accounts of peak experiences, Maslow identified a manner
of thought he called "Being-cognition" (or "B-cognition", which is
holistic and accepting, as opposed to the evaluative
"Deficiency-cognition" or "D-cognition") and values he called
"Being-values".<sup class="reference" id="cite_ref-37"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-37">[38]</a></sup> He listed the B-values as:<br />
<ul>
<li>Wholeness (unity; integration; tendency to one-ness;
interconnectedness; simplicity; organization; structure;
dichotomy-transcendence; order);</li>
<li>Perfection (necessity; just-right-ness; just-so-ness; inevitability; suitability; justice; completeness; "oughtness");</li>
<li>Completion (ending; finality; justice; "it's finished"; fulfillment; finis and telos; destiny; fate);</li>
<li>Justice (fairness; orderliness; lawfulness; "oughtness");</li>
<li>Aliveness (process; non-deadness; spontaneity; self-regulation; full-functioning);</li>
<li>Richness (differentiation, complexity; intricacy);</li>
<li>Simplicity (honesty; nakedness; essentiality; abstract, essential, skeletal structure);</li>
<li>Beauty (rightness; form; aliveness; simplicity; richness; wholeness; perfection; completion; uniqueness; honesty);</li>
<li>Goodness (rightness; desirability; oughtness; justice; benevolence; honesty);</li>
<li>Uniqueness (idiosyncrasy; individuality; non-comparability; novelty);</li>
<li>Effortlessness (ease; lack of strain, striving or difficulty; grace; perfect, beautiful functioning);</li>
<li>Playfulness (fun; joy; amusement; gaiety; humor; exuberance; effortlessness);</li>
<li>Truth (honesty; reality; nakedness; simplicity; richness; oughtness;
beauty; pure, clean and unadulterated; completeness; essentiality).</li>
<li>Self-sufficiency (autonomy; independence;
not-needing-other-than-itself-in-order-to-be-itself; self-determining;
environment-transcendence; separateness; living by its own laws).<h3>
<span class="mw-headline" id="Hierarchy_of_Needs">Hierarchy of Needs</span></h3>
</li>
</ul>
A visual aid was created to explain his theory, which was called the
Hierarchy of Needs, is a pyramid depicting the levels of human needs,
psychological and physical. When a human being ascends the steps of the
pyramid he reaches self-actualization.<br />
<ul>
<li>At the bottom of the pyramid are the “Basic needs or Physiological needs” of a human being: food, water, sleep and sex.</li>
<li>The next level is “Safety Needs: Security, Order, and Stability.”
These two steps are important to the physical survival of the person.
Once individuals have basic nutrition, shelter and safety, they attempt
to accomplish more.</li>
<li>The third level of need is “Love and Belonging,” which are
psychological needs; when individuals have taken care of themselves
physically, they are ready to share themselves with others, such as with
family and friends.</li>
<li>The fourth level is achieved when individuals feel comfortable with
what they have accomplished. This is the “Esteem” level, the need to be
competent and recognized, such as through status and level of success.</li>
<li>Then there is the “Cognitive” level, where individuals intellectually stimulate themselves and explore.</li>
<li>After that is the “Aesthetic” level, which is the need for harmony, order and beauty.<sup class="reference" id="cite_ref-31"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-31">[32]</a></sup></li>
<li>At the top of the pyramid, “Need for Self-actualization,” occurs
when individuals reach a state of harmony and understanding because they
have achieved their full potential.<sup class="reference" id="cite_ref-32"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-32">[33]</a></sup>
Once a person has reached the self-actualization state they focus on
themselves and try to build their own image. They may look at this in
terms of feelings such as self-confidence or by accomplishing a set
goal.<sup class="reference" id="cite_ref-33"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-33">[34]</a></sup></li>
</ul>
The first four levels are known as '<b>Deficit needs'</b> or '<b>D-needs'</b>.
This means that if you don't have enough of one of those 4 needs,
you'll have the feeling to get it. But when you do get them then you
feel content. These needs alone are not motivating.<sup class="reference" id="cite_ref-34"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-34">[35]</a></sup><br />
Maslow wrote that there are certain conditions that must be fulfilled
in order for the basic needs to be satisfied. For example, freedom of
speech, freedom to express oneself, and freedom to seek new information<sup class="reference" id="cite_ref-35"><a href="http://en.wikipedia.org/wiki/Abraham_Maslow#cite_note-35">[36]</a></sup> are a few of the prerequisites. Any blockages of these freedoms could prevent the satisfaction of the basic needs.<br />
<a href="http://upload.wikimedia.org/wikipedia/commons/6/60/Maslow%27s_Hierarchy_of_Needs.svg"><img alt="File:Maslow's Hierarchy of Needs.svg" height="480" src="http://upload.wikimedia.org/wikipedia/commons/thumb/6/60/Maslow%27s_Hierarchy_of_Needs.svg/800px-Maslow%27s_Hierarchy_of_Needs.svg.png" width="640" /></a></div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-71543093668658831942012-09-08T12:48:00.000+05:302012-09-08T12:48:36.689+05:30Linus Carl Pauling<div dir="ltr" style="text-align: left;" trbidi="on"><img alt="" height="267" src="http://upload.wikimedia.org/wikipedia/commons/thumb/5/58/L_Pauling.jpg/220px-L_Pauling.jpg" width="220" /><br />
<br />
<br />
<br />
<div style="background-color: white; font-family: sans-serif; font-size: 13px; line-height: 19px; margin-bottom: 0.5em; margin-top: 0.4em; text-align: -webkit-auto;"><b>Linus Carl Pauling</b> (February 28, 1901 – August 19, 1994)<sup class="reference" id="cite_ref-frs_0-0" style="line-height: 1em;"><a href="http://en.wikipedia.org/wiki/Linus_Pauling#cite_note-frs-0" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none; white-space: nowrap;">[1]</a></sup> was an American <a href="http://en.wikipedia.org/wiki/Chemist" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Chemist">chemist</a>, <a href="http://en.wikipedia.org/wiki/Biochemist" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Biochemist">biochemist</a>, <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Peace_activist" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Peace activist">peace activist</a>, author, and educator. He was one of the most influential chemists in history and ranks among the most important scientists of the 20th century.<sup class="reference" id="cite_ref-1" style="line-height: 1em;"><a href="http://en.wikipedia.org/wiki/Linus_Pauling#cite_note-1" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none; white-space: nowrap;">[2]</a></sup><sup class="reference" id="cite_ref-2" style="line-height: 1em;"><a href="http://en.wikipedia.org/wiki/Linus_Pauling#cite_note-2" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none; white-space: nowrap;">[3]</a></sup><sup class="reference" id="cite_ref-3" style="line-height: 1em;"><a href="http://en.wikipedia.org/wiki/Linus_Pauling#cite_note-3" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none; white-space: nowrap;">[4]</a></sup> Pauling was one of the founders of the fields of <a href="http://en.wikipedia.org/wiki/Quantum_chemistry" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Quantum chemistry">quantum chemistry</a> and <a href="http://en.wikipedia.org/wiki/Molecular_biology" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Molecular biology">molecular biology</a>.</div><div style="background-color: white; font-family: sans-serif; font-size: 13px; line-height: 19px; margin-bottom: 0.5em; margin-top: 0.4em; text-align: -webkit-auto;">Pauling is the only person to be awarded two unshared <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Nobel_Prizes" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Nobel Prizes">Nobel Prizes</a>, one of only four individuals to have won more than one (<a href="http://en.wikipedia.org/wiki/Marie_Curie" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Marie Curie">Marie Curie</a>, <a href="http://en.wikipedia.org/wiki/John_Bardeen" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="John Bardeen">John Bardeen</a> and <a href="http://en.wikipedia.org/wiki/Frederick_Sanger" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Frederick Sanger">Frederick Sanger</a> are the others) and one of only two people awarded Nobel Prizes in different fields (the Chemistry and Peace prizes), the other being <a href="http://en.wikipedia.org/wiki/Marie_Curie" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Marie Curie">Marie Curie</a> (the Chemistry and Physics prizes). </div></div>Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-68920330055391839102012-09-08T12:47:00.000+05:302012-09-08T12:47:02.233+05:30VITAMIN C AND CARDIOVASCULAR DISEASE<div dir="ltr" style="text-align: left;" trbidi="on"><br />
<div align="CENTER" class="western" style="background-color: white; margin-bottom: 0.49cm;"><span style="font-size: medium;"><span lang="en-US"><b>VITAMIN C AND CARDIOVASCULAR DISEASE</b></span></span><span style="font-size: small;"><span lang="en-US"><b>A Personal Viewpoint by Alan Spencer and Andrew W. Saul</b></span></span></div><div align="CENTER" class="western" style="background-color: white; margin-bottom: 0.49cm;"><br />
</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;">(OMNS, June 22, 2010) Linus Pauling was aware that studies of the animal kingdom showed that most animals have the ability to manufacture vitamin C in their bodies. Humans cannot. Furthermore, on average, mammals make 5,400mg daily when adjusted for body weight, and make more (often considerably more) when under stress or ill. This is about 100 times as much as the 50mg we get from a typical modern diet. It prompts the question, why do animals make so much vitamin C, and what purpose does it serve in the body.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;">A small number of animals which are known to share our inability to make vitamin C include the apes, the guinea pig, the fruit bat, and some birds, all of which will normally get a lot of vitamin C from their food. If you deprive a guinea pig of vitamin C it soon develops a form of cardiovascular disease (damage to its arteries showing within a few weeks). Similarly, studies of genetically modified mice have shown that if you switch off the gene that enables a mouse to produce vitamin C it will also soon show signs of heart disease. Re-introduction of a high vitamin C diet enables the damage to be reversed. While heart disease is rare in the animal kingdom, it is becoming a problem for apes in zoos where their diets are perhaps not as rich in vitamin C as when they are in the wild.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;"><b>Collagen</b><br />
A very important function of vitamin C in the body is its role in the production of collagen. Collagen is the most abundant protein in the body, and forms into fibres which are stronger than iron wire of comparable size. These fibres provide strength and stability to all body tissues, including the arteries. Vitamin C is absolutely essential for the production and repair of collagen, and is destroyed during the process, so a regular supply of vitamin C is necessary to maintain the strength of body tissues. Severe deficiency of vitamin C causes the total breakdown of body tissue witnessed in scurvy. Linus Pauling believed that whilst humans normally obtain sufficient vitamin C to prevent full-blown scurvy, we do not consume enough to maintain the strength of the walls of the arteries. He suggested that of all the structural tissues in the body, the walls of the arteries around the heart are subject to the greatest continual stress. Every time the heart beats the arteries are flattened and stretched, and this has been likened to standing on a garden hose thousands of times a day. Many tiny cracks and lesions develop and the artery walls become inflamed.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;">Dr. Pauling believed that in the presence of adequate supplies of vitamin C this damage can be readily repaired and heart disease is avoided. However, in the absence of adequate levels of vitamin C, the body attempts to repair the arteries using alternative materials: cholesterol and other fatty substances, which attach to the artery wall. (<a href="http://www.campaignfortruth.com/Eclub/220710/CTM-vitCandcardiovasculardisease.htm#1">1</a>-<a href="http://www.campaignfortruth.com/Eclub/220710/CTM-vitCandcardiovasculardisease.htm#8">8</a>)</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;"><b>Cholesterol and Lipoprotein (a), Lp(a)</b><br />
The most abundant amino acids (protein building blocks) in collagen are lysine and proline, and when collagen strands are damaged lysine and proline become exposed. A special kind of cholesterol, lipoprotein(a), is attracted to lysine and proline and will attach itself to the exposed damaged collagen strands. It is an attempt by the body to repair damage to the collagen of the artery walls in the absence of adequate levels of vitamin C. Unfortunately the repair is not ideal and over many years repeated deposits can cause the artery to become narrow and inflamed. Heart attack or stroke is likely to follow (usually caused by a clot forming at the site of the narrowed artery, or by a piece of plaque breaking off and blocking a smaller vessel downstream). When vitamin C levels are low, the body manufactures more cholesterol, especially Lp(a). Conversely, when vitamin C levels are high the body makes less cholesterol.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;">If high blood cholesterol were the primary cause of heart disease, all bears and other hibernating animals would have become extinct long ago. They naturally have high cholesterol levels. One reason bears are still with us is simple: they produce large amounts of vitamin C in their bodies, which stabilises the artery walls, and there is therefore no tendency to develop cholesterol deposits or plaque.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;"><b>Keeping healthy</b><br />
The low levels of vitamin C that are available through diet are inadequate to prevent many people developing arterial plaques, and over time this may result in cardiovascular disease. Post mortem examinations showed that 77% of young American soldiers killed in the Korean war (average age 22) already had well-advanced atherosclerosis (heart disease), and post mortem studies from the Vietnam war gave similar results. Heart disease is not just a disease of the elderly, although it does not usually become life threatening until later in life.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;">How can we prevent it? Pauling believed that once we start taking high levels of vitamin C, the disease process is halted, or at least slowed, as Lp(a) cholesterol is no longer needed as a repair material. He also believed that when we take adequate levels of vitamin C, existing arterial plaques may start to be removed from the arteries. He found that the removal of plaques is more rapid if the amino acid lysine is taken along with vitamin C. Lysine appears to attach to the Lp(a) in existing plaque deposits and helps to loosen them. Linus Pauling recommended at least 3000mg of vitamin C per day as a preventive dose, and significantly higher levels of both vitamin C and lysine for the treatment of existing heart disease. Dosage is a key factor: low doses are ineffective.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;"><b>Retention in the body</b><br />
Another important point is that a single dose of vitamin C is not retained in the body for very long. This fact has been used for a long time by those who do not support the use of high doses of vitamin C as evidence that the body does not need and cannot use large doses. After a single large dose of vitamin C, the blood level quite soon returns to a low level. A lot is excreted, the high blood level only remaining for a few hours.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;">The key factor here is that the body is not designed to function with just a single large dose of vitamin C once a day. Animals are able to manufacture vitamin C in their bodies and do so continuously throughout the day. They have an enzyme which converts glucose to vitamin C, and each day they produce on the order of a hundred times more vitamin C than we are able to get from even a good diet. When animals are ill they manufacture even more, perhaps thousands of times more than we can get from our diet.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;"><b>How much should we take?</b><br />
For people who are essentially fit and well, the Vitamin C Foundation recommends perhaps 3,000mg of vitamin C per day, taken in divided doses as 500mg every four hours, as a protection against the development of heart disease. The problem with even this protective dose is that taking a tablet every four hours is not something that many people would want to adopt as part of their daily routine. But there is good evidence to suggest that this level of intake will help maintain the strength of the arteries and prevent the build up of cholesterol plaques. If everybody were to do this, perhaps heart disease would become a largely a thing of the past (as might many other chronic diseases).</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;">When treating illness, "bowel tolerance" is the indicator of dosage level that should be used. This means taking just under the level of vitamin C (in divided doses) that results in loose stools. Everyone is different. Note that while a few 1,000mg doses a day might make you loose when you are fit and well, your "bowel tolerance" might increase to ten or even a hundred times this when very ill. So, for illness, the levels suggested by the Vitamin C Foundation are 6,000mg to 18,000mg of vitamin C per day (or up to bowel tolerance) plus 2,000mg to 6,000mg of lysine. These vitamin C levels may seem high, but are perhaps not particularly large when compared with levels seen in the animal kingdom. A substantial amount of lysine may be obtained from diet. For example, one may obtain 3,000 to 4,000 milligrams of lysine from about can and a half of beans. Supplementation reduces the need to consume that much.</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;"><b>Controversy</b><br />
<i>"Even though some physicians had observed forty or fifty years ago that amounts of vitamin C a hundred to a thousand times larger (than the RDA) have value in controlling various diseases, the medical profession and most scientists ignored this evidence."</i> (Linus Pauling, <i>How to Live Longer and Feel Better</i>)</div><div class="storybody" style="background-color: white; font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;">In medical circles, Pauling's recommendations remain controversial. However, his theory seems reasonable, and the implications are so significant that some major scientific trials should have been undertaken to assess it. This has not happened. Supporters of high-dose vitamin C have had their applications for research funding denied repeatedly, and have had to be content with carrying out small scale research projects and case studies. These have been very positive. Over the past fifteen years, Pauling therapy advocates have received hundreds of reports from heart patients who have self administered the therapy. It is reported that these people typically recover within 30 days, and the majority experience significant relief within as little as a week or two. In 1994, Linus Pauling wrote, <i>"I think we can get almost complete control of cardiovascular disease, heart attacks and strokes by the proper use of vitamin C and lysine. It can prevent cardiovascular disease and even cure it. If you are at risk of heart disease, or if there is a history of heart disease in your family, if your father or other members of the family died of a heart attack or stroke or whatever, or if you have a mild heart attack yourself, then you had better be taking vitamin C and lysine."</i></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0cm; text-align: -webkit-auto;"><span class="storybody" style="font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;"><br />
</span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span class="storybody" style="font-family: 'Palatino Linotype'; font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><b>References:</b></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"> <span style="font-size: x-small;"><span lang="en-US">(1<a href="" name="1"></a>) Rath M, Pauling L. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9388-90. PMID: 2147514. Free full text download: </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--www.pnas.org/content/87/23/9388.full.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://www.pnas.org/content/87/23/9388.full.pdf</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">(2<a href="" name="2"></a>) Rath M, Pauling L. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6204-7. [Erratum in: Proc Natl Acad Sci U S A 1991 Dec 5;88(24):11588.] PMID: 2143582. Free full text download: </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--www.pnas.org/content/87/16/6204.full.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://www.pnas.org/content/87/16/6204.full.pdf</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">(3<a href="" name="3"></a>) Rath M, Pauling L. Solution To the Puzzle of Human Cardiovascular Disease: Its Primary Cause Is Ascorbate Deficiency Leading to the Deposition of Lipoprotein(a) and Fibrinogen/Fibrin in the Vascular Wall. J Orthomolecular Med, Vol 6, 3&4th Quarters, 1991, p 125. Free full text download:</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/library/jom/1991/pdf/1991-v06n03--A-04-p125.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/library/jom/1991/pdf/1991-v06n03&04-p125.pdf</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">(4<a href="" name="4"></a>) Pauling L, Rath M. An Orthomolecular Theory of Human Health and Disease. J Orthomolecular Med, Vol 6, 3&4th Quarters, 1991, p 135. Free full text download:</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/library/jom/1991/pdf/1991-v06n03--A-04-p135.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/library/jom/1991/pdf/1991-v06n03&04-p135.pdf</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">(5<a href="" name="5"></a>) Rath M, Pauling L. Apoprotein(a) Is An Adhesive Protein. J Orthomolecular Med, Vol 6, 3&4th Quarters, 1991, p 139. Free full text download: </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/library/jom/1991/pdf/1991-v06n03--A-04-p139.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/library/jom/1991/pdf/1991-v06n03&04-p139.pdf</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">(6<a href="" name="6"></a>) Rath M, Pauling L. Case Report: Lysine/Ascorbate Related Amelioration of Angina Pectoris. J Orthomolecular Med, Vol 6, 3&4th Quarters, 1991, p 144. Free full text download:</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/library/jom/1991/pdf/1991-v06n03--A-04-p144.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/library/jom/1991/pdf/1991-v06n03&04-p144.pdf</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">(7<a href="" name="7"></a>) Rath M, Pauling L. A Unified theory of Human Cardiovascular Disease Leading the Way To the Abolition of This Diseases As A Cause for Human Mortality. J Orthomolecular Med, Vol 7, First Quarter 1992, p 5. Free full text download: </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/library/jom/1992/pdf/1992-v07n01-p005.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/library/jom/1992/pdf/1992-v07n01-p005.pdf</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">(8<a href="" name="8"></a>) Rath M, Pauling L. Plasmin-induced Proteolysis and the Role of Apoprotein(a), Lysine and Synthetic Lysine Analogs. J Orthomolecular Med, Vol 7, First Quarter 1992, p 17. Free full text download:</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/library/jom/1992/pdf/1992-v07n01-p017.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/library/jom/1992/pdf/1992-v07n01-p017.pdf</u></span></span></span></a></span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><b>For More Information:</b></span></span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;">Fonorow O. Practicing Medicine Without a License? The Story of the Linus Pauling Therapy for Heart Disease. 2008. Lulu.com. ISBN-10: 1435712935; ISBN-13: 978-1435712935. Reviewed in J Orthomolecular Med, 2009. Vol 24, No 1, p 51-5.</span></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">Hickey S and Roberts H. Ascorbate: The Science of Vitamin C. 2004. ISBN-10: 1411607244; ISBN-13: 978-1411607248. Lulu.com. This book contains 575 references, and is reviewed at</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--www.doctoryourself.com/ascorbate.html" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://www.doctoryourself.com/ascorbate.html</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">Hickey S, Saul AW. Vitamin C: The Real Story. Laguna Beach, CA: Basic Health Publications, 2008. ISBN: 978-1-59120-223-3. This book contains 387 references, and is reviewed at</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--www.doctoryourself.com/realstory.html" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://www.doctoryourself.com/realstory.html</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">Levy TE. Stop America's #1 Killer: Reversible vitamin deficiency found to be the origin of all coronary heart disease. 2006. ISBN-10: 0977952002; ISBN-13: 978-0977952007. (Dr. Levy is a board-certified cardiologist.) Reviewed in J Orthomolecular Med, 2006. Vol 21, No 3, p 177-178. This book contains 60 pages of references. To download the review: </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/library/jom/2006/pdf/2006-v21n03-p175.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/library/jom/2006/pdf/2006-v21n03-p175.pdf</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">Pauling L. How to Live Longer and Feel Better (Revised edition). Oregon State University Press, 2006. ISBN-10: 0870710966; ISBN-13: 978-0870710964. Reviewed in J Orthomolecular Med, 2006. Vol 21, No 3, p 175-177. To download the review: </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/library/jom/2006/pdf/2006-v21n03-p175.pdf" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/library/jom/2006/pdf/2006-v21n03-p175.pdf</u></span></span></span></a></span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><b>On the Web:</b></span></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">The Vitamin C Foundation </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--www.vitamincfoundation.org" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://www.vitamincfoundation.org</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">AscorbateWeb, a historical compendium of 20th-Century medical and scientific literature demonstrating the efficacy of vitamin C. </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--www.seanet.com/~alexs/ascorbate/" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://www.seanet.com/~alexs/ascorbate/</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">Putting the "C" in Cure: Quantity and frequency are the keys to ascorbate therapy.</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/resources/omns/v05n11.shtml" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/resources/omns/v05n11.shtml</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">Vitamin C Saves Lives. </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/resources/omns/v01n02.shtml" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/resources/omns/v01n02.shtml</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">RDA for Vitamin C is 10% of USDA Standard for Guinea Pigs.</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/resources/omns/v06n08.shtml" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/resources/omns/v06n08.shtml</u></span></span></span></a></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">Vitamin C: What Form is Best? </span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--orthomolecular.org/resources/omns/v05n10.shtml" target="_blank"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://orthomolecular.org/resources/omns/v05n10.shtml</u></span></span></span></a></span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><br />
</span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><b>Nutritional Medicine is Orthomolecular Medicine</b></span></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US">Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information:</span></span><a href="http://www.cihfimediaservices.org/12all/lt/t_go.php?i=83&e=MTc0OTk=&l=-http--www.orthomolecular.org"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u>http://www.orthomolecular.org</u></span></span></span></a></span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;">The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.</span></span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><br />
</span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><b>Editorial Review Board:</b></span></span></span></div><div class="western" lang="en-US" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;">Ralph K. Campbell, M.D. (USA)<br />
Carolyn Dean, M.D., N.D. (Canada)<br />
Damien Downing, M.D. (United Kingdom)<br />
Michael Ellis, M.D. (Australia)<br />
Michael Gonzalez, D.Sc., Ph.D. (Puerto Rico)<br />
Steve Hickey, Ph.D. (United Kingdom)<br />
James A. Jackson, Ph.D. (USA)<br />
Bo H. Jonsson, M.D., Ph.D. (Sweden)<br />
Thomas Levy, M.D., J.D. (USA)<br />
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)<br />
Erik Paterson, M.D. (Canada)<br />
Gert E. Shuitemaker, Ph.D. (Netherlands)</span></span></span></div><div class="western" style="background-color: white; margin-bottom: 0.49cm; margin-top: 0.49cm; text-align: -webkit-auto;"><span style="font-family: Palatino Linotype;"><span class="storybody" style="font-size: 11pt; text-align: justify;"><span style="font-size: x-small;"><span lang="en-US"><b>Andrew W. Saul, Ph.D. (USA), Editor and contact person. Email: </b></span></span><a href="mailto:omns@orthomolecular.org"><span style="color: blue;"><span style="font-size: x-small;"><span lang="en-US"><u><b>omns@orthomolecular.org</b></u></span></span></span></a></span></span></div></div>Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com1tag:blogger.com,1999:blog-5880677466498354462.post-75154656574137178632012-09-08T12:45:00.000+05:302012-09-08T12:45:28.473+05:30Lemon, raw, without peel : nutrition Facts<div dir="ltr" style="text-align: left;" trbidi="on"><table class="infobox" style="font-size: 11px; line-height: 1.5em; text-align: left; width: 22em;"><caption style="font-size: 14px; font-weight: bold;">Lemon, raw, without peel</caption><tbody>
<tr><th colspan="2" style="text-align: center;">Nutritional value per 100 g (3.5 oz)</th></tr>
<tr style="background-color: #e0e0e0;"><th><a href="http://en.wikipedia.org/wiki/Food_energy" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Food energy">Energy</a></th><td>121 kJ (29 kcal)</td></tr>
<tr><th><a href="http://en.wikipedia.org/wiki/Carbohydrate" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Carbohydrate">Carbohydrates</a></th><td>9.32 g</td></tr>
<tr><th>- <a href="http://en.wikipedia.org/wiki/Sugar" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Sugar">Sugars</a></th><td>2.50 g</td></tr>
<tr><th>- <a href="http://en.wikipedia.org/wiki/Dietary_fiber" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Dietary fiber">Dietary fiber</a></th><td>2.8 g</td></tr>
<tr><th><a href="http://en.wikipedia.org/wiki/Fat" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Fat">Fat</a></th><td>0.30 g</td></tr>
<tr><th><a href="http://en.wikipedia.org/wiki/Protein_(nutrient)" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Protein (nutrient)">Protein</a></th><td>1.10 g</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Thiamine" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Thiamine">Thiamine (vit. B<sub>1</sub>)</a></td><td>0.040 mg (3%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Riboflavin" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Riboflavin">Riboflavin (vit. B<sub>2</sub>)</a></td><td>0.020 mg (2%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Niacin" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Niacin">Niacin (vit. B<sub>3</sub>)</a></td><td>0.100 mg (1%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Pantothenic_acid" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Pantothenic acid">Pantothenic acid</a> (B<sub>5</sub>)</td><td>0.190 mg (4%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Vitamin_B6" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Vitamin B6">Vitamin B<sub>6</sub></a></td><td>0.080 mg (6%)</td></tr>
<tr><td><a class="mw-redirect" href="http://en.wikipedia.org/wiki/Folate" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Folate">Folate</a> (vit. B<sub>9</sub>)</td><td>11 μg (3%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Vitamin_C" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Vitamin C">Vitamin C</a></td><td>53.0 mg (64%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Calcium#Nutrition" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Calcium">Calcium</a></td><td>26 mg (3%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Iron#Biological_role" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Iron">Iron</a></td><td>0.60 mg (5%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Magnesium_in_biology" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Magnesium in biology">Magnesium</a></td><td>8 mg (2%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Phosphorus#Biological_role" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Phosphorus">Phosphorus</a></td><td>16 mg (2%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Potassium#Potassium_in_the_diet_and_by_supplement" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Potassium">Potassium</a></td><td>138 mg (3%)</td></tr>
<tr><td><a href="http://en.wikipedia.org/wiki/Zinc#Biological_role" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Zinc">Zinc</a></td><td>0.06 mg (1%)</td></tr>
<tr style="background-color: #e0e0e0; font-size: 10px; line-height: 1.25em; padding: 4pt; text-align: center;"><td colspan="2">Percentages are relative to<br />
<a href="http://en.wikipedia.org/wiki/Dietary_Reference_Intake" style="background-image: none; background-position: initial initial; background-repeat: initial initial; color: #0b0080; text-decoration: none;" title="Dietary Reference Intake">US recommendations</a> for adults.<br />
<small>Source: <a class="external text" href="http://www.nal.usda.gov/fnic/foodcomp/search/" rel="nofollow" style="background-image: url(data:image/png; background-position: 100% 50%; background-repeat: no-repeat no-repeat; color: #663366; padding-right: 13px; text-decoration: none;">USDA Nutrient Database</a></small></td></tr>
</tbody></table><img alt="" class="thumbimage" height="225" src="http://upload.wikimedia.org/wikipedia/commons/thumb/5/53/Bees-really-like-pollinating-my-myer-lemon-tree.jpg/300px-Bees-really-like-pollinating-my-myer-lemon-tree.jpg" width="300" /><br />
<span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 11px; line-height: 15px;">A bee on a Meyer lemon flower</span></div>Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com1tag:blogger.com,1999:blog-5880677466498354462.post-8417635240906135612012-07-28T12:13:00.002+05:302012-07-28T12:13:32.827+05:30MY sites Qr code...<div dir="ltr" style="text-align: left;" trbidi="on"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEivii3JfFgLMm1ysW4un-tC9xleM6bc5n_uSgAE5JFZVsrUHhJIJVeIfble3T1HbYRJx8aQGNi5XbPiV4AceLYQEnp4Jgl2g3YF6O0XjgVXMkOvmAmgjMzGD_SWWAZlpE-JBdeDk307S2s/s1600/my+site+qr+code+2.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" sda="true" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEivii3JfFgLMm1ysW4un-tC9xleM6bc5n_uSgAE5JFZVsrUHhJIJVeIfble3T1HbYRJx8aQGNi5XbPiV4AceLYQEnp4Jgl2g3YF6O0XjgVXMkOvmAmgjMzGD_SWWAZlpE-JBdeDk307S2s/s1600/my+site+qr+code+2.png" /></a></div></div>Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com2tag:blogger.com,1999:blog-5880677466498354462.post-63197506047737878922012-05-08T12:50:00.002+05:302013-05-22T15:23:07.091+05:30Janda Syndromes<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="headline_area">
<h1>
Janda Syndromes</h1>
</div>
<b>Janda’s Crossed Syndromes</b><br />
Over time, these imbalances will spread throughout the muscular
system in a predictable manner. Janda has classified these patterns as
“Upper Crossed Syndrome” (UCS), “Lower Crossed Syndrome” (LCS), and
“Layer Syndrome” (LS) (Janda, 1987, 1988). [UCS is also known as
“cervical crossed syndrome”; LCS is also known as “pelvic crossed
syndrome; and LS is also known as “stratification syndrome.”] Crossed
syndromes are characterized by alternating sides of inhibition and
facilitation in the upper quarter and lower quarter. Layer syndrome,
essentially a combination of UCS and LCS is characterized by alternating
patterns of tightness and weakness, indicating long-standing muscle
imbalance pathology. Janda’s syndromes are summarized in Figure 1.<br />
<a href="http://www.jandaapproach.com/wp-content/uploads/2010/10/JandaSyndromes.jpg"><img alt="Janda's Crossed Syndromes" class="aligncenter size-medium wp-image-63" height="192" src="http://www.jandaapproach.com/wp-content/uploads/2010/10/JandaSyndromes-300x192.jpg" title="Janda Crossed Syndromes" width="300" /></a><br />
Upper crossed syndrome is characterized by facilitation of the upper
trapezius, levator, sternocleidomastoid, and pectoralis muscles, as well
as inhibition of the deep cervical flexors, lower trapezius, and
serratus anterior. Lower crossed syndrome is characterized by
facilitation of the thoraco-lumbar extensors, rectus femoris, and
iliopsoas, as well as inhibition of the abdominals (particularly
transversus abdominus) and the gluteal muscles.<br />
By using Janda’s classification, clinicians can begin to predict
patterns of tightness and weakness in the sensorimotor system’s attempt
to reach homeostasis. Janda noted that these changes in muscular tone
create a muscle imbalance, which leads to movement dysfunction. Muscles
prone to tightness generally have a “lowered irritability threshold” and
are readily activated with any movement, thus creating abnormal
movement patterns. These imbalances and movement dysfunctions may have
direct effect on joint surfaces, thus potentially leading to joint
degeneration. In some cases, joint degeneration may be a direct source
of pain, but the actual cause of pain is often secondary to muscle
imbalance. Therefore, clinicians should find and treat the cause of the
pain rather than focus on the source of the pain.<br />
<br />
<br />
<div class="headline_area">
<h1>
Janda Evaluation</h1>
</div>
Systematic evaluation of muscular imbalance begins with static
postural assessment, observing muscles for characteristic signs of
hypertonicity or hypotonicity. This is followed by observation of single
leg stance and gait. Static posture, gait and balance often give the
best indication of the status of the sensorimotor system. Computerized
force plate posturography is often valuable in quantifying sensory and
motor deficits. Next, characteristic movement patterns are assessed, and
specific muscles are tested for tightness or shortness. Surface
electromyography is useful in quantifying muscle activation patterns.
All the above information collected provides the clinician a system to
determine or rule out the presence of muscle imbalance syndromes.
Furthermore, identification of specific patterns and syndromes of
imbalance also provides the clinician to choose appropriate
interventions to address the cause of the dysfunction.<br />
<br />
<div class="headline_area">
<h1>
Janda Treatment</h1>
</div>
<strong>Janda’s Approach to Treatment</strong><br />
<em>1. Normalize the periphery. </em>The Janda approach to treatment
of musculoskeletal pain follows several steps. Treatment of muscle
imbalance and movement impairment begins with normalizing afferent
information entering the sensorimotor system. This includes providing an
optimal environment for healing (by reducing effusion and protection of
healing tissues, restoring proper postural alignment (through postural
and ergonomic education), and correcting the biomechanics of a
peripheral joint (through manual therapy techniques).<br />
<em>2. Restore Muscle Balance.</em> Once peripheral structures are
normalized, muscle balance is restored. Normal muscle tone surrounding
joints must be restored. Sherrington’s law of reciprocal inhibition
(Sherrington, 1907) states that a hypertonic antagonist muscle may be
reflexively inhibiting their agonist. Therefore, in the presence of
tight and/or short antagonistic muscles, restoring normal muscle tone
and/or length must first be addressed before attempting to strengthen a
weakened or inhibited muscle. Techniques to decrease tone must be
specific to the cause of the hypertonicity. These include post-isometric
relaxation (PIR) (Lewit, 1994) and post-facilitation stretch (PFS)
(Janda, 1988).<br />
Muscles that have been reflexively inhibited by tight antagonists
often recover spontaneously after addressing the tightness. In the Janda
approach, the coordinated firing patterns of muscle are more important
than the absolute strength of muscles. The strongest muscle is not
functional if it cannot contract quickly and in coordination with other
muscles; therefore, isolated muscle strengthening is not emphasized in
the Janda approach. Instead, muscles are facilitated to contract at the
proper time during coordinated movement patterns to provide reflexive
joint stabilization.<br />
<em>3. Increase afferent input to facilitate reflexive stabilization.</em>
Once muscle balance has been addressed, Janda stresses increasing
proprioceptive input into the CNS with a specific exercise program,
“Sensorimotor Training” (SMT) (Janda & Vavrova, 1996). This program
increases afferent information entering the subcortical pathways
(including spinocerebellar, spinothalamic, and vestibulocerebellar
pathways) to facilitate automatic coordinated movements. SMT involves
progressive stimulation through specific exercises with increasing level
of challenge to the sensorimotor system. SMT has been proven to improve
proprioception, strength, and postural stability in ankle instability
(Freeman et al. 1965), knee instability (Ihara & Nakayam, 1996), and
after ACL reconstruction (Pavlu & Novosadova, 2001).<br />
<em>4. Increase endurance in coordinated movement patterns. </em>Finally,
endurance is increased through repetitive, coordinated movement
patterns. Since fatigue is a predisposing factor to compensated movement
patterns, endurance is also more important than absolute strength.
Exercises are performed at low intensities and high volumes to simulate
activities of daily living.<br />
The Janda approach is valuable in today’s managed care environment.
Once these patterns and syndromes are identified, specific treatment can
be implemented without expensive equipment. Early detection of these
causes of chronic pain allows the clinician to treat the patient with
fewer visits and less expensive equipment compared to traditional
interventions that emphasize modalities and passive treatments. The key
to the Janda approach is in the home exercise program. Inexpensive home
exercise equipment such as wobble boards, elastic bands, and foam pads
are used with a specific progression of exercises as the patient
improves in function.<br />
<strong>Summary</strong><br />
In summary, the Janda approach emphasizes the importance of the CNS
in the sensorimotor system, and its role in the pathogenesis in
musculoskeletal pain. In particular: the neurological pre-disposition of
muscles to exhibit predictable changes in tone, and the importance of
proprioception and afferent information in the regulation of muscle tone
and movement. Therefore, assessment and treatment focus on the
sensorimotor system, rather than the musculoskeletal system itself.
Using a functional, rather than a structural approach, the cause of
musculoskeletal pain can be quickly identified and addressed. The Janda
approach can be a valuable tool for the clinician in the evaluation and
treatment of chronic musculoskeletal pain.<br />
<br /></div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-70827680728727276122012-05-08T12:49:00.002+05:302013-05-22T15:23:22.119+05:30Janda Philosophy<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="headline_area">
<h1>
Janda Philosophy</h1>
</div>
Janda’s approach to the evaluation and management of chronic
musculoskeletal pain focuses on the importance of the central nervous
system in mediating chronic pain through neuromuscular imbalance.<br />
<strong>Structure vs. Function</strong><br />
<br />
In musculoskeletal medicine, there are two main schools of thought,
that is, a structural or functional approach. In the structural
approach, the pathology of specific static structures is emphasized;
this is the typical orthopaedic approach that emphasizes diagnosis based
on localized evaluation and special tests (X-Ray, MRI, CT Scan, etc).
On the other hand, the functional approach recognizes the function of
all processes and systems within the body, rather than focusing on a
single site of pathology. While the structural approach is necessary and
valuable for acute injury or exacerbation, the functional approach is
preferable when addressing chronic musculoskeletal pain.<br />
<strong>The Sensorimotor System</strong><br />
In chronic pain, special diagnostic tests of localized areas (for
example, low back radiographs) are often normal, although the patient
complains of pain. The site of pain is often not the cause of the pain.
Recent evidence by supports the fact that chronic pain is
centrally-mediated (Staud et al. 2001). Similarly, research on the
efficacy of different modes of exercise management of chronic pain has
shown a central effect of exercise in decreasing chronic low back pain
(Mannion et al. 1999). This research supports the basis of Janda’s
approach: the interdependence of the musculoskeletal and central nervous
system. Janda states that these two anatomical systems cannot be
separated functionally. Therefore, the term “sensorimotor” system is
used to define the functional system of human movement. In addition,
changes within one part of the system will be reflected by compensations
or adaptations elsewhere within the system because of the body’s
attempt at homeostasis (Panjabi, 1992).<br />
The muscular system often reflects the status of the sensorimotor
system, as it receives information from both the musculoskeletal and
central nervous systems. Changes in tone within the muscle are the first
responses to nociception by the sensorimotor system. This has been
supported by various studies demonstrating the effect of joint pathology
on muscle tone. For example, the presence of knee effusion causes
reflex inhibition of the vastus medialis (Stokes & Young, 1984). The
multifidus has been shown to atrophy in patients with chronic low back
pain (Hides et al. 1994), and muscles demonstrate increased latency
after ankle sprains (Konradsen & Raven, 1990) and ACL tears (Ihara
& Nakayama, 1986). The global effect of joint pathology on the
sensorimotor system was demonstrated by Bullock-Saxton (1994). She noted
a delay in firing patterns of the hip muscles and decreased vibratory
sensation in patients with ankle sprains.<br />
Because of the involvement of the CNS in muscle imbalance and pain,
Janda emphasizes the importance of the afferent proprioceptive system. A
reflex loop from the joint capsular mechanoreceptors and the muscles
surrounding the joint is responsible for reflexive joint stabilization
(Guanche et al. 1995; Tsuda et al. 2001). In chronic instability,
deafferentation (the loss of proper afferent information from a joint)
is often responsible for poor joint stabilization (Freeman et al. 1965).<br />
<strong>Tonic and Phasic Muscle Systems</strong><br />
Janda identified two groups of muscles based on their phylogenetic
development (Janda, 1987). Functionally, muscles can be classified as
“tonic” or “phasic”. The <strong>tonic</strong> system consists of the
“flexors”, and is phylogenetically older and dominant. These muscles are
involved in repetitive or rhythmic activity (Umphred, 2001), and are
activated in flexor synergies. The <strong>phasic</strong> system
consists of the “extensors”, and emerges shortly after birth. These
muscles work eccentrically against the force of gravity and emerge in
extensor synergies (Umphred, 2001).<br />
Janda noted that the tonic system muscles are prone to tightness or
shortness, and the phasic system muscles are prone to weakness or
inhibition (Table 1). Based on his clinical observations of orthopedic
and neurological patients, Janda found that this response is based on
the neurological response of nociception in the muscular system. For
example, following structural lesions in the central nervous systems
(such cerebral palsy or cerebrovascular accident), the tonic flexor
muscles tend to be spastic and the phasic extensor muscles tend to be
flaccid. Therefore, patterns of muscle imbalance may be due to CNS
influence, rather than structural changes within the muscle itself.<br />
It’s important to note that this classification is not rigid, in that
some muscles may exhibit both tonic and phasic characteristics. It
should also be noted that in addition to neurological predisposition to
tightness or weakness, structural changes within the muscle also
contribute to muscle imbalance. However, in chronic pain that is
centralized within the CNS, patterns of muscle imbalance are often a
result of neurological influence rather than structural changes.<br />
<table border="1" cellpadding="0" cellspacing="0">
<tbody>
<tr>
<td style="text-align: center;" valign="top" width="295">Tonic Muscles
<br />
<div style="text-align: center;">
Prone to Tightness or Shortness</div>
</td>
<td style="text-align: center;" valign="top" width="295">Phasic MusclesProne to Weakness or Inhibition</td>
</tr>
<tr>
<td valign="top" width="295">Gastroc-SoleusTibialis Posterior
Hip Adductors<br />
Hamstrings<br />
Rectus Femoris<br />
Iliopsoas<br />
Tensor Fascia Lata<br />
Piriformis<br />
Thoraco-lumbar extensors<br />
Quadratus Lumborum<br />
Pectoralis Major<br />
Upper Trapezius<br />
Levator Scapulae<br />
Scalenes<br />
Sternocleidomastoid<br />
Upper limb flexors</td>
<td valign="top" width="295">Peroneus Longus, BrevisTibialis Anterior
Vastus Medialis, Lateralis<br />
Gluteus Maximus, Medius, Minimus<br />
Rectus Abdominus<br />
Serratus Anterior<br />
Rhomboids<br />
Lower Trapezius<br />
Deep neck flexors<br />
Upper limb extensors</td>
</tr>
</tbody>
</table>
<div style="text-align: left;">
Table 1: Tonic & Phasic Muscles</div>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-2038685360138395202012-05-08T12:48:00.002+05:302013-05-22T15:23:34.798+05:30About Dr. Janda<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="headline_area">
<h1>
About Dr. Janda</h1>
</div>
<a href="http://www.jandaapproach.com/wp-content/uploads/2010/10/vlad.jpg"><img alt="Dr. Vladimir Janda" class="alignleft size-thumbnail wp-image-57" height="150" src="http://www.jandaapproach.com/wp-content/uploads/2010/10/vlad-150x150.jpg" title="Dr. Vladimir Janda" width="150" /></a>Excerpted from <a href="http://astore.amazon.com/jandabook-20/detail/0736074007"><em>Assessment and Treatment of Muscle Imbalance: The Janda Approach</em></a><br />
<strong>Vladimir Janda</strong> was born in 1928. At the age of 15,
he contracted polio. He was paralyzed as a quadriplegic and unable to
walk for 2 years. He eventually recovered walking function, but
developed post-polio syndrome and was forced to use a walker until the
end of his life in 2002.<br />
As a physician, he focused on post-polio patients early on. One of his early influences was <strong>Sister Kinney</strong>
in 1947, who introduced the treatment of polio in Czechoslovakia. He
served as an interpreter for Sister Kinney as a first year medical
student, and decided to pursue an interest in physiotherapy after
medical school. He received the “Kinney Physiotherapist” certificate
after graduation from medical school. He was one of the first physicians
to combine therapy and medicine in a ‘hands-on’ approach, becoming one
of the earliest to practice physical medicine and rehabilitation.<br />
He became more interested in pain syndromes of the locomotor system.
His first book in 1949 at the age of 21 was on muscle testing and
function, which was the first of its kind in Czech. He continued as a
prolific researcher and writer; before his death, he published over 16
books and over 200 papers on muscle function.<br />
At the age of 24, he was working in a rehabilitation center for
post-polio patients. He was interested in evaluating the claims from
muscle testing textbooks at the time. Using EMG, he began studying the
muscle activity of the hip joint in physiotherapist students. He found
muscles that weren’t supposed to be activated actually were, noting the
accessory role of muscles outside of their primary movements.
Specifically, he found subjects without activity in the gluteus maximus
during hip extension movements used an increased pelvic tilt to
accomplish the extension. This led to his lifelong passion to study
movements, rather than individual muscles as was common at the time of
the polio era. He recognized the importance of testing muscle function
rather than strength. This was the beginning of thinking globally rather
than locally in terms of muscle function.<br />
In the 1960s, Freeman and Wyke published several papers on the
importance of afferent input and mechanoreceptors. They described the
use of wobble boards in the treatment of chronic ankle instability.
Janda noted a connection between chronic ankle instability and chronic
low back pain: proprioception. This led to Janda’s development of
“Sensorimotor Training”, a progressive exercise program using simple
exercises and unstable surfaces. He rarely recommended strengthening
exercises, instead focusing on balance and function. This was in
contrast to the traditional rehabilitation approach in the 60’s and 70’s
emphasizing strength training.<br />
Janda completed his thesis in 1964 on patients with sacroiliac
dysfunction, finding weakness and inhibition of the gluteus maximus,
even in the absence of pain. He recognized that certain other muscles
were prone to weakness. Janda subsequently defined movement patterns to
estimate the quality of movement. He discovered that muscle imbalance
was systematic, predictable, and involved the entire body.<br />
In 1979, he defined his “crossed syndromes”: Upper crossed, lower
crossed, and layer syndrome. He subsequently noted that his crossed
syndromes were his only ‘discovery’; he always gave credit to others
influencing his approach. Janda had a wide range of influences that
provided him a comprehensive viewpoint:<br />
<ul>
<li><strong>Berta Botath</strong>, a physiotherapist and her husband <strong>Karel Bobath</strong>, a neurophysiologist from London, who were leaders in neurodevelopmental principles and treatment in physiotherapy</li>
<li>Austrian physician <strong>Hans Kraus</strong>, who first described
“hypokinetic disease” in low back pain before the second world war,
which as noted as a “lack of movement.”</li>
<li>His colleague and lifelong friend, <strong>Karel Lewit MD</strong>, who practiced with Janda in Prague for many years and shared his expertise on manual therapy and the locomotor system.</li>
<li><strong>Vaclav Vojta MD</strong>, a Czech physician who described the influence of developmental kinesiology in human movement and pathology.</li>
<li><strong>Alois Brugger MD</strong>, A Swiss neurologist who described the neurologic basis muscle imbalance.</li>
<li><strong>Florence Kendall PT</strong>, who first influenced Janda on the concept of muscle imbalances.</li>
<li><strong>John Basmajian MD</strong>, a Canadian expert in EMG analysis who lead Janda’s postdoctoral studies</li>
<li><strong>David Simons MD</strong>, an expert in trigger points and muscle pain</li>
</ul>
Janda was an avid reader and collector of books and papers on
muscles. His ability to fluently speak as many as 5 different languages
gave him the ability to read and learn more from all over the world.
His international influence continued to spread as a consultant to the
World Health Organization in the 1960s and 70s.<br />
Janda founded the Department of Rehabilitation Medicine and directed
the physiotherapy school at the Charles University Third School of
Medicine, where he continued to practice until his death on November 25,
2002. The authors of this text had the opportunity to be with him
three months prior on his last visit to North America. The “Father of
Czech Rehabilitation” will continue to be missed by many. For an
excellent review of Janda’s life and contributions, read the paper by
Morris and colleagues, <a href="http://www.ncbi.nlm.nih.gov/pubmed/16641785" target="_blank"><em>Vladimir Janda, MD, DSc: tribute to a master of rehabilitation</em>. (<span style="text-decoration: underline;">Spine</span>. 2006 Apr 20;31(9):1060-4.)</a></div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-41244721594166836932012-05-08T12:26:00.000+05:302013-05-22T15:24:00.150+05:30Know your food!<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="c">
<div class="container">
<div class="boxContent clearfix innerHtml">
<div style="text-align: center;">
<h1>
Know your food!</h1>
<h2>
Food Groups: Base of the food balance</h2>
</div>
<div style="text-align: justify;">
You
are what you eat. Everything that you eat and drink has an effect on
your body. Nutrition is the basic prerequisite to sustain a healthy
life. All the food that we eat provides us with a range of nutrients,
each with its own role to play. Eating a balanced, varied diet everyday
ensures that you have everything you need for a good health. Our diet
must provide all the essential nutrients in the right amounts. To
perform various functions normally you need a complete range of
nutrients from various food groups. Broadly there are 7 food groups
which have been grouped together as they share similar nutritional
properties. These food groups are:<br />
<img alt="" height="655" src="http://www.nestle.in/asset-libraries/PublishingImages/NHW/pyramid.png" style="height: 525px; width: 527px;" width="658" /><br />
<ol style="list-style-type: upper-roman;">
<li><strong>Cereals:</strong>Cereals
form the staple diet in India, e.g., rice, wheat, maize. Cereals are
the main source of energy, contributing 60-70% of daily energy needs.
Cereals are a source of protein, calcium, iron and B-complex vitamins.
Whole-grains (grains with the intact outer layer like in brown rice,
corn) are a good source of fibre and B-complex vitamins and should be
included in daily diet. </li>
<li><strong>Pulses (legumes):</strong>Pulses
are a rich source of proteins (up to 22%) and meet the protein
requirement of the vegetarians. They are also rich in B complex
vitamins. Germination (sprouting) of pulses increases the vitamin C and B
group vitamins and also improves the digestibility. </li>
<li><strong>Milk and Milk Products:</strong><br />This
category includes liquid and powdered milk, paneer, curd, buttermilk
etc. They are not only a good source of quality protein but also calcium
and riboflavin. These should be a part of everyday’s diet and
especially essential for children as they support healthy growth. </li>
<li><strong>Fruits and Vegetables:</strong> these include<ol style="list-style-type: lower-alpha;">
<li><strong>Roots and Tubers:</strong>
these are rich in carbohydrates and are good sources of energy and
calcium. Root vegetables like carrots are a good source of vitamin A. </li>
<li><strong>Vegetables and Green Leafy Vegetables (GLV’s):</strong>
vegetables add both color and variety to the diet. They provide
minerals, vitamins and fiber (which add bulk to the diet). GLV’s are a
rich source of calcium iron, vitamin A (β-carotene), vitamin C, folic
acid. </li>
<li><strong>Fruits:</strong> these provide vitamins and
fiber. Green, Yellow and Orange fruits are a rich source of beta
carotene. Citrus fruits, amla, and guava are rich in vitamin C. dried
fruits like dates supply iron. Seasonal fruits should be encouraged.
Fruits also contain pectins which provide bulk to the diet and helps
bowel movement. </li>
</ol>
</li>
<li><strong>Animal Foods:</strong>This
category includes eggs, chicken, meat, fish etc. They are a good source
of high quality protein and other important nutrients. Fish is rich in
omega-3 PUFA which is protective against cardiovascular diseases and
calcium as well. A special feature in flesh foods is the presence of
vitamin B12, which is absent in plant foods. </li>
<li><strong>Fats, Nuts and Oils:</strong><br />These
are calorie-rich foods, and are useful for increasing the energy
density of foods. Fats can be the visible fats (ghee, butter, oil) or
the invisible fats (present inherently in each food). They are required
in moderate quantities in the daily diet as they provide essential fatty
acids and promote absorption of fat soluble vitamins along with
improving the palatability of the food. However, the total calories from
fat should not exceed 10-15%. </li>
<li><strong>Sugars:</strong><br />This
group includes table sugar, jaggery, honey, syrups etc which are energy
concentrates. They are the sweetening agents which should be consumed
in moderation as they provide calories but not much in the way of
nutrition. Also excessive sugar consumption has been linked to weight
gain. </li>
</ol>
</div>
</div>
</div>
</div>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-78576155058745089852012-02-21T12:17:00.002+05:302013-05-22T15:25:33.540+05:30<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<h1 class="firstHeading" id="firstHeading" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;">
<a class="image" href="http://en.wikipedia.org/wiki/File:Dr_Ponset%C3%AD.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="" class="thumbimage" height="330" src="http://upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Dr_Ponset%C3%AD.jpg/220px-Dr_Ponset%C3%AD.jpg" width="220" /></a> </h1>
<br />
<h1 class="firstHeading" id="firstHeading">
Ignacio Ponseti <a href="data:image/png;base64,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" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="" border="0" src="data:image/png;base64,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" /></a></h1>
<h1 class="firstHeading" id="firstHeading">
</h1>
<b>Ignacio Ponseti</b> (3 June 1914 – 18 October 2009) was a physician, specializing in <a href="http://en.wikipedia.org/wiki/Orthopedics" title="Orthopedics">orthopedics</a>. A native of Spain, he fled the <a href="http://en.wikipedia.org/wiki/Spanish_Civil_War" title="Spanish Civil War">Spanish Civil War</a> and became a faculty member and practicing physician at the <a href="http://en.wikipedia.org/wiki/University_of_Iowa" title="University of Iowa">University of Iowa</a>.<br />
He developed in the 1950s the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Ponseti_Method" title="Ponseti Method">Ponseti Method</a> (also known as the Ponseti Technique), a non-surgical technique that uses a series of casts, followed by a brace, to correct <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Congenital" title="Congenital">congenital</a> <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Clubfoot" title="Clubfoot">clubfoot</a>. The condition causes a baby's feet to turn inward and downward; if not corrected, a child is unable to walk or move properly.<br />
<br />
<h2>
<span class="mw-headline" id="Biography">Biography</span></h2>
Known for the method for the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Clubfoot" title="Clubfoot">clubfoot</a>
treatment that bears his name, Ignacio Ponseti was Professor Emeritus
in the Department of Orthopaedic Surgery at University of Iowa Hospitals
and Clinics.<br />
Born 3 June 1914 in Menorca, part of the Balearic Islands, Spain,
Ponseti was the son of a watchmaker and helped repair watches. The skill
was said to eventually contribute to his abilities as an orthopedist.<sup class="reference" id="cite_ref-Wilcox_0-0"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-Wilcox-0">[1]</a></sup><br />
Ponseti studied medicine at Barcelona University. Not long after he
graduated, fighting broke out between the Nationalists and the
Republicans - the start of the Spanish Civil War. Ponseti served as a
medical officer with the Loyalists as a lieutenant, then captain, in the
Orthopaedic and Fracture Service. His duties included setting
fractures, which put him on a career in orthopaedics. Without
ambulances, Ponseti used the help of local smugglers to take the injured
into France.<sup class="reference" id="cite_ref-Wilcox_0-1"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-Wilcox-0">[1]</a></sup>
He soon escaped to France himself and went to Mexico, where for two
years he practiced family medicine. A physician there helped Ponseti get
to Iowa in 1941 to study orthopaedics under Arthur Steindler, M.D.
Ponseti completed a residency at Iowa in 1944 and became a member of the
orthopaedic faculty at <a href="http://en.wikipedia.org/wiki/University_of_Iowa_Hospitals_and_Clinics" title="University of Iowa Hospitals and Clinics">University of Iowa Hospitals and Clinics</a>.<br />
Early in his career at Iowa, Ponseti saw that the outcomes of
clubfoot surgical treatments were not very good—patients had limited
movement. He set out to develop a treatment that made the most of
babies' flexible ligaments.<sup class="reference" id="cite_ref-McKee_1-0"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-McKee-1">[2]</a></sup>
The method was met with some opposition but over the past 50 years it
has been adopted by many doctors and other health care providers
worldwide, including in Britain <sup class="reference" id="cite_ref-2"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-2">[3]</a></sup> and Turkey <sup class="reference" id="cite_ref-3"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-3">[4]</a></sup><br />
Well into his nineties, Ponseti continued to see patients and trained
visiting doctors from around the world. He also developed new
prosthetic devices with John Mitchell of MD Orthotics <a class="external autonumber" href="http://www.mdorthopaedics.com/index.html" rel="nofollow">[1]</a> and produced training and information DVD's on the method.<br />
Ponseti's other research focused on <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Congenital" title="Congenital">congenital</a>
and developmental bone and joint disorders, skeletal growth disorders
in children, and the biochemistry of cartilage. He gained insight in the
early 1950s on the effect of amino nitriles on collagen cross linking,
defined the curvature patterns of idiopathic <a href="http://en.wikipedia.org/wiki/Scoliosis" title="Scoliosis">scoliosis</a>,
and demonstrated that curves progressed after skeletal maturity. He
also conducted many studies evaluating the long-range results of
treatments for congenital dislocation of the hip, clubfoot and
scoliosis.<br />
<h2>
<span class="editsection"></span><span class="mw-headline" id="The_Ponseti_Method">The Ponseti Method</span></h2>
<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Clubfoot" title="Clubfoot">Clubfoot</a> affects well over 100,000 newborns annually.<sup class="reference" id="cite_ref-4"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-4">[5]</a></sup>
Early in his career at the University of Iowa, Ponseti realized that
surgical approaches did not fully correct clubfoot and/or created
problems later in life, such as severe arthritis or even requiring more
surgery.<sup class="reference" id="cite_ref-McKee_1-1"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-McKee-1">[2]</a></sup>
In working to develop a new approach, he determined it could be
nonsurgical. The Ponseti method uses gentle, manual manipulation of the
foot, followed by application of toe-to-groin plaster casts. The casts
are changed weekly after a clinician manipulates softened foot ligaments
to gradually achieve near-normal muscle and bone alignment.<br />
In addition to the improved physical outcomes, compared to surgery,
the Ponseti method is less expensive and can be taught to nonphysician
health care providers, which is useful in areas with few or no doctors.
Nearly 80 percent of children born with clubfoot live in impoverished
nations. The Ponseti method is used, for example, in Uganda, where
efforts continue to improve the availability of the treatment.<sup class="reference" id="cite_ref-5"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-5">[6]</a></sup><br />
Information about the use of Ponseti method can be found at these sites: <a class="external text" href="http://www.who.int/mediacentre/news/notes/2007/np30/en/" rel="nofollow">World Health Organisation</a>, <a class="external text" href="http://www3.aaos.org/search/search.asp?client=my_collection&site=my_collection&output=xml&ie=&lr=&q=ponseti&btnG=Search" rel="nofollow">American Academy of Orthopedic Surgeons</a>, <a class="external text" href="http://www.posna.org/members/coreCurr/clubfootInfant.cfm?showreg=yes&showreg9=yes" rel="nofollow">Pediatric Orthopaedic Society of North America</a>, <a class="external text" href="http://www.steps-charity.org.uk/links/4-28-clubfoot_treatment:_ponseti_method.php" rel="nofollow">STEPS Charity UK</a> and <a class="external text" href="http://www.steps.org.za/information/ponseti-technique-for-congenital-clubfoot.html" rel="nofollow">STEPS Charity South Africa</a>.<br />
At the 2007 International Clubfoot Symposium attended by 200 doctors
from 44 countries, papers were presented regarding an estimated 10,000
children successfully treated with the technique around the world in the
past few years.<br />
The <a class="external text" href="http://www.ponseti.info/" rel="nofollow">Ponseti International Association</a>
for the Advancement of Clubfoot Treatment was founded in 2006 to
improve the treatment of children born with clubfoot through education,
research and improved access to care. PIA has a related Web site devoted
to the interests and needs of parents.<sup class="reference" id="cite_ref-6"><a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti#cite_note-6">[7]</a></sup> Groups that work with Ponseti International include <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Cure_International" title="Cure International">Cure International</a> and A Leg to Stand On (India).<br />
<br />
<br />
The <b>Ponseti method</b> is a manipulative technique that corrects congenital clubfoot without invasive surgery. It was developed by <a href="http://en.wikipedia.org/wiki/Ignacio_Ponseti" title="Ignacio Ponseti">Dr. Ignacio V. Ponseti</a>
of the University of Iowa, USA in the 1950s, and was repopularized in
2000 by Dr. John Herzenberg in the USA and Europe and in Africa by NHS
surgeon Steve Mannion. It is a standard<sup class="reference" id="cite_ref-0"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-0">[1]</a></sup> for the treatment of <a href="http://en.wikipedia.org/wiki/Club_foot" title="Club foot">club foot</a>.<br />
<h2>
<span class="editsection"></span><span class="mw-headline" id="Description">Description</span></h2>
Ponseti treatment was introduced in UK in the late 1990s and widely
popularized around the country by NHS physiotherapist Steve Wildon. The
manipulative treatment of <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Clubfoot" title="Clubfoot">clubfoot</a>
deformity is based on the inherent properties of the connective tissue,
cartilage, and bone, which respond to the proper mechanical stimuli
created by the gradual reduction of the deformity. The ligaments, joint
capsules, and tendons are stretched under gentle manipulations. A
plaster cast is applied after each manipulation to retain the degree of
correction and soften the ligaments. The displaced bones are thus
gradually brought into the correct alignment with their joint surfaces
progressively remodeled yet maintaining congruency. After two months of
manipulation and casting the foot appears slightly over-corrected. After
a few weeks in splints however, the foot looks normal.<br />
Proper foot manipulations require a thorough understanding of the
anatomy and kinematics of the normal foot and of the deviations of the
tarsal bones in the clubfoot. Poorly conducted manipulations will
further complicate the clubfoot deformity. The non-operative treatment
will succeed better if it is started a few days or weeks after birth and
if the podiatrist understands the nature of the deformity and possesses
manipulative skill and expertise in plaster-cast applications.<sup class="reference" id="cite_ref-1"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-1">[2]</a></sup><br />
<br />
<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Clubfoot" title="Clubfoot">Clubfoot</a>
(talipes equinovarus) affects almost 150,000 children annually. Almost
80% of these children live in developing nations. Dr Ponseti's technique
is painless, fast, cost-effective and successful in almost 100% of all
congenital clubfoot cases. The Ponseti method is endorsed and supported
by World Health Organization<sup class="reference" id="cite_ref-2"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-2">[3]</a></sup><sup class="reference" id="cite_ref-3"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-3">[4]</a></sup>National Institutes of Health<sup class="reference" id="cite_ref-4"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-4">[5]</a></sup>, American Academy of Orthopedic Surgeons<sup class="reference" id="cite_ref-5"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-5">[6]</a></sup>, Pediatric Orthopedic Society of North America<sup class="reference" id="cite_ref-6"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-6">[7]</a></sup>, European Pediatric Orthopedic Society<sup class="reference" id="cite_ref-7"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-7">[8]</a></sup>, CURE<sup class="reference" id="cite_ref-8"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-8">[9]</a></sup>, STEPS Charity UK<sup class="reference" id="cite_ref-9"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-9">[10]</a></sup>, STEPS Charity South Africa<sup class="reference" id="cite_ref-10"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-10">[11]</a></sup>, A Leg to Stand On (India)<sup class="reference" id="cite_ref-11"><a href="http://en.wikipedia.org/wiki/Ponseti_Method#cite_note-11">[12]</a></sup> and others.<br />
At the 2007 International Clubfoot Symposium attended by 200 doctors
from 44 countries, papers were presented for an estimated 10,000
children successfully treated with the technique around the world in the
past few years.<br />
The Ponseti International Association for the Advancement of Clubfoot
Treatment was founded in 2006 at the University of Iowa. The Ponseti
International Association aims to improve the treatment of children born
with clubfoot through education, research and improved access to care.<br />
Steps are as follows:<br />
1. The calcaneal internal rotation (adduction) and plantar flexion is
the key deformity. The foot is adducted and planter-flexed at the
subtalar joint, and the goal is to abduct the foot and dorsiflex it. In
order to achieve correction of the clubfoot, the calcaneum should be
allowed to rotate freely under the talus, which also is free to rotate
in the ankle mortise. The correction takes place through the normal arc
of the subtalar joint. This is achieved by placing the index finger of
the operator on the medial malleolus to stabilize the leg and levering
on the thumb placed on the lateral aspect head of the talus while
abducting the forefoot in supination. Forcible attempts at correcting
the heel varus by abducting the forefoot while applying counter pressure
at the calcaneocuboid joint prevents the calcaneum from abducting and
therefore everting.<br />
2. Foot cavus increases when the forefoot is pronated. If cavus is
present, the first step in the manipulation process is to supinate the
forefoot by gently lifting the dropped first metatarsal to correct the
cavus. Once the cavus is corrected, the forefoot can be abducted as
outlined in step 1.<br />
3. Pronation of the foot also causes the calcaneum to jam under the
talus. The calcaneum cannot rotate and stays in varus. The cavus
increases as outlined in step 2. This results in a bean-shaped foot. At
the end of step 1, the foot is maximally abducted but never pronated.<br />
4. The manipulation is carried out in the cast room, with the baby
having been fed just prior to the treatment or even during the
treatment. After the foot is manipulated, a long leg cast is applied to
hold the correction. Initially, the short leg component is applied. The
cast should be snug with minimal but adequate padding. The authors paint
or spray the limb with tincture of benzoin to allow adherence of the
padding to the limb. The authors prefer to apply additional padding
strips along the medial and lateral borders to facilitate safe removal
of the cast with a cast saw. The cast must incorporate the toes right up
to the tips but not squeeze the toes or obliterate the transverse arch.
The cast is molded to contour around the heel while abducting the
forefoot against counter pressure on the lateral aspect of the head of
the talus. The knee is flexed to 90° for the long leg component of the
cast. The parents can soak these casts for 30–45 minutes prior to
removal with a plaster knife. The authors' preferred method is to use
the oscillating plaster saw for cast removal. The cast is bivalved and
removed. The cast then is reconstituted by coapting the 2 halves. This
allows for monitoring of the progress of the forefoot abduction and, in
the later stages, the amount of dorsiflexion or equinus correction.<br />
5. Forcible correction of the equinus (and cavus) by dorsiflexion
against a tight Achilles tendon results in a spurious correction through
a break in the midfoot, resulting in a rockerbottom foot. The cavus
should be separately treated as outlined in step 2, and the equinus
should be corrected without causing a midfoot break. It generally takes
up to 4–7 casts to achieve maximum foot abduction. The casts are changed
weekly. The foot abduction (correction) can be considered adequate when
the thigh-foot axis is 60°After maximal foot abduction is obtained,
most cases require a percutaneous Achilles tenotomy. This is performed
in the cast room under aseptic conditions. The local area is
anesthetized with a combination of a topical lignocaine preparation (eg,
EMLA cream) and minimal local infiltration of lidocaine. The tenotomy
is performed through a stab incision with a round tip (#6400) Beaver
blade. The wound is closed with a single absorbable suture or with
adhesive strips.The final cast is applied with the foot in maximum
dorsiflexion, and the foot is held in the cast for 2–3 weeks.<br />
6. Following the manipulation and casting phase, the feet are fitted
with open-toed straight-laced shoes attached to a Dennis Brown bar. The
affected foot is abducted (externally rotated) to 70° with the
unaffected foot set at 45° of abduction. The shoes also have a heel
counter bumper to prevent the heel from slipping out of the shoe. The
shoes are worn for 23 hours a day for 3 months and are worn at night and
during naps for up to 3 years.<br />
7. In 10–30% of cases, a tibialis anterior tendon transfer to the
lateral cuneiform is performed when the child is approximately 3 years
of age. This gives lasting correction of the forefoot, preventing
metatarsus adductus and foot inversion. This procedure is indicated in a
child aged 2–2.5 years with dynamic supination of the foot. Prior to
surgery, cast the foot in a long leg cast for a few weeks to regain the
correction.<br />
<br />
<h1 class="firstHeading" id="firstHeading">
</h1>
<h1 class="firstHeading" id="firstHeading">
</h1>
<h1 class="firstHeading" id="firstHeading">
</h1>
<a href="data:image/png;base64,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" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"></a></div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-84427098821828961882012-02-21T12:12:00.000+05:302012-02-21T12:12:02.317+05:30<div dir="ltr" style="text-align: left;" trbidi="on">
<a class="image" href="http://en.wikipedia.org/wiki/File:Hugh_Owen_Thomas.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="" class="thumbimage" height="400" src="http://upload.wikimedia.org/wikipedia/en/4/4f/Hugh_Owen_Thomas.jpg" width="282" /></a><br />
<h1 class="page-head">
Hugh Owen Thomas</h1>
<table>
<thead>
</thead>
<tbody>
<tr>
<td>Born</td>
<td>
1834 </td>
</tr>
<tr>
<td>Died</td>
<td>
1891 </td>
</tr>
</tbody>
</table>
<h2>
</h2>
<ul class="associated">
<li><a href="http://www.whonamedit.com/synd.cfm/3550.html">Thomas's collar (Hugh Owen Thomas)</a></li>
<li><a href="http://www.whonamedit.com/synd.cfm/3549.html">Thomas's manoeuvre (Hugh Owen Thomas)</a></li>
<li><a href="http://www.whonamedit.com/synd.cfm/3551.html">Thomas's sign (Hugh Owen Thomas)</a></li>
<li><a href="http://www.whonamedit.com/synd.cfm/3552.html">Thomas's splint (Hugh Owen Thomas)</a></li>
<li><a href="http://www.whonamedit.com/synd.cfm/3548.html">Thomas's test (Hugh Owen Thomas)</a></li>
<li><a href="http://www.whonamedit.com/synd.cfm/3553.html">Thomas's wrench (Hugh Owen Thomas)</a></li>
</ul>
<h2>
<a href="http://www.whonamedit.com/person_bibliography/2947/">Bibliography</a></h2>
<div id="short-description">
British orthopaedic suregon, 1834-1891.
</div>
<div id="description">
<h2>
Biography of Hugh Owen Thomas</h2>
<strong>Hugh Owen Thomas</strong> has been called
"the father of British Orthopaedics". He came from a family of
bone-setters which descended from the survivor of a shipwreck in 1745
off the north-west coast of the island of Anglesey in North Wales. One
of the survivors became a bonesetter, starting a family tradition whose
secrets were passed down from father to son for generations. By the
middle of the nineteenth century, Evan Thomas, aged 19 and a grandson of
the original survivor, had moved to Liverpool to work amongst the
seafarers and dockers, but he was finding that the practice of
bonesetting, however successful as a treatment, was causing him to be
brought to court. There was much jealousy on the part of the orthodox
practitioners in the city and, although he never lost a case, he
resolved that his sons should train and qualify as doctors, which is
what all five of them did.<br />
Hugh was apprenticed to his uncle, Dr. Owen Roberts at St Asaph in
North Wales for four years and then studied medicine at the University
of Edinborgh and University College, London. He qualified MRCS in 1857
and then returned to Liverpool to help his father, but two years later
he moved to another part of the city to set up his independent practice.
He was a general practitioner in the slums of Liverpool most of his
professional life, treating the poor rather than the affluent Victorian
middle classes. He concerned himself primarily with orthopaedic
suergery, and is considered the founder of orthopedic surgery in
Britain. <br />
In the treatment of tuberculosis and fractures, Thomas strongly
advocated the use of rest which should be 'enforced, uninterrupted and
prolonged'. The Thomas Test demonstrated the need to keep the spine
flat on the bed when examining for hip deformity. For inflamed joints,
he made splints that kept the limbs motionless while allowing the
patient to walk. His 'Thomas Splint' was introduced to the battlefields
of the First World War by his nephew, Sir Robert Jones, and was credited
with cutting the death rate from compound fractures from eighty per
cent to twenty per cent. The splints were manufactured in his own
workshop by both a blacksmith and a saddler. He also invented a wrench
for the reduction of fractures and an osteoclast to break and reset
bones, as well as a collar for tuberculosis of the cervical spine.<br /> <br />Hugh
Owen Thomas was a thin and nervous child who was somewhat delicate. His
peculiar temperament in adulthood led many to ignore him and his
immense contributions to Orthopaedic Surgery during his lifetime. He
could not even work with his father and never held a hospital
appointment. The people of Liverpool knew Thomas as a short and quick
man, only a few inches over five feet, who always wore a black coat
buttoned up to the neck and a sailors cap pulled over a damaged eye. A
cigarette was also seen constantly in his mouth. He treated all his
patients at his home. His practice was so busy that he started his
rounds at five or six in the morning and never left his home for other
than professional purposes. The only exception to this were the three
times a year when he visited his mother's grave. <br />
Thomas would designate Sunday as his "free day", when hundreds of
patients from all over the countryside besieged Nelson Street in the
morning, filling the house to overflowing and the surrounding streets
with carriages and invalid chairs.<br />
</div>
</div>Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-62007768753167308232012-02-21T12:08:00.000+05:302012-02-21T12:08:33.665+05:30<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
DR RAJAN's BLOG SITE VERY USEFUL<br />
<br />
http://rajansorthopaedics.blogspot.com/<br />
<br /></div>Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com1tag:blogger.com,1999:blog-5880677466498354462.post-71170603550672736362012-02-03T10:37:00.000+05:302012-02-03T10:37:00.852+05:30Doctor (title)<div dir="ltr" style="text-align: left;" trbidi="on">
<b>Doctor</b>, as a title, originates from the Latin word of the same spelling and meaning.<sup class="reference" id="cite_ref-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-0">[1]</a></sup> The word is originally an <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Agentive" title="Agentive">agentive</a> noun of the Latin verb <i>docēre</i> (<small>Latin pronunciation: </small><span class="IPA" title="Pronunciation in IPA"><a href="http://en.wikipedia.org/wiki/Wikipedia:IPA_for_Latin" title="Wikipedia:IPA for Latin">[dɔk'e:rɛ]</a></span>, 'to teach'). It has been used as an honored academic title for over a <a href="http://en.wikipedia.org/wiki/Millennium" title="Millennium">millennium</a> in Europe, where it dates back to the rise of the <a href="http://en.wikipedia.org/wiki/University" title="University">university</a>. This use spread to the <a href="http://en.wikipedia.org/wiki/Americas" title="Americas">Americas</a>, former European <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Colonies" title="Colonies">colonies</a>, and is now prevalent in most of the world. Abbreviated "Dr" or "Dr.", it is used as a designation for a person who has obtained a <a href="http://en.wikipedia.org/wiki/Doctorate" title="Doctorate">doctorate</a>-level degree. Doctorates may be <a href="http://en.wikipedia.org/wiki/Doctorate#Research_doctorates" title="Doctorate">research doctorates</a> or <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Professional_doctorate" title="Professional doctorate">professional doctorates</a>. When addressing several people, each of whom holds a doctoral title, one may use the plural abbreviation "Drs." or in some languages (for example, German) "Dres." may be used, for example, instead of Dr. Miller and Dr. Rubinstein: Drs. Miller and Rubinstein. When referring to relatives with the same surname the form "The Doctors Smith" can be used. The plural abbreviation Drs. can also mean <a href="http://en.wikipedia.org/wiki/Doctorandus" title="Doctorandus">doctorandus</a>, a <a href="http://en.wikipedia.org/wiki/Dutch_people" title="Dutch people">Dutch</a> academic title.<br />
<br />
<br />
<h2>
<span class="mw-headline" id="Origins">Origins</span></h2>
The doctorate (<a href="http://en.wikipedia.org/wiki/Latin" title="Latin">Latin</a>: <i>doceō</i>, I teach) appeared in <a href="http://en.wikipedia.org/wiki/Middle_Ages" title="Middle Ages">medieval Europe</a> as a license to teach (<a href="http://en.wikipedia.org/wiki/Latin" title="Latin">Latin</a>: <i>licentia docendi</i>) at a <a href="http://en.wikipedia.org/wiki/Medieval_university" title="Medieval university">medieval university</a>.<sup class="reference" id="cite_ref-Lexikon_des_Mittelalters:_Doctor.2C_doctoratus_1-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Lexikon_des_Mittelalters:_Doctor.2C_doctoratus-1">[2]</a></sup> Its roots can be traced to the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Early_church" title="Early church">early church</a> when the term "doctor" referred to the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Apostles" title="Apostles">Apostles</a>, <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Church_fathers" title="Church fathers">church fathers</a> and other <a href="http://en.wikipedia.org/wiki/Christianity" title="Christianity">Christian</a> authorities who taught and interpreted the <a href="http://en.wikipedia.org/wiki/Bible" title="Bible">Bible</a>.<sup class="reference" id="cite_ref-Lexikon_des_Mittelalters:_Doctor.2C_doctoratus_1-1"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Lexikon_des_Mittelalters:_Doctor.2C_doctoratus-1">[2]</a></sup> The right to grant a <i>licentia docendi</i> was originally reserved to the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Catholic_church" title="Catholic church">church</a> which required the applicant to pass a test, to take oath of allegiance and pay a fee. The <a href="http://en.wikipedia.org/wiki/Third_Council_of_the_Lateran" title="Third Council of the Lateran">Third Council of the Lateran</a> of 1179 guaranteed the access – now largely free of charge – of all able applicants, who were, however, still tested for aptitude by the ecclesiastic scholastic.<sup class="reference" id="cite_ref-Lexikon_des_Mittelalters:_Licentia_2-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Lexikon_des_Mittelalters:_Licentia-2">[3]</a></sup> This right remained a bone of contention between the church authorities and the slowly emancipating universities, but was granted by the <a href="http://en.wikipedia.org/wiki/Pope" title="Pope">pope</a> to the <a href="http://en.wikipedia.org/wiki/University_of_Paris" title="University of Paris">University of Paris</a> in 1213 where it became a universal license to teach (<i>licentia ubiquie docendi</i>).<sup class="reference" id="cite_ref-Lexikon_des_Mittelalters:_Licentia_2-1"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Lexikon_des_Mittelalters:_Licentia-2">[3]</a></sup> However, while the licentia continued to hold a higher prestige than the bachelor's degree (<i>Baccalaureus</i>), it was ultimately reduced to a intermediate step to the Magister and doctorate, both of which now became the exclusive qualification for teaching.<sup class="reference" id="cite_ref-Lexikon_des_Mittelalters:_Licentia_2-2"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Lexikon_des_Mittelalters:_Licentia-2">[3]</a></sup><br />
The first <a href="http://en.wikipedia.org/wiki/Academic_degree" title="Academic degree">academic degrees</a> were all <a href="http://en.wikipedia.org/wiki/Law_degree" title="Law degree">law degrees</a>, and the first law degrees were <a href="http://en.wikipedia.org/wiki/Doctorate" title="Doctorate">doctorates</a>. The foundations for the <a href="http://en.wikipedia.org/wiki/Medieval_university" title="Medieval university">first European universities</a> were the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Glossators" title="Glossators">glossators</a> of the 11th century, which were <a href="http://en.wikipedia.org/wiki/Law_school" title="Law school">schools of law</a> that taught <a href="http://en.wikipedia.org/wiki/Canon_law" title="Canon law">Canon law</a> and <a href="http://en.wikipedia.org/wiki/Roman_law" title="Roman law">Roman law</a>.<sup class="reference" id="cite_ref-Catholic_Encyclopedia_3-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Catholic_Encyclopedia-3">[4]</a></sup> The first European university, the <a href="http://en.wikipedia.org/wiki/University_of_Bologna" title="University of Bologna">University of Bologna</a>, was founded as a school of law by four famous legal scholars in the 12th century who were students of the glossator school in <a href="http://en.wikipedia.org/wiki/Bologna" title="Bologna">Bologna</a>. It is from this history that it is said that the first academic title of doctor applied to scholars of law. The degree and title were not applied to scholars of other disciplines until the 13th century.<sup class="reference" id="cite_ref-4"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-4">[5]</a></sup> At the <a href="http://en.wikipedia.org/wiki/University_of_Bologna" title="University of Bologna">University of Bologna</a>, from its founding in the 12th century until the end of the 20th century, the only degree conferred was the doctorate, usually earned after five years of intensive study after secondary school. The rising of the doctor of philosophy to its present level is a modern novelty.<sup class="reference" id="cite_ref-carnegie_5-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-carnegie-5">[6]</a></sup> At its origins, a doctorate was simply a qualification for a <a href="http://en.wikipedia.org/wiki/Guild" title="Guild">guild</a>—that of teaching law.<sup class="reference" id="cite_ref-6"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-6">[7]</a></sup><br />
The earliest doctoral degrees (theology, law, and medicine) reflected the historical separation of all university study into these three fields. Over time the D.D. has gradually become less common and studies outside theology and medicine have become more common (such studies were then called "philosophy", but are now classified as sciences and humanities - however this usage survives in the degree of Doctor of Philosophy).<br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=2" title="Edit section: Doctor as a noun">edit</a>]</span> <span class="mw-headline" id="Doctor_as_a_noun">Doctor as a noun</span></h2>
Throughout much of the academic world, the term "doctor" refers to an individual who has earned a degree of Doctor of Philosophy, or <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Ph.D." title="Ph.D.">Ph.D.</a> (an abbreviation for the Latin <i>Philosophiæ Doctor</i>; or alternatively <i>Doctor philosophiæ</i>, D.Phil., meaning Teacher of Philosophy), or other research doctorate such as the Doctor of Science, or <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Sc.D." title="Sc.D.">Sc.D.</a> (an abbreviation of the Latin <i>Scientiae Doctor</i>). Beyond academia and in the classical professions, such as law and medicine, professional doctorates emerged such as the Juris Doctor <a href="http://en.wikipedia.org/wiki/Juris_Doctor" title="Juris Doctor">J.D.</a>, Doctor of Medicine <a href="http://en.wikipedia.org/wiki/Doctor_of_Medicine" title="Doctor of Medicine">M.D.</a> (an abbreviation of the Latin <i>Medicinæ Doctor</i>), Doctor of Osteopathic Medicine <a href="http://en.wikipedia.org/wiki/Doctor_of_Osteopathic_Medicine" title="Doctor of Osteopathic Medicine">D.O.</a>, Doctor of Dental Surgery (<a class="mw-redirect" href="http://en.wikipedia.org/wiki/D.D.S." title="D.D.S.">D.D.S.</a>) or Doctor of Dental Medicine (<a class="mw-redirect" href="http://en.wikipedia.org/wiki/D.M.D." title="D.M.D.">D.M.D.</a>), Doctor of Optometry (<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Doctor_of_Optometry" title="Doctor of Optometry">O.D.</a>), Doctor of Psychology (<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Psy.D." title="Psy.D.">Psy.D.</a>), Doctor of Chiropractic (<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Doctor_of_Chiropractic" title="Doctor of Chiropractic">D.C.</a>), Doctor of Engineering (D.Eng), Doctor of Pharmacy (<a class="mw-redirect" href="http://en.wikipedia.org/wiki/PharmD" title="PharmD">PharmD</a>), Doctor of Physical Therapy (<a class="mw-redirect" href="http://en.wikipedia.org/wiki/D.P.T." title="D.P.T.">D.P.T.</a>), and as a courtesy since the 14th century (though in the UK prohibited by section 49(1) of the Medical Act 1983 <a href="http://en.wikipedia.org/wiki/List_of_Privy_Council_Orders" title="List of Privy Council Orders">List of Privy Council Orders</a>) Bachelor of Medicine and Surgery <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Bachelor_of_Medicine_and_Surgery" title="Bachelor of Medicine and Surgery">MBBS, MBChB, MB, BCh, etc.</a> (an abbreviation of the Latin Medicinae Baccalaureus et Baccalaureus Chirurgiae), BHMS (Bachelor of Homeopathic Medicine and Surgery), and BAMS (Bachelor of Ayurvedic Medicine).<br />
The Ph.D. was originally a <a href="http://en.wikipedia.org/wiki/Academic_degree" title="Academic degree">degree</a> granted by a <a href="http://en.wikipedia.org/wiki/University" title="University">university</a> to learned individuals who had achieved the approval of their peers and who had demonstrated a long and productive career in the field of philosophy. The appellation of "Doctor" (from Latin: teacher) was usually awarded only when the individual was in middle age. It indicated a life dedicated to learning, to knowledge, and to the spread of knowledge.<br />
The Ph.D. entered widespread use in the 19th century at the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Friedrich_Wilhelm_University" title="Friedrich Wilhelm University">Friedrich Wilhelm University</a> in Berlin as a degree to be granted to someone who had undertaken original research in the sciences or humanities. From there it spread to the United States, arriving at <a href="http://en.wikipedia.org/wiki/Yale_University" title="Yale University">Yale University</a> in 1861, and then to the <a href="http://en.wikipedia.org/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> in 1921. This displaced the existing Doctor of Philosophy degree in some Universities; for instance, the D.Phil. (higher doctorate in the faculty of philosophy) at the <a href="http://en.wikipedia.org/wiki/University_of_St_Andrews" title="University of St Andrews">University of St Andrews</a> was discontinued and replaced with the Ph.D. (research doctorate). However, some UK universities such as <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Oxford_University" title="Oxford University">Oxford</a> and <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Sussex_University" title="Sussex University">Sussex</a> (and, until recently, <a href="http://en.wikipedia.org/wiki/University_of_York" title="University of York">York</a>) retain the D.Phil. appellation for their research degrees, as, until recently, did the <a href="http://en.wikipedia.org/wiki/University_of_Waikato" title="University of Waikato">University of Waikato</a> in <a href="http://en.wikipedia.org/wiki/New_Zealand" title="New Zealand">New Zealand</a>.<br />
In the US, the <a href="http://en.wikipedia.org/wiki/Doctor_of_Science" title="Doctor of Science">Doctor of Science</a>, <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Sc.D." title="Sc.D.">Sc.D.</a>, is an academic research degree that was first conferred in North America by <a href="http://en.wikipedia.org/wiki/Harvard_University" title="Harvard University">Harvard University</a> in 1872, and is relatively rarer than the Ph.D. However, the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Sc.D." title="Sc.D.">Sc.D.</a> degree has long been awarded by leading institutions such as Harvard University, Johns Hopkins University, Massachusetts Institute of Technology, Boston University, Washington University in St. Louis, and so on. At many of these universities, the academic requirements for the Ph.D. and Sc.D. are identical, and with identical doctoral academic regalia (though the Sc.D. hood is gold to represent Science rather than Ph.D. blue). In an effort to standardize doctoral degree conferral at these large research institutions, the Ph.D. has replaced and grandfathered the Sc.D. in certain programs, while the Sc.D. is preserved in parallel to the Ph.D. as the highest conferred research doctorate.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=3" title="Edit section: Healthcare">edit</a>]</span> <span class="mw-headline" id="Healthcare">Healthcare</span></h3>
<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Healthcare" title="Healthcare">Healthcare</a> professions such as <a href="http://en.wikipedia.org/wiki/Chiropractic" title="Chiropractic">chiropractic</a>, <a href="http://en.wikipedia.org/wiki/Clinical_psychology" title="Clinical psychology">clinical psychology</a>, <a href="http://en.wikipedia.org/wiki/Dentistry" title="Dentistry">dentistry</a>, <a href="http://en.wikipedia.org/wiki/Medicine" title="Medicine">medicine</a>, <a href="http://en.wikipedia.org/wiki/Nursing" title="Nursing">nursing</a>, <a href="http://en.wikipedia.org/wiki/Optometry" title="Optometry">optometry</a>, <a href="http://en.wikipedia.org/wiki/Podiatry" title="Podiatry">podiatry</a>, <a href="http://en.wikipedia.org/wiki/Pharmacy" title="Pharmacy">pharmacy</a>, <a href="http://en.wikipedia.org/wiki/Physical_therapy" title="Physical therapy">physical therapy</a>, and <a href="http://en.wikipedia.org/wiki/Veterinary_medicine" title="Veterinary medicine">veterinary medicine</a> use the title doctor professionally.<br />
In the <a href="http://en.wikipedia.org/wiki/United_States" title="United States">United States</a>, those training to become physicians complete a four-year undergraduate course of study, followed by a four-year graduate program in medicine to earn either the <a href="http://en.wikipedia.org/wiki/Doctor_of_Medicine" title="Doctor of Medicine">Doctor of Medicine</a> (M.D.) degree or the <a href="http://en.wikipedia.org/wiki/Doctor_of_Osteopathic_Medicine" title="Doctor of Osteopathic Medicine">Doctor of Osteopathic Medicine</a> (D.O.). Those training to become dentists, optometrists or chiropractors also complete a four-year undergraduate course of study, followed by a four-year post-graduate program to earn the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Doctor_of_Dental_Surgery" title="Doctor of Dental Surgery">Doctor of Dental Surgery</a> (D.D.S.) or <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Doctor_of_Dental_Medicine" title="Doctor of Dental Medicine">Doctor of Dental Medicine</a> (D.M.D.), <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Doctor_of_Optometry" title="Doctor of Optometry">Doctor of Optometry</a> (O.D.), or <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Doctor_of_Chiropractic" title="Doctor of Chiropractic">Doctor of Chiropractic</a> (D.C.), degrees, or Doctor of Pharmacy (PharmD), respectively. Some programs offer programs with 2 pre-professional years followed by 4 professional years, while others require a 4 year undergraduate/ bachelor's degree. Doctors of Physical Therapy complete a four-year undergraduate course of study, followed by a three plus year graduate program to earn the <a href="http://en.wikipedia.org/wiki/Doctor_of_Physical_Therapy" title="Doctor of Physical Therapy">Doctor of Physical Therapy</a> (DPT).<br />
In the <a href="http://en.wikipedia.org/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> and many <a href="http://en.wikipedia.org/wiki/Commonwealth_of_Nations" title="Commonwealth of Nations">Commonwealth</a> countries, those training for the medical profession complete either a 5-6 year course of study or an accelerated 4-year <a href="http://en.wikipedia.org/wiki/Graduate_entry" title="Graduate entry">graduate entry</a> course of study that leads to the degree of Bachelor of Medicine and Bachelor of Surgery (MBBS or MBChB, standing for the <a href="http://en.wikipedia.org/wiki/Latin" title="Latin">Latin</a> <i>Medicinae Baccalaureus et Chirurgiae Baccalaureus</i>).<sup class="reference" id="cite_ref-7"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-7">[8]</a></sup> The higher postgraduate degree of Doctor of Medicine (M.D.) is reserved for those who can prove a particular distinction in the field, usually through a body of published work or the submission of a <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Dissertation" title="Dissertation">dissertation</a>.<sup class="reference" id="cite_ref-8"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-8">[9]</a></sup> To be eligible for a MD degree in the UK one must already hold an entry level medical degree (for example, MBBS, MBChB, BMed, or a North American MD degree) and usually must have had at least 5 years of post graduate training and experience. In guidance issued by <i>Who's Who</i> published by A & C Black,<sup class="reference" id="cite_ref-9"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-9">[10]</a></sup> it is noted that in the context of the UK, "not all qualified medical practitioner hold the (M.D.) degree" but that "those ... who have not taken it are addressed as if they had." A & C Black also note that British <i>surgeons</i> - a designation reserved for those who have obtained membership of the Royal College of Surgeons - are addressed as Mr, Mrs or Miss rather than Dr. This custom has been commented on in the <i><a class="mw-redirect" href="http://en.wikipedia.org/wiki/British_Medical_Journal" title="British Medical Journal">British Medical Journal</a></i> and may stem from the historical origins of the profession.<sup class="reference" id="cite_ref-10"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-10">[11]</a></sup> Those training to become dentists usually graduate with a dental degree (for example, BDS, BDent, BDentSc, BChD, and so on) and are also referred to as "doctor". In the <a href="http://en.wikipedia.org/wiki/House_of_Commons_of_the_United_Kingdom" title="House of Commons of the United Kingdom">House of Commons of the United Kingdom</a> on January 19, 1996, health minister <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Gerald_Malone" title="Gerald Malone">Gerald Malone</a> noted that the title doctor had never been restricted to either medical practitioners or those with doctoral degrees in the UK, commenting that the word was defined by common usage but that the titles "physician, doctor of medicine, licentiate in medicine and surgery, bachelor of medicine, surgeon, general practitioner and apothecary" did have special protection in law.<sup class="reference" id="cite_ref-11"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-11">[12]</a></sup><br />
In <a href="http://en.wikipedia.org/wiki/India" title="India">India</a>, the MBBS (graduate entry) medical degree is required to become a doctor. The higher postgraduate Doctor of Medicine (M.D.) is required to become a specialist in a particular field.<br />
In <a href="http://en.wikipedia.org/wiki/German_language" title="German language">German language</a>-speaking countries, the word <i>Doktor</i> always refers to a research doctorate awardee, and is distinct from <i>Arzt</i>, a medical practitioner.<br />
In the <a href="http://en.wikipedia.org/wiki/Dutch_language" title="Dutch language">Dutch language</a> the word "dokter" refers to a physician, whereas "doctor" refers to high academic rank.<br />
<a href="http://en.wikipedia.org/wiki/Hong_Kong" title="Hong Kong">Hong Kong</a> follows British practice in calling physicians "Doctor" even though many of them hold only an MBBS qualification. An attempt by their professional body to prevent <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Chiropractors" title="Chiropractors">chiropractors</a> from calling themselves "Doctor" failed in the courts, in part because it was pointed out that practicing chiropractic physicians hold a doctorate in their discipline, and it would be anomalous to prevent them using the title when holders of doctorates in non-medical disciplines faced no such restriction.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=4" title="Edit section: Legal profession">edit</a>]</span> <span class="mw-headline" id="Legal_profession">Legal profession</span></h3>
Historically, lawyers in most European countries were addressed with the title of doctor, and countries outside of Europe have generally followed the practice of the European country which had policy influence through modernization or colonialization. The first university degrees, starting with the law school of the University of Bologna (or glossators) in the 11th century, were all law degrees and doctorates.<sup class="reference" id="cite_ref-12"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-12">[13]</a></sup> Degrees in other fields were not granted until the 13th century, but the doctorate continued to be the only degree offered at many of the old universities up until the 20th century. As a result, in many of the southern European countries, including Portugal, Spain and Italy,<sup class="reference" id="cite_ref-13"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-13">[14]</a></sup> lawyers have traditionally been addressed as “doctor,” a practice which was transferred to many countries in South America<sup class="reference" id="cite_ref-14"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-14">[15]</a></sup> (as well as Macau in China).<sup class="reference" id="cite_ref-15"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-15">[16]</a></sup><br />
The title of doctor has not customarily been used to address lawyers in England or other common law countries because until 1846 lawyers in England were not required to have a university degree and were trained by other attorneys by apprenticeship or in the Inns of Court.<sup class="reference" id="cite_ref-16"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-16">[17]</a></sup> The exception being those areas where, up to the 19th century, civil law rather than common law was the governing tradition, including admiralty law, probate and ecclesiastical law, such cases were heard in the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Doctor%27s_Commons" title="Doctor's Commons">Doctor's Commons</a>, and argued by advocates who held degrees either of doctor of civil law at Oxford or doctor of law at Cambridge. As such, lawyers practicing common law in England were not doctoral candidates and had not earned the doctorate level degree. When university degrees became a prerequisite to become a lawyer in England, the degree awarded was the undergraduate LL.B.<br />
Though lawyers in the United States do not customarily use such a title, the law degree in that country is the <a href="http://en.wikipedia.org/wiki/Juris_Doctor" title="Juris Doctor">Juris Doctor</a>, a professional doctorate degree,<sup class="reference" id="cite_ref-Ethics_Opinion_1969-5_17-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Ethics_Opinion_1969-5-17">[18]</a></sup> and some J.D. holders in the United States use the title of doctor in professional<sup class="reference" id="cite_ref-law.cornell.edu_18-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-law.cornell.edu-18">[19]</a></sup> and academic situations.<sup class="reference" id="cite_ref-Profile_of_Dr._Michael_Harrington_19-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Profile_of_Dr._Michael_Harrington-19">[20]</a></sup><br />
In countries where holders of the first law degree traditionally use the title of doctor (for example, Peru, Brazil, Macau, Portugal, Argentina, and Italy),<sup class="reference" id="cite_ref-20"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-20">[21]</a></sup> J.D. holders who are attorneys may use the title of doctor in advertisements in Spanish.<sup class="reference" id="cite_ref-21"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-21">[22]</a></sup><br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=5" title="Edit section: Worldwide usage">edit</a>]</span> <span class="mw-headline" id="Worldwide_usage">Worldwide usage</span></h2>
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=6" title="Edit section: Austria">edit</a>]</span> <span class="mw-headline" id="Austria">Austria</span></h3>
In Austria, the title "Doktor" is granted to physicians and dentists (Dr. med. univ. and Dr. med. dent., which are technically not "doctorate degrees") as well as to holders of postgraduate research degrees (Dr. techn., Dr. phil., Dr. rer. nat., etc.).<sup class="reference" id="cite_ref-22"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-22">[23]</a></sup> They are addressed as "Doktor ______", and the title is usually abbreviated to "Dr. ______". Contrary to popular belief, "Dr." is not part of the name but just an academic title like "Mag." or "Dipl.-Ing.". It is not mandatory to use the title, although it can be added to official documents (driver's license, passport, etc.), if desired.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=7" title="Edit section: Commonwealth countries">edit</a>]</span> <span class="mw-headline" id="Commonwealth_countries">Commonwealth countries</span></h3>
In the <a href="http://en.wikipedia.org/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>, <a href="http://en.wikipedia.org/wiki/South_Africa" title="South Africa">South Africa</a>, <a href="http://en.wikipedia.org/wiki/Australia" title="Australia">Australia</a>, <a href="http://en.wikipedia.org/wiki/New_Zealand" title="New Zealand">New Zealand</a> and other areas whose cultures were recently linked to the UK, the title <i>Doctor</i> generally applies in both the academic and clinical fields. "<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Registered_medical_practitioner" title="Registered medical practitioner">Registered medical practitioners</a>" hold the degree of <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Bachelor_of_Medicine" title="Bachelor of Medicine">Bachelor of Medicine</a> (usually also with surgery). Cultural conventions exist, clinicians who are <a href="http://en.wikipedia.org/wiki/Membership_of_the_Royal_College_of_Surgeons" title="Membership of the Royal College of Surgeons">Members</a> or <a href="http://en.wikipedia.org/wiki/Fellowship_of_the_Royal_College_of_Surgeons" title="Fellowship of the Royal College of Surgeons">Fellows of the Royal College of Surgeons</a> are an exception. As a homage to their predecessors, the <a href="http://en.wikipedia.org/wiki/Barber_surgeon" title="Barber surgeon">barber surgeons</a>, they prefer to be addressed as <i><a class="mw-redirect" href="http://en.wikipedia.org/wiki/Mister_%28Mr.%29" title="Mister (Mr.)">Mr</a>, <a href="http://en.wikipedia.org/wiki/Mrs." title="Mrs.">Mrs</a>, <a href="http://en.wikipedia.org/wiki/Ms." title="Ms.">Ms</a> or <a href="http://en.wikipedia.org/wiki/Miss" title="Miss">Miss</a></i>, even if they do hold a medical degree. When a medical doctor passes the examinations which enable them to become a member of one or more of the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Royal_Surgical_Colleges" title="Royal Surgical Colleges">Royal Surgical Colleges</a> and become "<a href="http://en.wikipedia.org/wiki/Membership_of_the_Royal_College_of_Surgeons" title="Membership of the Royal College of Surgeons">MRCS</a>", it is customary for them to drop the "Doctor" prefix and take up "Miss", "Mister", or and so on. This rule applies to any doctor of any grade who has passed the appropriate exams, and is not the exclusive province of consultant-level surgeons. In recent times, other surgically-orientated specialists, such as <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Gynaecologist" title="Gynaecologist">gynaecologists</a>, have also adopted these prefixes. A surgeon who is also a professor is usually known as "Professor" and, similarly, a surgeon who has been ennobled, knighted, created a baronet or appointed a dame uses the corresponding title (Lord, Sir, Dame). <a href="http://en.wikipedia.org/wiki/Physician" title="Physician">Physicians</a>, on the other hand, when they pass their "<a href="http://en.wikipedia.org/wiki/Membership_of_the_Royal_College_of_Physicians" title="Membership of the Royal College of Physicians">MRCP</a>" examinations, which enable them to become members of the <a href="http://en.wikipedia.org/wiki/Royal_College_of_Physicians" title="Royal College of Physicians">Royal College of Physicians</a>, do not drop the "Doctor" prefix and remain Doctor, even when they are consultants. In the United Kingdom the status and rank of consultant surgeons with the MRCS, titled "Mister", etc., and consultant physicians with the MRCP, titled "Doctor", is identical. Surgeons in the USA and elsewhere continue to use the title "Doctor", although <a href="http://en.wikipedia.org/wiki/New_Zealand" title="New Zealand">New Zealand</a> uses the titles of <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Mister_%28Mr.%29" title="Mister (Mr.)">Mr</a> and Doctor, in the same way as the <a href="http://en.wikipedia.org/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>.<br />
In the UK, an equivalent formation to a doctorate is the NVQ 5 or QCF 8.<sup class="reference" id="cite_ref-23"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-23">[24]</a></sup> However, an NVQ 5 is less work than a doctorate and such a person is not allowed to use the prefix "Dr."<br />
<dl>
<dt>Australia</dt>
</dl>
With the introduction of National Health Practitioner registration legislation on July 1, 2010, the title "doctor" is not restricted in any Australian state. The title "medical practitioner" is restricted for use by registered medical practitioners, while the title "doctor" is not restricted by law.<sup class="reference" id="cite_ref-24"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-24">[25]</a></sup><br />
<dl>
<dt>Canada</dt>
</dl>
Canada lies somewhere between British and American usage of the degree and terminology of "doctor". Research doctorates - PhDs and ScDs - are entitled to use the title "doctor". In medicine, all medical practitioners trained in Canada receive the MD degree (or MDCM in the case of graduates of <a href="http://en.wikipedia.org/wiki/McGill_University_Faculty_of_Medicine" title="McGill University Faculty of Medicine">McGill University</a>) and are referred to as "Doctor". The British use of "Mr", "Mrs", and so on for surgeons is not followed in Canada. In the legal profession, graduates of almost all Canadian law schools receive the LLB degree and are not referred to as "doctor" (in a growing number of Canadian law schools the degree of <a href="http://en.wikipedia.org/wiki/Juris_Doctor" title="Juris Doctor">Juris Doctor</a> is conferred, but the title is not used in practice). Medicine, Dentistry, Optometry, Chiropractic and Law (as well as other <a href="http://en.wikipedia.org/wiki/First_professional_degree" title="First professional degree">first professional degree</a> programs) are generally considered, in Canada, to be a specialized professional undergraduate program. Practitioners in veterinary medicine, optometry and dentistry have doctorate degrees and are very commonly referred to with the title "Dr" preceding the specific name, but not referred to as "a doctor". Practitioners of podiatry and alternative medicine may not be referred to with the "Dr" honorific in relation to providing the public with health care services. In Ontario, only chiropractors, dentists, medical doctors, optometrists and psychologists can use the title "doctor".<sup class="reference" id="cite_ref-25"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-25">[26]</a></sup> A registered <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Naturopathic_doctor" title="Naturopathic doctor">naturopathic doctor</a> may only use the title “doctor” in written format if he or she also uses the phrase, "naturopathic doctor" immediately following his or her name.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=8" title="Edit section: European Union">edit</a>]</span> <span class="mw-headline" id="European_Union">European Union</span></h3>
Double doctorates are indicated in the title by <i>"Dr. Dr."</i> or <i>"DDr."</i> and triple doctorates as <i>"Dr. Dr. Dr."</i> or <i>"DDDr."</i>. More doctorates are indicated by the addition of <i>"mult."</i>, such as <i>"Dr. mult."</i>. Honorary titles are shown with the addition of <i>"h.c."</i>, which stands for <i>"honoris causa"</i>. Example: <i>"Dr. h.c. mult."</i><br />
European Union (EU) legislation recognises academic qualifications (including higher degrees and doctorates) of all member states. In Germany, a recent federal law (signed by all Cultural and Educational Ministers in accord with the EU law) confirmed the standardisation of qualifications. Until this Federal Law was introduced, there was no recognised mechanism to prevent administrators in private bodies and civil servants in public-funded bodies (such as universities) from automatically discriminating between the qualifications of people with German doctorates compared to holders of doctorates from an EU member state. The German university bureaucratic practice of using the post-nominal form, "Ph.D." (or equivalent), to distinguish non-German doctorates can be challenged legally as evidence of arbitrary discrimination and prejudice against non-German nationals (academics). All EU citizens are now "legally entitled" to use and be titled (addressed) as "Doctor" or "Dr." in all formal, legal and published communications (provided they do in fact hold the appropriate degree). For academics with doctorates from non-EU member states, the qualification must be recognised formally ("validated") by the Federal Educational Ministry in Bonn. The recognition process can be done by the employer or employee and may be part of the official bureaucracy for confirming professional status and is dependent on individual bilateral agreements between Germany and other countries.<br />
An example of mutual recognition of Doctor titles among EU countries is the "Bonn Agreement of November 14, 1994", signed between Germany and Spain.<sup class="reference" id="cite_ref-26"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-26">[27]</a></sup><br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=9" title="Edit section: Finland">edit</a>]</span> <span class="mw-headline" id="Finland">Finland</span></h3>
In <a href="http://en.wikipedia.org/wiki/Finland" title="Finland">Finland</a>, the term <i>tohtori/doktor</i> is applied only to holders of the postgraduate research doctor's degree. The most common is <i>filosofian tohtori/filosofie doktor</i> (Doctor of Philosophy), but more specializations are used than in English (for example, <i>tekniikan tohtori/teknologie doktor</i> "Doctor of Science in Technology"). The degree requisite for a physician's or dentist's license is called <a href="http://en.wikipedia.org/wiki/Licentiate" title="Licentiate">Licentiate</a> of Medicine or Dentistry (<i>lääketieteen/hammaslääketieteen lisensiaatti medicine/odontologie licentiat</i>). The degree <i>lääketieteen tohtori/medecine doktor</i> is the postgraduate "professor's degree". However, in rustic or old-fashioned unofficial usage, <i>tohtori/doktor</i> might refer to physicians also.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=10" title="Edit section: France">edit</a>]</span> <span class="mw-headline" id="France">France</span></h3>
In <a href="http://en.wikipedia.org/wiki/France" title="France">France</a>, the title of <i>Docteur</i> is only used in the current language for <a href="http://en.wikipedia.org/wiki/Physician" title="Physician">physicians</a>, <a href="http://en.wikipedia.org/wiki/Dentist" title="Dentist">dentists</a>, <a href="http://en.wikipedia.org/wiki/Veterinarian" title="Veterinarian">veterinarians</a> and <a href="http://en.wikipedia.org/wiki/Pharmacist" title="Pharmacist">pharmacists</a>. Confusingly, the professionals from these medical domains do not hold a <a href="http://en.wikipedia.org/wiki/Doctorate" title="Doctorate">doctorate</a>, which is in France only a research doctorate, but a "State Diploma of Doctor". The holders of a doctorate are only rarely referred to as "Doctors", especially by the people who are themselves from an academic environment.<sup class="Template-Fact" style="white-space: nowrap;" title="This claim needs references to reliable sources from October 2009">[<i><a href="http://en.wikipedia.org/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</sup><br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=11" title="Edit section: Germany">edit</a>]</span> <span class="mw-headline" id="Germany">Germany</span></h3>
In <a href="http://en.wikipedia.org/wiki/Germany" title="Germany">Germany</a>, the most common doctoral degrees are <i>Dr. med.</i> (medicine), <i>Dr. med. dent.</i> (dentistry), <i>Dr. med. vet.</i> (veterinary medicine), <i>Dr. rer. nat.</i> (natural sciences), <i>Dr. phil.</i> (philosophy and many other subjects), <i>Dr. iur.</i> (law), <i>Dr. oec.</i> (economy), <i>Dr. rer. pol.</i> (political sciences), <i>Dr.-Ing.</i> (engineering), and <i>Dr. theol.</i> (theology). All holders of doctorate degrees are appropriately addressed as "Herr/Frau Dr. _____" in all social situations. In professional situations, PhDs are recognized under the condition that the degree was granted by a university authorized to grant the degree according to the laws of the country of origin. Holders of PhDs granted in the E.U. can be addressed as "Dr." in Germany without any further addenda. According to a decision by The Standing Conference of the Ministers of Education and Cultural Affairs of the Länder in the Federal Republic of Germany of September 21, 2001, in the version from May 15, 2008, this also applies to PhDs that were awarded in Australia, Israel, Japan, or Canada. PhDs that were awarded in the United States are recognized if the awarding institution is classified by the Carnegie Foundation for the Advancement of Teaching as a "Research University (high research activity)" or as a "Research University (very high research activity)." Different conditions apply for professional degrees such as the M.D. or J.D.<sup class="reference" id="cite_ref-27"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-27">[28]</a></sup><br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=12" title="Edit section: Greece">edit</a>]</span> <span class="mw-headline" id="Greece">Greece</span></h3>
In Greece, the term "Doctor" (Δόκτωρ, Δρ.) (pron. <i>doktōr</i>) is used to formally address both holders of a doctorate degree and physicians. The title "Διδάκτωρ" (<i>didaktōr</i>) is used to reference holders of a doctorate degree, while the term "Ιατρός" (<i>iatros</i>) is used for physicians of any specialty.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=13" title="Edit section: Hungary">edit</a>]</span> <span class="mw-headline" id="Hungary">Hungary</span></h3>
<h4>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=14" title="Edit section: Dr as part of the name">edit</a>]</span> <span class="mw-headline" id="Dr_as_part_of_the_name">Dr as part of the name</span></h4>
In Hungary the title of Doctor used to become a part of the name and was added as such to personal ID documents. This practice is still common and graduates after receiving their "diploma" would usually change their personal documents in order to officially indicate the achievement.<br />
<h4>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=15" title="Edit section: Requirements for the doctor title">edit</a>]</span> <span class="mw-headline" id="Requirements_for_the_doctor_title">Requirements for the doctor title</span></h4>
Graduates of the 6 year medical schools, the 5 year law schools and the 5 year veterinary medical schools receive the doctor title at the end of their studies. Completing a PhD research programme also leads to the doctor title. A large part of Hungarians with doctor titles received their titles for research in the old academic system before introducing PhD in Hungary. Recently pharmacists have obtained the right to use the title "Dr" after successfully completed the faculty of pharmaceutical-chemistry in relevant universities.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=16" title="Edit section: Italy">edit</a>]</span> <span class="mw-headline" id="Italy">Italy</span></h3>
The first university of Western civilization, the <a href="http://en.wikipedia.org/wiki/University_of_Bologna" title="University of Bologna">University of Bologna</a>, is located in Italy, where until modern times the only degree granted was that of the doctorate,<sup class="reference" id="cite_ref-Catholic_Encyclopedia_3-1"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Catholic_Encyclopedia-3">[4]</a></sup> and all other Italian universities followed that model. During the 20th century Italian universities introduced more advanced research degrees, such as the Ph.D., and now that it is part of the E.U. <a href="http://en.wikipedia.org/wiki/Bologna_Process" title="Bologna Process">Bologna Process</a>, a new 3-year first degree, or “laurea breve o triennale” (equivalent to a B.A. of other countries), has been introduced. The old-style "laurea" is now known as "laurea specialistica o magistrale" (master or specialistic degree, equivalent of a master's degree). For historical reasons, even to this day, the title of "dottore/dottoressa" (abbrev. both as dott/dott.ssa or as dr./dr.ssa <sup class="reference" id="cite_ref-28"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-28">[29]</a></sup> ) is awarded even to those who have attended a "laurea breve o triennale". Upper levels of degree are anyway shown in the title, as those who obtain a master's degree can be referred as "dottore/dottoressa magistrale" (masterly doctor) while those who achieve the relatively new program of "dottorato di ricerca" (research doctorate, equivalent of a Ph.D.), carry the title of "dottore/dottoressa di ricerca" (research doctor), which can be abbreviated as "Dott. Ric." or "Ph.D." <sup class="reference" id="cite_ref-29"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-29">[30]</a></sup><br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=17" title="Edit section: The Philippines">edit</a>]</span> <span class="mw-headline" id="The_Philippines">The Philippines</span></h3>
In the <a href="http://en.wikipedia.org/wiki/Philippines" title="Philippines">Philippines</a>, titles and names of occupations usually follow <a href="http://en.wikipedia.org/wiki/Spanish_language" title="Spanish language">Spanish</a> naming conventions which utilise gender-specific terms. "<i>Doktór</i>" is the masculine form, which retains the abbreviation <i>Dr.</i>; the feminine form is "<i>Doktóra</i>", and is abbreviated usually as "<i>Dra.</i>"; others, however, some being <a href="http://en.wikipedia.org/wiki/English_language" title="English language">Anglophones</a> who wish to sound modern and Westernised (or were raised in an almost exclusively English-speaking family environment), or some who advocate gender equality, would dispense with the distinction altogether. There does exist in <a href="http://en.wikipedia.org/wiki/Filipino_language" title="Filipino language">Filipino</a> an equivalent, gender-neutral term for the professional that carries the more general notion of "healer", traditional (for example, an <i><a href="http://en.wikipedia.org/wiki/Albularyo" title="Albularyo">albuláryo</a></i>) or otherwise: <i>manggagámot</i>.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=18" title="Edit section: Portugal">edit</a>]</span> <span class="mw-headline" id="Portugal">Portugal</span></h3>
In <a href="http://en.wikipedia.org/wiki/Portugal" title="Portugal">Portugal</a>, up to recent times after the completion of an undergraduate degree - except in <a href="http://en.wikipedia.org/wiki/Architecture" title="Architecture">architecture</a> and <a href="http://en.wikipedia.org/wiki/Engineering" title="Engineering">engineering</a> - a person was referred to as <i>doutor (Dr.) - male</i> or <i>doutora (Dra.) - female</i>. The architects and engineers were referred by their professional titles: <i>arquitecto</i> (Arq.) and <i>engenheiro</i> (Eng.).<br />
Nowadays Portugal is a signatory to the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Bologna_process" title="Bologna process">Bologna process</a> and according to the current legislation the title of doctor (<i>doutor, doutora</i>) is reserved for graduate holders of an academic <a href="http://en.wikipedia.org/wiki/Doctorate" title="Doctorate">doctorate</a>.<sup class="reference" id="cite_ref-30"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-30">[31]</a></sup> <a href="http://en.wikipedia.org/wiki/Physician" title="Physician">Physicians</a>, graduates in <a href="http://en.wikipedia.org/wiki/Medicine" title="Medicine">medicine</a>, are usually referred to by the title Dr. (doutor) even if they have not been awarded a doctoral degree.<br />
However, custom gives the legislation little strength and all graduates keep their titles, and those with a doctorate are referred as Professor Doutor.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=19" title="Edit section: Spain">edit</a>]</span> <span class="mw-headline" id="Spain">Spain</span></h3>
The social standing of Doctors in Spain is evidenced by the fact that only <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Ph.D." title="Ph.D.">Ph.D.</a> holders, <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Grandees" title="Grandees">Grandees</a> and <a href="http://en.wikipedia.org/wiki/Duke" title="Duke">Dukes</a> can take seat and cover their heads in the presence of the King.<sup class="reference" id="cite_ref-31"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-31">[32]</a></sup><br />
<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Ph.D." title="Ph.D.">Ph.D.</a> Degrees are regulated by Royal Decree (R.D. 1393/2007),<sup class="reference" id="cite_ref-32"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-32">[33]</a></sup> <i>Real Decreto</i> (in <a href="http://en.wikipedia.org/wiki/Spanish_language" title="Spanish language">Spanish</a>). They are granted by the University on behalf of the King, and its Diploma has the force of a public document. The Ministry of Science keeps a National Registry of <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Ph.D." title="Ph.D.">Ph.D.s</a> called TESEO.<sup class="reference" id="cite_ref-33"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-33">[34]</a></sup> Any person who uses the <a href="http://en.wikipedia.org/wiki/Spanish_people" title="Spanish people">Spanish</a> title of "Doctor" (or "Dr.") without being included in this Government database can be prosecuted for fraud.<br />
Unlike other countries, Spain registers a comparatively small number of Doctor degree holders. According to the National Institute of Statistics (INE), less than 5% of M.Sc. degree holders are admitted to Ph.D. programs<sup class="Template-Fact" style="white-space: nowrap;" title="This claim needs references to reliable sources from June 2010">[<i><a href="http://en.wikipedia.org/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</sup>. This reinforces the prestige that Doctors enjoy in Spain's society.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=20" title="Edit section: Thailand">edit</a>]</span> <span class="mw-headline" id="Thailand">Thailand</span></h3>
The usage of Doctor (ดอกเตอร์) or Dr (ดร.) has been borrowed from English. It can be seen as a title in academic circles and in the mass media. In contrast to other academic titles (Professor, Associate Professor and Assistance Professor), the use of Doctor as a title has not been recognized by the <a href="http://en.wikipedia.org/wiki/Royal_Institute_of_Thailand" title="Royal Institute of Thailand">Royal Institute of Thailand</a>. Therefore, this title, in theory, cannot be used officially. For example, in court of justice where strictly formal Thai language is used, Dr cannot be mentioned as a person's title.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=21" title="Edit section: United States">edit</a>]</span> <span class="mw-headline" id="United_States">United States</span></h3>
In the United States, the title Doctor is commonly used professionally by those who have earned a doctorate-level degree, though those with earned Phds are educationally qualified for the title.<sup class="reference" id="cite_ref-34"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-34">[35]</a></sup><sup class="reference" id="cite_ref-35"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-35">[36]</a></sup><sup class="reference" id="cite_ref-36"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-36">[37]</a></sup><sup class="reference" id="cite_ref-37"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-37">[38]</a></sup> In addition, those who have been granted honorary doctorates are entitled to do so, especially in academic settings. The title is also commonly used socially by those holding a doctoral-level degree.<sup class="reference" id="cite_ref-38"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-38">[39]</a></sup> There is a division between <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Letitia_Baldridge" title="Letitia Baldridge">Letitia Baldridge</a> and <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Miss_Manners" title="Miss Manners">Miss Manners</a> on its social usage by those who are not physicians.<sup class="reference" id="cite_ref-kip_39-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-kip-39">[40]</a></sup> Baldridge sees this usage as acceptable; Miss Manners writes that "only people of the medical profession correctly use the title of doctor socially," but supports those who wish to use it in social contexts in the spirit of addressing people according to their wishes.<sup class="reference" id="cite_ref-kip_39-1"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-kip-39">[40]</a></sup><sup class="reference" id="cite_ref-Martin2005_40-0"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-Martin2005-40">[41]</a></sup><br />
The American College of Clinicians and at least one state<sup class="reference" id="cite_ref-41"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-41">[42]</a></sup> recommends that health care professionals, including physicians, in the clinical setting use identification with an appropriate badge or name tag, as patients encounter a number of different practitioners. For example, all health care professionals should identify themselves and their profession when first meeting a patient.<sup class="reference" id="cite_ref-42"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-42">[43]</a></sup><sup class="reference" id="cite_ref-43"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-43">[44]</a></sup><br />
Attorneys in the United States rarely use any title, but some common ones include "<a href="http://en.wikipedia.org/wiki/Esquire" title="Esquire">Esquire</a>" ("Esq."), "Attorney," or "attorney-at-law." As the academic degree held by U.S. attorneys is the Juris Doctor, a professional doctorate,<sup class="reference" id="cite_ref-44"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-44">[45]</a></sup> some J.D. holders in the United States do use the honorific "Dr." in professional<sup class="reference" id="cite_ref-law.cornell.edu_18-1"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-law.cornell.edu-18">[19]</a></sup> and academic situations.<sup class="reference" id="cite_ref-45"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-45">[46]</a></sup><br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=22" title="Edit section: Abbreviation">edit</a>]</span> <span class="mw-headline" id="Abbreviation">Abbreviation</span></h2>
In <a href="http://en.wikipedia.org/wiki/British_English" title="British English">British English</a> it is not necessary to indicate an abbreviation with a full stop (period) after the abbreviation, when the last letter of the abbreviation is the same as the unabbreviated word,<sup class="reference" id="cite_ref-46"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-46">[47]</a></sup> while the opposite holds true in <a href="http://en.wikipedia.org/wiki/North_American_English" title="North American English">North American English</a>. This means that while the abbreviation of Doctor is usually written as "Dr" in most of the Commonwealth, it is usually written as "Dr." in North America.<sup class="reference" id="cite_ref-47"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-47">[48]</a></sup><br />
Similarly, conventions regarding the punctuation of degree abbreviations vary. In the <a href="http://en.wikipedia.org/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>, it is increasingly common to omit punctuations from abbreviations that are not truncations: while the usual abbreviation of "Esquire" is "Esq.", the usual abbreviation for "Doctor of Philosophy" is "PhD". It is not incorrect to use the fully punctuated "Ph.D.", though if this pattern is used, it should be used consistently; practice in particular situations may vary, and it is always more elegant to be consistent with local patterns of usage than to deviate from them.<br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=23" title="Edit section: Honorary doctorates">edit</a>]</span> <span class="mw-headline" id="Honorary_doctorates">Honorary doctorates</span></h2>
<div class="rellink relarticle mainarticle">
Main article: <a href="http://en.wikipedia.org/wiki/Honorary_degree" title="Honorary degree">Honorary degree</a></div>
An honorary doctorate is a doctoral degree awarded for service to the institution or the wider community. This service does not need to be academic in nature. Often, the same set of degrees is used for higher doctorates, but they are distinguished as being <i>honoris causa</i>: in comprehensive lists, the lettering used to indicate the possession of a higher doctorate is often adjusted to indicate this, for example, "Hon. Sc.D.", as opposed to the earned research doctorate "<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Sc.D." title="Sc.D.">Sc.D.</a>". The degrees of Doctor of the University (D.Univ.) and Doctor of Humane Letters (D.H.L.), however, are only awarded as an honorary degree.<br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Doctor_%28title%29&action=edit&section=24" title="Edit section: Other uses of "Doctor"">edit</a>]</span> <span class="mw-headline" id="Other_uses_of_.22Doctor.22">Other uses of "Doctor"</span></h2>
<ul>
<li>In some regions, such as the <a href="http://en.wikipedia.org/wiki/Southern_United_States" title="Southern United States">Southern United States</a>, "Doctor" is traditionally added to the first name of people holding doctorates, where it is used in either direct or indirect familiar address.<sup class="Template-Fact" style="white-space: nowrap;" title="This claim needs references to reliable sources from August 2008">[<i><a href="http://en.wikipedia.org/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</sup></li>
<li>"<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Doc_%28disambiguation%29" title="Doc (disambiguation)">Doc</a>" is a common nickname for someone with a doctoral degree, in real life and in fiction — for example, the gunfighter <a href="http://en.wikipedia.org/wiki/Doc_Holliday" title="Doc Holliday">Doc Holliday</a>, the character "Doc" in <a href="http://en.wikipedia.org/wiki/Gunsmoke" title="Gunsmoke">Gunsmoke</a>, and pulp hero <a href="http://en.wikipedia.org/wiki/Doc_Savage" title="Doc Savage">Doc Savage</a></li>
<li>In <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Roman_Catholicism" title="Roman Catholicism">Roman Catholicism</a> and several other <a href="http://en.wikipedia.org/wiki/Christian" title="Christian">Christian</a> denominations, a <a href="http://en.wikipedia.org/wiki/Doctor_of_the_Church" title="Doctor of the Church">Doctor of the Church</a> is an eminent <a href="http://en.wikipedia.org/wiki/Theology" title="Theology">theologian</a> (for example, <a href="http://en.wikipedia.org/wiki/Thomas_Aquinas" title="Thomas Aquinas">Thomas Aquinas</a>, also known as the Angelic Doctor) from whose teachings the whole Church is held to have derived great advantage.<sup class="reference" id="cite_ref-48"><a href="http://en.wikipedia.org/wiki/Doctor_%28title%29#cite_note-48">[49]</a></sup></li>
</ul>
<br /></div>Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0tag:blogger.com,1999:blog-5880677466498354462.post-71312726639511308532012-02-03T10:36:00.000+05:302013-05-22T15:25:56.330+05:30Parkour<div dir="ltr" style="text-align: left;" trbidi="on">
<h3>
Parkour<span style="font-weight: normal;"> (sometimes abbreviated </span>PK<span style="font-weight: normal;">) is a method of movement focused on moving around obstacles with speed and efficiency. Originally developed in France, the main purpose of the discipline is to teach participants how to move through their environment by vaulting, rolling, running, climbing and jumping. Traceurs (parkour practitioners) train to be able to identify and utilize alternate or the more efficient paths. Parkour can be practiced anywhere, but areas dense with obstacles offer many different training opportunities.</span><span class="mw-headline" id="Basic_movements"><span style="font-weight: normal;"> </span></span></h3>
<h2>
<span class="mw-headline" id="Overview">Overview</span></h2>
Two primary characteristics of parkour are efficiency and speed. Traceurs take the most direct path through an obstacle as rapidly as that route can be traversed safely. Developing one's level of <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Spatial_awareness" title="Spatial awareness">spatial awareness</a> is often used to aid development in these areas. Also, efficiency involves avoiding injuries, both short and long term. This idea embodying parkour's unofficial motto is <i>être et durer</i> ("to be and to last").<br />
Traceurs say that parkour also influences one's thought processes by enhancing self-confidence and critical-thinking skills that allow one to overcome everyday physical and mental obstacles.<sup class="reference" id="cite_ref-TheLantern_0-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-TheLantern-0">[1]</a></sup><sup class="reference" id="cite_ref-parkour-journeys_1-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-parkour-journeys-1">[2]</a></sup><sup class="reference" id="cite_ref-GYamakasi_2-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-GYamakasi-2">[3]</a></sup> A study by <i>Neuropsychiatrie de l'Enfance et de l'Adolescence</i> (Neuropsychiatry of Childhood and Adolescence) in France reflects that traceurs seek more excitement and leadership situations than do <a href="http://en.wikipedia.org/wiki/Gymnastics" title="Gymnastics">gymnastic practitioners</a>.<sup class="reference" id="cite_ref-3"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-3">[4]</a></sup><br />
<br />
<h2>
<span class="mw-headline" id="Terminology">Terminology</span></h2>
The first terms used to describe this form of training were "l'art du déplacement" and "le parcours".<sup class="reference" id="cite_ref-4"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-4">[5]</a></sup> The term "parkour" (<small>French pronunciation: </small><span class="IPA" title="Pronunciation in IPA"><a href="http://en.wikipedia.org/wiki/Wikipedia:IPA_for_French" title="Wikipedia:IPA for French">[paʁˈkuʁ]</a></span>) was coined by <a href="http://en.wikipedia.org/wiki/Hubert_Kound%C3%A9" title="Hubert Koundé">Hubert Koundé</a>. It derives from "parcours du combattant", the classic obstacle course method of military training proposed by <a href="http://en.wikipedia.org/wiki/Georges_H%C3%A9bert" title="Georges Hébert">Georges Hébert</a>.<sup class="reference" id="cite_ref-PAWA-Welcome_5-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-PAWA-Welcome-5">[6]</a></sup><sup class="reference" id="cite_ref-6"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-6">[7]</a></sup><sup class="reference" id="cite_ref-7"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-7">[8]</a></sup><br />
A practitioner of parkour is called a "traceur" <span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[tʁasœʁ]</span>, with the feminine form being "traceuse" <span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[tʁasøz]</span>. They are <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Noun_substantive" title="Noun substantive">substantives</a> derived from the French verb "tracer", which normally means "trace",<sup class="reference" id="cite_ref-8"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-8">[9]</a></sup> or "trail" (as in "he escaped without a trace").<sup class="reference" id="cite_ref-9"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-9">[10]</a></sup><br />
<br />
<h3>
<span class="mw-headline" id="Historical_precedents">Historical precedents</span></h3>
In the film <i><a href="http://en.wikipedia.org/wiki/Jump_London" title="Jump London">Jump London</a></i>, <a href="http://en.wikipedia.org/wiki/S%C3%A9bastien_Foucan" title="Sébastien Foucan">Sébastien Foucan</a> states that "Le Parkour has always existed, free running has always been there, the thing is that no one gave it a name, we didn’t put it in the box. It is an ancient art [...] The Neanderthals, to hunt, or to chase, or to move around, they had to practice the free run." The latter was also an inspiration for the famous on-foot chase scenes of <a href="http://en.wikipedia.org/wiki/Hong_Kong" title="Hong Kong">Hong Kong</a> stuntman, martial artist and actor <a href="http://en.wikipedia.org/wiki/Jackie_Chan" title="Jackie Chan">Jackie Chan</a>.<sup class="reference" id="cite_ref-10"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-10">[11]</a></sup> In Eastern martial arts such as <a href="http://en.wikipedia.org/wiki/Ninjutsu" title="Ninjutsu">Ninjutsu</a> and <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Qing_Gong" title="Qing Gong">Qing Gong</a>, movements similar to those of Parkour have been taught for centuries and with a similar aim. In <i>Jump London</i>, Foucan does acknowledge the influence of martial arts movies on the development of Parkour: "We also climbed onto the roof of our school. We pretended we were Ninja warriors".<br />
<div class="thumb tright">
<div class="thumbinner" style="width: 222px;">
<a class="image" href="http://en.wikipedia.org/wiki/File:Parkour_-_Passe_muraille_2.jpg"><img alt="" class="thumbimage" height="293" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Parkour_-_Passe_muraille_2.jpg/220px-Parkour_-_Passe_muraille_2.jpg" width="220" /></a> <br />
<div class="thumbcaption">
<div class="magnify">
<a class="internal" href="http://en.wikipedia.org/wiki/File:Parkour_-_Passe_muraille_2.jpg" title="Enlarge"><img alt="" height="11" src="http://bits.wikimedia.org/skins-1.17/common/images/magnify-clip.png" width="15" /></a></div>
A "traceur" performing a "<a href="http://en.wikipedia.org/wiki/Parkour#Basic_movements">passe muraille</a>"</div>
</div>
</div>
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=5" title="Edit section: Hébert's legacy">edit</a>]</span> <span class="mw-headline" id="H.C3.A9bert.27s_legacy">Hébert's legacy</span></h3>
<div class="rellink relarticle mainarticle">
Main article: <a href="http://en.wikipedia.org/wiki/Georges_H%C3%A9bert" title="Georges Hébert">Georges Hébert</a></div>
Before <a href="http://en.wikipedia.org/wiki/World_War_I" title="World War I">World War I</a>, former naval officer Georges Hébert travelled throughout the world. During a visit to Africa, he was impressed by the physical development and skills of indigenous tribes that he met:<sup class="reference" id="cite_ref-HerbertUFF_11-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-HerbertUFF-11">[12]</a></sup> He noted, "their bodies were splendid, flexible, nimble, skillful, enduring, and resistant but yet they had no other tutor in gymnastics but their lives in nature." <sup class="reference" id="cite_ref-HerbertUFF_11-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-HerbertUFF-11">[12]</a></sup><br />
On May 8, 1902, <a href="http://en.wikipedia.org/wiki/Saint-Pierre,_Martinique" title="Saint-Pierre, Martinique">Saint-Pierre, Martinique</a>, where Hébert was stationed, suffered from a volcanic eruption of <a href="http://en.wikipedia.org/wiki/Mount_Pel%C3%A9e" title="Mount Pelée">Mount Pelée</a>. Hébert coordinated the escape and rescue of some 700 people. This experience had a profound effect on him, and reinforced his belief that athletic skill must be combined with courage and altruism. He eventually developed this ethos into his motto "être fort pour être utile" (" be strong to be useful").<sup class="reference" id="cite_ref-HerbertUFF_11-2"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-HerbertUFF-11">[12]</a></sup> Inspired by indigenous tribes, Hébert became a physical education tutor at the college of <a href="http://en.wikipedia.org/wiki/Reims" title="Reims">Reims</a> in France. He began to define the principles of his own system of physical education and to create various apparatuses and exercises to teach his "méthode naturelle"<sup class="reference" id="cite_ref-HerbertUFF_11-3"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-HerbertUFF-11">[12]</a></sup> which he defined as: "Methodical, progressive and continuous action, from childhood to adulthood, that has as its objective: assuring integrated physical development; increasing organic resistances; emphasizing aptitudes across all genres of natural exercise and indispensable utilities (walking, running, jumping, quadrupedal movement, climbing, equilibrium (balancing), throwing, lifting, defending and swimming); developing one's energy and all other facets of action or virility such that all assets, both physical and virile, are mastered; one dominant moral idea: altruism."<sup class="reference" id="cite_ref-HebertINSEP_12-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-HebertINSEP-12">[13]</a></sup><br />
Hébert set up a "méthode naturelle" session consisting of ten fundamental groups: walking, running, jumping, quadrupedal movement, climbing, balancing, throwing, lifting, self-defense, swimming, which are part of three main forces:<sup class="reference" id="cite_ref-HebertINSEP_12-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-HebertINSEP-12">[13]</a></sup><br />
<ul>
<li>Energetic or virile sense: energy, willpower, courage, coolness, and firmness</li>
<li>Moral sense: benevolence, assistance, honor, and honesty</li>
<li>Physical sense: muscles and breath</li>
</ul>
During World War I and World War II, Hébert's teaching continued to expand, becoming the standard system of French military education and training. Thus, Hébert was one of the proponents of "parcours", an obstacle course, developed by a Swiss architect,<sup class="reference" id="cite_ref-No_Obstacles_13-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-No_Obstacles-13">[14]</a></sup> which is standard in the military training and led to the development of civilian <a href="http://en.wikipedia.org/wiki/Fitness_trail" title="Fitness trail">fitness trails</a> and confidence courses.<sup class="reference" id="cite_ref-HerbertUFF_11-4"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-HerbertUFF-11">[12]</a></sup> Also, French soldiers and firefighters developed their obstacle courses known as "parcours du combattant" and parcours SP".<sup class="reference" id="cite_ref-David_Belle_Bio_14-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-David_Belle_Bio-14">[15]</a></sup><br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=6" title="Edit section: Belle family">edit</a>]</span> <span class="mw-headline" id="Belle_family">Belle family</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width: 222px;">
<a class="image" href="http://en.wikipedia.org/wiki/File:David_Belle_NewYorker.jpg"><img alt="" class="thumbimage" height="269" src="http://upload.wikimedia.org/wikipedia/commons/thumb/a/ab/David_Belle_NewYorker.jpg/220px-David_Belle_NewYorker.jpg" width="220" /></a> <br />
<div class="thumbcaption">
<div class="magnify">
<a class="internal" href="http://en.wikipedia.org/wiki/File:David_Belle_NewYorker.jpg" title="Enlarge"><img alt="" height="11" src="http://bits.wikimedia.org/skins-1.17/common/images/magnify-clip.png" width="15" /></a></div>
<a href="http://en.wikipedia.org/wiki/David_Belle" title="David Belle">David Belle</a>, parkour founder, at The New Yorker Festival</div>
</div>
</div>
<div class="rellink relarticle mainarticle">
Main articles: <a href="http://en.wikipedia.org/wiki/Raymond_Belle" title="Raymond Belle">Raymond Belle</a> and <a href="http://en.wikipedia.org/wiki/David_Belle" title="David Belle">David Belle</a></div>
Raymond Belle was born in <a href="http://en.wikipedia.org/wiki/Vietnam" title="Vietnam">Vietnam</a>, at the time part of <a href="http://en.wikipedia.org/wiki/French_Indochina" title="French Indochina">French Indochina</a>. His father died during the <a href="http://en.wikipedia.org/wiki/First_Indochina_War" title="First Indochina War">First Indochina War</a> and Raymond was separated from his mother during the <a href="http://en.wikipedia.org/wiki/First_Indochina_War#Geneva_Conference_and_Partition" title="First Indochina War">division of Vietnam in 1954</a>. He was taken by the French Army in <a href="http://en.wikipedia.org/wiki/Da_Lat" title="Da Lat">Da Lat</a> and received a military education and training that shaped his character.<sup class="reference" id="cite_ref-Raymond_Belle_Bio_15-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-Raymond_Belle_Bio-15">[16]</a></sup> After the <a href="http://en.wikipedia.org/wiki/Battle_of_Dien_Bien_Phu" title="Battle of Dien Bien Phu">Battle of Dien Bien Phu</a>, Raymond was repatriated to France and completed his military education in 1958. At age 19, his dedication to fitness helped him serve in Paris's regiment of "<a class="mw-redirect" href="http://en.wikipedia.org/wiki/Sapeur-pompier" title="Sapeur-pompier">sapeurs-pompiers</a>" (the French fire service).<sup class="reference" id="cite_ref-Raymond_Belle_Bio_15-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-Raymond_Belle_Bio-15">[16]</a></sup><br />
David participated in activities such as martial arts and gymnastics and sought to apply his athletic prowess for some practical purpose. He trained extremely hard mostly to try to win the approval of his father (Raymond).<sup class="reference" id="cite_ref-David_Belle_Bio_14-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-David_Belle_Bio-14">[15]</a></sup> At age 17, David left school seeking freedom and action. He continued to develop his strength and dexterity in order to be useful in life, as Raymond had advised him.<sup class="reference" id="cite_ref-David_Belle_Bio_14-2"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-David_Belle_Bio-14">[15]</a></sup><br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=7" title="Edit section: Development in Lisses">edit</a>]</span> <span class="mw-headline" id="Development_in_Lisses">Development in Lisses</span></h3>
After moving to <a href="http://en.wikipedia.org/wiki/Lisses" title="Lisses">Lisses</a> commune, David Belle continued his journey with others who would later form the group the <a href="http://en.wikipedia.org/wiki/Yamakasi" title="Yamakasi">Yamakasi</a>.<sup class="reference" id="cite_ref-David_Belle_Bio_14-3"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-David_Belle_Bio-14">[15]</a></sup> <a href="http://en.wikipedia.org/wiki/S%C3%A9bastien_Foucan" title="Sébastien Foucan">Sébastien Foucan</a> noted in <i><a href="http://en.wikipedia.org/wiki/Jump_London" title="Jump London">Jump London</a></i> "From then on we developed and really the whole town was there for us; there for parkour. You just have to look, you just have to think, like children." This, as he describes, is "the vision of parkour."<br />
In 1997, Yann Hnautra, Charles Perriere, Chau Belle, David Belle, Laurent Piemontesi, Sébastien Foucan, Guylain Perriere, Malik Diouf and Williams Belle created the group Yamakasi,<sup class="reference" id="cite_ref-16"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-16">[17]</a></sup> whose name comes from the <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Lingala" title="Lingala">Lingala</a> language of <a href="http://en.wikipedia.org/wiki/Democratic_Republic_of_the_Congo" title="Democratic Republic of the Congo">Congo</a>, and means "strong spirit, strong body, strong man, endurance". After the musical show <i><a class="mw-redirect" href="http://en.wikipedia.org/wiki/Notre_Dame_de_Paris_%28musical%29" title="Notre Dame de Paris (musical)">Notre Dame de Paris</a></i>, Belle and Foucan split up due to money and disagreements over the definition of "l'art du déplacement",<sup class="reference" id="cite_ref-foucan_interview_17-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-foucan_interview-17">[18]</a></sup> The film <i><a href="http://en.wikipedia.org/wiki/Yamakasi_%28film%29" title="Yamakasi (film)">Yamakasi</a></i> (2001), and the French documentary <i>Génération Yamakasi</i> were created without Belle and Foucan.<sup class="Template-Fact" style="white-space: nowrap;">[<i><a href="http://en.wikipedia.org/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources from August 2011">citation needed</span></a></i>]</sup><br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=8" title="Edit section: Philosophy and theories">edit</a>]</span> <span class="mw-headline" id="Philosophy_and_theories">Philosophy and theories</span></h2>
According to Williams Belle, the philosophies and theories behind parkour are an integral aspect of the art, one that many non-practitioners have never been exposed to. Belle trains people because he wants "it to be alive" and for "people to use it".<sup class="reference" id="cite_ref-GYamakasi_2-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-GYamakasi-2">[3]</a></sup> Châu Belle explains it is a "type of freedom" or "kind of expression"; that parkour is "only a state of mind" rather than a set of actions, and that it is about overcoming and adapting to mental and emotional obstacles as well as physical barriers.<sup class="reference" id="cite_ref-GYamakasi_2-2"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-GYamakasi-2">[3]</a></sup><br />
A newer convention of parkour philosophy has been the idea of "human reclamation".<sup class="reference" id="cite_ref-two-theories_18-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-two-theories-18">[19]</a></sup> Andy (Animus of Parkour North America) clarifies it as "a means of reclaiming what it means to be a human being. It teaches us to move using the natural methods that we should have learned from infancy. It teaches us to touch the world and interact with it, instead of being sheltered by it."<sup class="reference" id="cite_ref-two-theories_18-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-two-theories-18">[19]</a></sup>"It is as much as a part of truly learning the physical art as well as being able to master the movements, it gives you the ability to overcome your fears and pains and reapply this to life as you must be able to control your mind in order to master the art of parkour."<sup class="reference" id="cite_ref-19"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-19">[20]</a></sup><br />
A point has been made about the similarities between the martial arts philosophy of <a href="http://en.wikipedia.org/wiki/Bruce_Lee" title="Bruce Lee">Bruce Lee</a> and Parkour.<sup class="reference" id="cite_ref-Bruce_Lee_and_the_Philosophy_of_Parkour_20-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-Bruce_Lee_and_the_Philosophy_of_Parkour-20">[21]</a></sup> In an interview with <i>The New Yorker</i>, David Belle acknowledges the influence of Lee's thinking: "There’s a quote by Bruce Lee that’s my motto: ‘There are no limits. There are plateaus, but you must not stay there, you must go beyond them. A man must constantly exceed his level.’ If you’re not better than you were the day before, then what are you doing—what’s the point?".<sup class="reference" id="cite_ref-21"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-21">[22]</a></sup><br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=9" title="Edit section: Non-rivalry">edit</a>]</span> <span class="mw-headline" id="Non-rivalry">Non-rivalry</span></h3>
A campaign was started on 1 May 2007 by Parkour.NET portal<sup class="reference" id="cite_ref-rivalry-free_22-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-rivalry-free-22">[23]</a></sup> to preserve parkour's philosophy against sport competition and rivalry.<sup class="reference" id="cite_ref-23"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-23">[24]</a></sup> In the words of Erwan LeCorre: "Competition pushes people to fight against others for the satisfaction of a crowd and/or the benefits of a few business people by changing its mindset. Parkour is unique and cannot be a competitive sport unless it ignores its altruistic core of self development. If parkour becomes a sport, it will be hard to seriously teach and spread parkour as a non-competitive activity. And a new sport will be spread that may be called parkour, but that won't hold its philosophical essence anymore."<sup class="reference" id="cite_ref-rivalry-free_22-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-rivalry-free-22">[23]</a></sup> According to LeCorre, those who truly practice Parkour have the same mind aspect of each other, therefore it brings people to work together rather than compete, it allows them to be united internationally and forget the social and economical problems which separated them globally, ultimately leading one giant community working and growing together.<br />
<h3>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=10" title="Edit section: Free running">edit</a>]</span> <span class="mw-headline" id="Free_running">Free running</span></h3>
<div class="rellink relarticle mainarticle">
Main article: <a href="http://en.wikipedia.org/wiki/Free_running" title="Free running">Free running</a></div>
<div class="thumb tright">
<div class="thumbinner" style="width: 222px;">
<a class="image" href="http://en.wikipedia.org/wiki/File:Parkour-MontrealPK-Oct02-2005094.jpg"><img alt="" class="thumbimage" height="165" src="http://upload.wikimedia.org/wikipedia/commons/thumb/2/24/Parkour-MontrealPK-Oct02-2005094.jpg/220px-Parkour-MontrealPK-Oct02-2005094.jpg" width="220" /></a> <br />
<div class="thumbcaption">
<div class="magnify">
<a class="internal" href="http://en.wikipedia.org/wiki/File:Parkour-MontrealPK-Oct02-2005094.jpg" title="Enlarge"><img alt="" height="11" src="http://bits.wikimedia.org/skins-1.17/common/images/magnify-clip.png" width="15" /></a></div>
A <a href="http://en.wikipedia.org/wiki/Parkour#Basic_movements">saut de bras</a></div>
</div>
</div>
Free running is a form of urban acrobatics in which participants, known as free runners, use the city and rural landscape to perform movements through its structures. The term free running was coined during the filming of <i><a href="http://en.wikipedia.org/wiki/Jump_London" title="Jump London">Jump London</a></i>, as a way to present parkour to the English-speaking world. Parkour's emphasis on efficiency distinguishes it from the similar practice of free running, which places more emphasis on freedom of movement and creativity.<br />
The man who coined the phrase, <a href="http://en.wikipedia.org/wiki/S%C3%A9bastien_Foucan" title="Sébastien Foucan">Sébastien Foucan</a>, defines free running as a discipline for self development, of following your own way<sup class="Template-Fact" style="white-space: nowrap;">[<i><a href="http://en.wikipedia.org/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources from August 2010">citation needed</span></a></i>]</sup>. His dissatisfaction with the limited creativity and self-expression in Parkour was the motivation for Sebastian Foucan to develop a similar but also very different art of movement that became known as free running.<sup class="reference" id="cite_ref-24"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-24">[25]</a></sup> He notes "Understand that this form of art has been created by few soldiers in Vietnam to escape or reach: and this is the spirit we'd like parkour to keep. You have to make the difference between what is useful and what is not in emergency situations. Then you'll know what is parkour and what is not. So if you do acrobatics things on the street with no other goal than showing off, please don't say it's parkour. Acrobatics existed a long time ago before parkour."<sup class="reference" id="cite_ref-PAWA-Welcome_5-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-PAWA-Welcome-5">[6]</a></sup><br />
When questions are raised between the differences of parkour and free running, the <a href="http://en.wikipedia.org/wiki/Yamakasi" title="Yamakasi">Yamakasi</a> group deny the differences and say: "parkour, l'art du deplacement, free running, the art of movement... they are all the same thing. They are all movement and they all came from the same place, the same nine guys originally. The only thing that differs is each individual's way of moving". <sup class="reference" id="cite_ref-25"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-25">[26]</a></sup><br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=11" title="Edit section: Military training">edit</a>]</span> <span class="mw-headline" id="Military_training">Military training</span></h2>
After the attention that parkour received following the film <i><a href="http://en.wikipedia.org/wiki/Casino_Royale_%282006_film%29" title="Casino Royale (2006 film)">Casino Royale</a></i>, militaries from different countries began looking for ways to incorporate parkour into <a class="mw-redirect" href="http://en.wikipedia.org/wiki/Military_training" title="Military training">training</a>. The British Royal Marines hired parkour athletes to train their members.<sup class="reference" id="cite_ref-26"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-26">[27]</a></sup> Colorado Parkour began a project to introduce parkour into the U.S. military<sup class="reference" id="cite_ref-27"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-27">[28]</a></sup> and parkour is slowly being introduced into the <a href="http://en.wikipedia.org/wiki/United_States_Marine_Corps" title="United States Marine Corps">United States Marine Corps</a>.<sup class="reference" id="cite_ref-28"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-28">[29]</a></sup><br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=12" title="Edit section: Criticism">edit</a>]</span> <span class="mw-headline" id="Criticism">Criticism</span></h2>
Parkour is not widely practiced in dedicated public facilities such as skateparks. Although efforts are being made to create places for it, most Traceurs do not like the idea as it is contradictory to the philosophy of freedom. <sup class="reference" id="cite_ref-29"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-29">[30]</a></sup> Traceurs practice parkour in urban areas such as gyms, parks, playgrounds, offices, and abandoned structures. Concerns have been raised regarding trespassing, damage of property,<sup class="reference" id="cite_ref-30"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-30">[31]</a></sup> and the practice in inappropriate places.<sup class="reference" id="cite_ref-31"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-31">[32]</a></sup> However, most traceurs will take care of their training spots and will remove themselves quickly and quietly from a public place if asked.<sup class="reference" id="cite_ref-32"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-32">[33]</a></sup><sup class="reference" id="cite_ref-33"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-33">[34]</a></sup> The Magpie Youth Centre free running club in <a href="http://en.wikipedia.org/wiki/Glen_Parva" title="Glen Parva">Glen Parva</a>, Leicester has raised 40,000 Euros to build a free running park/training utility on the park opposite the youth center.<br />
Concerns have been raised by law enforcement and fire and rescue teams of the risk in jumping off high buildings.<sup class="reference" id="cite_ref-34"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-34">[35]</a></sup> They argue that practitioners are needlessly risking damage to both themselves and rooftops by practicing at height, with police forces calling for practitioners to stay off the rooftops. <sup class="reference" id="cite_ref-BBCArr_35-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-BBCArr-35">[36]</a></sup><sup class="reference" id="cite_ref-ULGuardian_36-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-ULGuardian-36">[37]</a></sup><sup class="reference" id="cite_ref-37"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-37">[38]</a></sup> Some figures within the parkour community agree that this sort of behaviour is not to be encouraged.<sup class="reference" id="cite_ref-ULGuardian_36-1"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-ULGuardian-36">[37]</a></sup><sup class="reference" id="cite_ref-38"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-38">[39]</a></sup><sup class="reference" id="cite_ref-39"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-39">[40]</a></sup><sup class="reference" id="cite_ref-40"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-40">[41]</a></sup><br />
American traceur Mark Toorock says that injuries are rare "because participants rely not on what they can't control – wheels or the icy surfaces of snowboarding and skiing – but their own hands and feet," but Lanier Johnson, executive director of the <a href="http://en.wikipedia.org/wiki/American_Sports_Medicine_Institute" title="American Sports Medicine Institute">American Sports Medicine Institute</a>, notes that many of the injuries are not reported.<sup class="reference" id="cite_ref-41"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-41">[42]</a></sup> Even when injuries do occur, many members in the parkour community encourage pursuing the most scientifically sound method to recovery and future prevention. <sup class="reference" id="cite_ref-42"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-42">[43]</a></sup><br />
Comedian <a href="http://en.wikipedia.org/wiki/Daniel_Tosh" title="Daniel Tosh">Daniel Tosh</a> made fun of the discipline on one episode of his show, <a href="http://en.wikipedia.org/wiki/Tosh.0" title="Tosh.0">Tosh.0</a>, calling it "Nothing more than extreme walking."<br />
<h2>
<span class="editsection">[<a href="http://en.wikipedia.org/w/index.php?title=Parkour&action=edit&section=13" title="Edit section: Movements">edit</a>]</span> <span class="mw-headline" id="Movements">Movements</span></h2>
There are fewer pre-defined movements in parkour than in gymnastics, as there is no list of "moves". Each obstacle a traceur faces presents a unique challenge, committed Tracuers tend to shy away from defining movement. The ability to overcome the challenge depends on multiple factors, for example, on body type, speed, angle of approach, the physical make-up of the obstacle. Parkour is about training the body and mind to react to those obstacles appropriately with a technique that is effective. Often that technique cannot and need not be classified and given a name. In many cases effective parkour techniques depend on fast redistribution of body weight and the use of momentum to perform seemingly difficult or impossible body maneuvers at great speed. Absorption and redistribution of energy is also an important factor, such as <a href="http://en.wikipedia.org/wiki/Parachute_landing_fall" title="Parachute landing fall">body rolls</a> when landing which reduce impact forces on the legs and <a href="http://en.wikipedia.org/wiki/Vertebral_column" title="Vertebral column">spine</a>, allowing a traceur to jump from greater heights than those often considered sensible in other forms of acrobatics and gymnastics.<br />
According to David Belle, the practice is to move in such a way that will help you gain the most ground as if escaping or chasing something. Also, if you go from A to B, you need to be able to get back from B to A,<sup class="reference" id="cite_ref-Cali_meets_David_Belle_43-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-Cali_meets_David_Belle-43">[44]</a></sup> but not necessarily with the same movements or "passements". Despite this, there are many basic versatile and effective techniques that are emphasized for beginners. Most important are good jumping and landing techniques. The roll, used to limit impact after a drop and to carry one's momentum onward, is often stressed as the most important technique to learn.<br />
<br />
<br />
<h2>
<span class="mw-headline" id="Overview"> </span></h2>
<h3>
<span class="mw-headline" id="Basic_movements"><br />
</span></h3>
<h3>
<span class="mw-headline" id="Basic_movements"> </span></h3>
<h3>
<span class="mw-headline" id="Basic_movements"> </span></h3>
<h3>
<span class="mw-headline" id="Basic_movements"> </span></h3>
<h3>
<span class="mw-headline" id="Basic_movements">Basic movements</span></h3>
Some movements defined in parkour are:<sup class="reference" id="cite_ref-the-tree_44-0"><a href="http://en.wikipedia.org/wiki/Parkour#cite_note-the-tree-44">[45]</a></sup><br />
<table class="wikitable"><tbody>
<tr> <th colspan="3">Synonym</th> <th rowspan="2">Description</th> </tr>
<tr> <th>French</th> <th>French pronouncation</th> <th>English</th> </tr>
<tr> <td>Atterrissage</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[ateʁisaʒ]</span></td> <td>Landing</td> <td rowspan="2">Bending the knees when toes make contact with ground (never land flat footed; always land on toes and ball of your foot, or whole footed).</td> </tr>
<tr> <td>réception</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[ʁesɛpsjɔ̃]</span></td> </tr>
<tr> <td>Équilibre</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[ekilibʁ]</span></td> <td>Balance</td> <td>Walking along the crest of an obstacle; literally "balance."</td> </tr>
<tr> <td>Équilibre de chat</td> <td><br /></td> <td>Cat Crawl</td> <td>Quadrupedal movement along the crest of an obstacle.</td> </tr>
<tr> <td>Franchissement</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[fʁɑ̃ʃismɑ̃]</span>Z</td> <td>Underbar</td> <td>Jumping or swinging through a gap between obstacles; literally "to cross" or "to break through."</td> </tr>
<tr> <td rowspan="2">Lâché</td> <td rowspan="2"><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[laʃe]</span></td> <td>Lache</td> <td rowspan="2">Hanging drop; <i>lâcher</i> literally meaning "to let go." To hang or swing (on a bar, on a wall, on a branch) and let go, dropping to the ground or to hang from another object. This can refer to almost all hanging/swinging type movements.</td> </tr>
<tr> <td>swing</td> </tr>
<tr> <td>Passe muraille</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[pas myʁaj]</span></td> <td>Pop vault, wall hop, Wallpass, wallrun</td> <td>Overcoming a tall structure, usually by use of a step off the wall to transform forward momentum into upward momentum, then using the arms to climb onto and over the object.</td> </tr>
<tr> <td colspan="2"><br /></td> <td>Dyno (shortened from "Dynamic<sup class="noprint Inline-Template" style="white-space: nowrap;">[<i><a href="http://en.wikipedia.org/wiki/Wikipedia:Please_clarify" title="Wikipedia:Please clarify"><span title="The text in the vicinity of this tag needs clarification or removal of jargon from January 2011">clarification needed</span></a></i>]</sup>", opposite to "Static")</td> <td>This movement comes from climbing terminology, and encompasses leaping from a position similar to an armjump, then grabbing an obstacle usually higher than the initial starting place, often used for an overhang. This movement is used when a simpler movement is not possible.</td> </tr>
<tr> <td>Passement</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[pasmɑ̃]</span></td> <td><a href="http://en.wikipedia.org/wiki/Vault_%28parkour%29" title="Vault (parkour)">Vault</a>, Pass</td> <td>To move over an object with one's hand(s) on an object to ease the movement.</td> </tr>
<tr> <td rowspan="2">Demitour</td> <td rowspan="2"><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[dəmi tuʁ]</span></td> <td>Turn vault</td> <td rowspan="2">A vault or dropping movement involving a 180° turn; literally "half turn." This move is often used to place yourself hanging from an object in order to shorten a drop or prepare for a jump.</td> </tr>
<tr> <td>Turn Down</td> </tr>
<tr> <td>Passement</td> <td><br /></td> <td>Speed vault</td> <td>To overcome an obstacle by jumping side-ways first, then placing one hand on the obstacle to self-right your body and continue running.</td> </tr>
<tr> <td rowspan="2"><br /></td> <td rowspan="2"><br /></td> <td>Thief</td> <td rowspan="2">To overcome an obstacle by using a one-handed vault, then using the other hand at the end of the vault to push oneself forwards in order to finish the move.</td> </tr>
<tr> <td>Lazy vault</td> </tr>
<tr> <td>Saut de chat</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[sod ʃa]</span></td> <td>Cat pass/jump, (king) kong vault, monkey vault</td> <td>The <i>saut de chat</i> involves diving forward over an obstacle so that the body becomes horizontal, pushing off with the hands and tucking the legs, such that the body is brought back to a vertical position, ready to land.</td> </tr>
<tr> <td colspan="2">Passement assis</td> <td>Dash vault</td> <td>This vault involves using the hands to move oneself forwards at the end of the vault. One uses both hands to overcome an obstacle by jumping feet first over the obstacle and pushing off with the hands at the end. Visually, this might seem similar to the <i>saut de chat</i>, but reversed. Allegedly David Belle has questioned the effectiveness of this movement.</td> </tr>
<tr> <td colspan="2">Saut de chat inversé</td> <td>Reverse vault</td> <td>A vault involving a 180° rotation such that the traceur's back faces forward as they pass the obstacle. The purpose of the rotation is ease of technique in the case of otherwise awkward body position or loss of momentum prior to the vault.</td> </tr>
<tr> <td><br /></td> <td><br /></td> <td>Kash vault</td> <td>This vault is a combination of two vaults; the kong vault and the dash vault. After pushing off with the hands in a kong vault, the body continues past vertical over the object until the feet are leading the body. The kash vault is then finished by pushing off the object at the end, as in a dash vault.</td> </tr>
<tr> <td rowspan="2">Planche</td> <td rowspan="2"><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[plɑ̃ʃ]</span></td> <td><a href="http://en.wikipedia.org/wiki/Pull-up_%28exercise%29" title="Pull-up (exercise)">Muscle-up</a></td> <td rowspan="2">To get from a hanging position (wall, rail, branch, arm jump, etc.) into a position where your upper body is above the obstacle, supported by the arms. This then allows for you to climb up onto the obstacle and continue.</td> </tr>
<tr> <td>climb-up</td> </tr>
<tr> <td>Roulade</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[ʁulad]</span></td> <td>Roll</td> <td>A forward roll where the hands, arms and diagonal of the back contact the ground, often called breakfall. Used primarily to transfer the momentum/energy from jumps and to minimize impact, preventing a painful landing. It is similar to the basic kaiten or <a href="http://en.wikipedia.org/wiki/Uke_%28martial_arts%29" title="Uke (martial arts)">ukemi</a> and it was taken from martial arts such as <a href="http://en.wikipedia.org/wiki/Judo" title="Judo">judo</a>, <a href="http://en.wikipedia.org/wiki/Ninjutsu" title="Ninjutsu">ninjutsu</a>, <a href="http://en.wikipedia.org/wiki/Jujutsu" title="Jujutsu">jujutsu</a>, <a href="http://en.wikipedia.org/wiki/Hapkido" title="Hapkido">hapkido</a> and <a href="http://en.wikipedia.org/wiki/Aikido" title="Aikido">aikido</a>.</td> </tr>
<tr> <td rowspan="3">Saut de bras</td> <td rowspan="3"><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[sodbra]</span></td> <td>Arm jump</td> <td rowspan="3">To land on the side of an obstacle in a hanging/crouched position, the hands gripping the top edge, holding the body, ready to perform a muscle up.</td> </tr>
<tr> <td>cat leap</td> </tr>
<tr> <td>cat grab</td> </tr>
<tr> <td>Saut de fond</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[sodfɔ̃]</span></td> <td>Drop</td> <td>Literally 'jump to the ground' / 'jump to the floor'. To jump down, or drop down from something.</td> </tr>
<tr> <td>Saut de détente</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[sodə detɑ̃t]</span></td> <td>Gap jump, running jump</td> <td>To jump from one place/object to another, over a gap/distance. This technique is most often followed with a roll.</td> </tr>
<tr> <td>Saut de précision</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[so d presiziɔ̃]</span></td> <td rowspan="2">Precision</td> <td rowspan="2">Static or moving jump from one object to a precise spot on another object. This term can refer to any form of jumping however. Often abbreviated to "pre"</td> </tr>
<tr> <td>précision</td> <td><span class="IPA" title="Representation in the International Phonetic Alphabet (IPA)">[presiziɔ̃]</span></td> </tr>
<tr> <td rowspan="2">Saut de mur</td> <td rowspan="2"><br /></td> <td>Wall Jump</td> <td rowspan="2">To step off a wall in order to overcome another obstacle or gain height to grab something</td> </tr>
<tr> <td>Tic-Tac</td> </tr>
<tr> <td rowspan="2">Saut de rotation</td> <td rowspan="2"><br /></td> <td>Rotary jump</td> <td rowspan="2">Similar to a kong vault, the person dives and then rotates their lower body around the obstacle. Used for shorter to medium obstacles. For people that have trouble with kong vaults.</td> </tr>
<tr> <td>Rotary vault</td> </tr>
<tr> <td><br /></td> <td><br /></td> <td>Side vault</td> <td>A vault where the person is parallel to the obstacle and places one hand on the obstacle. When performing the vault, the person's back should be facing down.</td></tr>
</tbody></table>
</div>
Koushik physiohttp://www.blogger.com/profile/14387394000470631062noreply@blogger.com0